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ABSTRACT 
Background:  Cardiovascular disease (CVD) remains among the leading causes of death 
in the United States despite widespread knowledge about risk factors as well as effective 
primary prevention strategies. Risk perception is a complex phenomenon that plays an 
important role in how persons view disease and ultimately how they make health 
behavior choices. This study is supported by the knowledge that few studies have 
examined how persons perceive cardiovascular risk or the variables thought to contribute 
to the formation of risk perception.    
Purpose:  The purpose of this study was to examine how accurately persons perceive 
personal risk for cardiovascular disease and identify variables that contribute to the 
formation of risk perception.  
Methods:  This study used a cross-sectional descriptive correlational design with adults 
 at least forty years old and without known cardiovascular disease. The nonprobability  
convenience sample was recruited at health screenings held at multiple locations within a  
single hospital system in Northwest Indiana. One hundred thirteen participants who could  
read, write, and speak English completed the study booklet containing a compendium of 
questions regarding knowledge and awareness of CVD from the American Heart 
Association, as well as established tools to measure the key variables: the Cardiovascular  
Risk Individual Perception instrument (CRIP) measuring risk perception, the Revised  
Life Orientation Test (LOT-r) measuring optimism, the Life Engagement Test (LET) 
measuring life satisfaction, and the Patient Health Questionnaire (PHQ-8) measuring 
xvi 
 
depression. Participants also consented to share physiological measurements and 
laboratory results from the community screening program. Actual cardiovascular risk was 
calculated using two tools: the Heart Health Scale (HHS; Wellsource screening tool) that 
provides information on “current risk”, and the Framingham Risk Score (FRS) that 
“projects one’s 10-year risk” for a cardiac event.  The study was approved by the 
institutional review boards from Loyola University Chicago, the hospital where the 
screenings were held and the university where the investigator is on faculty.  
Results:  Study participants had a mean age of 58 years, 69% were female, 70% were 
White Caucasian (non-Hispanic), and the majority were married, well-educated, 
employed, and had private insurance. Overall the sample recognized heart disease as the 
leading cause of death for men and women and could identify the key prevention steps to 
reduce personal risk. While physiological measurements obtained during the screenings 
revealed a relatively healthy group, with the majority of participants at goal for glucose, 
LDL-C, HDL-C and triglyceride levels, the majority were also found to be either 
overweight or obese, and physically inactive.  Overall, 80% had two or more self-
reported risk factors, and 43% had three or more. 
Participants did accurately perceive their personal risk, with the 
prevalence/number of self-reported risk factors  being significantly correlated with higher 
levels of risk perception as measured by the CRIP (r=.44, p < .01). HHS scores showed 
that more than 55% of the participants were categorized as either “Needs Improving” or 
“High Risk”, indicating the presence of multiple risk factors. HHS scores were also 
statistically correlated with risk perception (r=-.40, p < .01). In addition, chi square 
analysis showed a significant relationship between increased risk (using HHS) and 
xvii 
 
increased risk perception scores (using CRIP). Framingham Risk Scores, a measure of 
projected future cardiac risk, were not correlated with current risk perception. 
The majority of the sample had increased levels of optimism and life satisfaction 
and low levels of depression.  While three variables (having a friend with CVD, 
optimism, and depression) were correlated with risk perception, depression was found to 
be the single predictor when entered into multiple regression analysis (β = .278, p = 
.003).  
Implications for Providers:  Community based health screenings play an important role 
in primary prevention strategies. Although persons may accurately recognize that they 
have risk factors for CVD, this alone may not be enough to prompt positive health 
behavior changes. Persons often need further counseling to understand the role risk 
factors play in subsequent subclinical atherosclerosis. While mass media campaigns 
related to healthy eating, exercise, and heart disease have increased health literacy in this 
area, health care providers need to be part of this dialogue since they are uniquely 
positioned to counsel patients on effective methods for promoting positive health 
behaviors. 
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CHAPTER ONE 
INTRODUCTION 
 Although much is known about cardiovascular risk factors and the subsequent 
development of related co-morbid conditions, the United States and much of the world 
continue to face cardiovascular disease (CVD) as the number one killer among the adult 
population (American Heart Association [AHA], 2013). Risk factor modification is 
crucial in reducing the development of CVD. The way an individual views risk has an 
impact on decision-making and ultimately health behavior choices. Thus risk perception 
plays an important role in primary prevention strategies. This study describes the 
phenomena of risk perception and its related concepts and proposed  relationships 
between them. This introductory chapter provides support for the need for this study 
through an overview of the problem of CVD, how primary prevention efforts can reduce 
CVD, and the importance of risk perception in the design of intervention strategies. The 
chapter ends with a description of the research questions for this study and their 
significance. 
Overview of the Problem of CVD 
 CVD encompasses coronary heart disease (CHD), peripheral vascular disease 
(PVD), stroke, and heart failure (HF). It is estimated that one in every three adults has 
some form of cardiovascular disease. Furthermore, 600,000 people die annually from 
heart disease alone accounting for one in every four deaths in the United States (Centers 
for Disease Control [CDC], 2013). These statistics are expected to increase as the 
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population ages in the United States (AHA, 2013). Consequently, CVD will continue to 
threaten lives and, in addition, have a great economic impact. 
The economic burden of CVD is astounding. As cited in the 2013 update from the 
AHA, the annual projected estimated direct and indirect costs of CVD in the United 
States is $312.6 billion. Direct costs are defined in terms of financial cost of 
hospitalization and treatment, while indirect costs are defined in terms of healthcare visits 
and lost productivity. However, using a methodology to project future cost of care, it is 
estimated that by 2030, 40.8% of the US population will have some form of CVD with 
predicted costs topping $818 billion annually (AHA, 2013). Therefore, the importance of 
CVD prevention is paramount because it not only reduces morbidity and mortality, but 
also the associated economic burden.  
Primary Prevention 
 There is overwhelming evidence to confirm that both modifiable and non-
modifiable risk factors contribute to the development of CVD. Therefore, risk factor 
modification is crucial in reducing the development of CVD. The CDC and the National 
Heart, Lung, and Blood Institute (NHLBI) have recognized that more emphasis needs to 
be placed on primary prevention strategies in an effort to impact this growing problem 
and reverse the “epidemic” of heart disease. “Primary prevention pertains to the 
prevention of the onset of symptomatic disease in persons without prior symptoms of 
cardiovascular disease” (Wilson & Pearson, 2005, p. 494). One example of primary 
prevention in cardiovascular disease is to treat hypertension through lifestyle changes or 
medications. Primary prevention interventions that target individuals at increased risk 
have been proven successful in reducing the incidence of CVD and in decreasing 
3 
morbidity and mortality (AHA, 2013; Bacon, Sherwood, Hindliter, & Blumenthal, 2004; 
CDC, 2008; Crichley & Capewell, 2003; Warburton, Nicol, & Bredin, 2006; Wilson & 
Pearson, 2005).  Not only does risk factor reduction reduce atherogenesis through 
endothelial stabilization, but it also prevents/addresses CVD and other co-morbid 
conditions such as hypertension and obesity. 
The AHA has emphasized that those adults who maintain healthy lifestyles and do 
not present with traditional risk factors for CVD by approximately 50 years of age have a 
greater likelihood of sustaining longevity (AHA, 2013). While many states fund primary 
prevention programs, this author’s home state of Indiana remains an unfunded state, 
despite ranking among the highest for total CVD and coronary heart disease (CHD). In 
fact, Indiana is one of 12 states which has a multiple risk factor prevalence of greater than 
40% (AHA, 2013). However, primary prevention cannot occur unless there is awareness 
regarding the presence of risk factors and counseling on ways to address these risks.   
Risk Perception 
 Even though knowledge and awareness about risk factors and CVD is crucial in 
addressing its development, it is not enough. Examining areas that impact how 
individuals view risk for the development of CVD and ultimately make decisions 
regarding health behavior choices is crucial. In order to be effective, interventions will 
need to be tailored to individual health beliefs and perception of risk for CVD 
development. Thus, an underlying challenge for healthcare providers is to examine 
individual risk perception for cardiovascular disease.  
 Risk perception implies that risk is perceived, not assigned or calculated. It 
surrounds an individual on a daily basis; however, these risks all vary in degree. For 
4 
example, risks related to which product to purchase is, overall, less threatening than risk 
related to a health threat. The way in which an individual views risk has an impact on 
decision-making and ultimately health behavior choices. Risk perception plays an 
important role in primary prevention strategies. It is through cognitive realization that an 
individual recognizes the threat of risk to their well-being. Once an individual realizes the 
threat to well-being, prevention strategies can be utilized to foster health behavior choices 
and ultimately prevent the onset of the threat.  
 Risk perception is not a new concept in the field of behavioral science. In fact, its 
roots stretch back as far as the late 1970s. It has been studied in topics such as 
environmental risk and consumer purchasing to examine why and how individuals form 
perceptions related to risk. More recently, healthcare researchers have investigated risk 
perception. 
 A large challenge to addressing individual risk perception is identifying how 
perception is formed. In fact, risk perception is a multifaceted concept comprised of 
overlapping concepts.  Initially, risk perception was identified in the cancer literature, but 
was actually being measured and reported as optimism and optimistic bias (Katapodi, 
Lee, Facione, & Dodd, 2004). These areas have overlap both conceptually and 
contextually. Therefore, the concepts of optimism and optimistic bias need to be explored 
as they relate to risk perception. Although optimism and optimistic bias have been 
studied in disease processes such as arthritis progression and breast, colon and skin 
cancers, they have not been studied in depth in cardiovascular disease. In addition, the 
concept of “negative emotions”, specifically depression, has emerged as yet another link 
to risk perception and health behaviors. It has been purported that the opposite of 
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 optimism may not be pessimism, but actually depression. Lastly, the concept of life 
purpose has been associated with risk perception. Thus, risk perception needs to be 
viewed as a complex phenomenon with attention to how all these concepts contribute to 
an individual’s risk perception. In doing so, new intervention strategies can be tailored to 
increase health behavior choices that will ultimately affect morbidity and mortality 
related to CVD development. 
Significance/Research Questions 
 This study examines the concept of risk perception in cardiovascular disease. The 
primary aims are to: examine the accuracy of one’s perceived risk for CVD; and to 
examine the relationship between perceived risk and key demographic and psychological 
variables that may influence risk perception. Therefore, this study is framed by the 
following research questions: 
1. Do persons perceive their risk for cardiovascular disease accurately?  
2. Do the psychological variables of optimism, life purpose, and depressive symptoms 
predict risk perception?  
3. Do the sociodemographic variables (age, gender, family history, personal knowledge, 
level of education, and socioeconomic status) predict risk perception? By 
examining risk perception and the associated terms of optimism, life purpose, 
optimistic bias, and negative emotions, it is this researcher’s hope that there will 
be a greater understanding of the variables affecting health behavior 
choices. Through this understanding, nurses can address more meaningful and 
effective ways to assist persons to incorporate primary prevention strategies that 
will impact and maintain optimal health. 
CHAPTER TWO 
LITERATURE REVIEW 
 There is little dispute that CVD causes both personal and social burden. Chapter 
one explained how morbidity, mortality and economics are all affected by the epidemic 
of CVD. Furthermore, a brief discussion of prevention highlighted the need to understand 
the concept of risk perception and the related psychological variables of optimism, life 
purpose, and depressive symptoms (or so called “negative emotions”). Before exploring 
the literature on risk perception and its related variables, this chapter will begin with a 
brief overview of the pathogenesis of atherosclerosis leading to CVD. Known risk factors 
that contribute to atherosclerosis and CVD will be reviewed, including: smoking, obesity, 
sedentary lifestyle, dyslipidemia, and hypertension. Benefits of reducing these risk 
factors will be highlighted. Measurements for predicting an individual’s personal risk for 
a future cardiac event will be discussed. Finally, the concept of risk perception will be 
explored in depth, since successful risk factors reduction cannot occur unless individuals 
are aware of their personal CVD risk. 
  Atherogenesis 
The Endothelium 
 The relationship between endothelial dysfunction and cardiovascular events has 
been clearly established, with endothelial dysfunction found to be an independent 
predictor of future cardiac events (Gokce et al., 2002; Halcox, et al., 2002; Perticone et  
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al., 2001). The function of the endothelium is complex as it acts to maintain both 
homeostasis and hemostasis within the vascular bed (Corti, Fuster, & Badimon, 2003; 
Davignon & Ganz, 2004; Halcox et al., 2002). The healthy endothelium exhibits 
atheroprotective properties that include promotion of vasodilation; anti-inflammatory, 
anticoagulant, and profibrinolytic effects, while inhibiting leukocyte adhesion and 
migration, smooth muscle cell proliferation and migration, and platelet aggregation and 
adhesion (Bonetti, Lerman, & Lerman 2003).  Conversely, when these properties are 
disrupted and the endothelium becomes less stable, atherogenic manifestations take place. 
Plaque Formation 
 Atherogenesis is an immune/inflammatory response that develops as a complex, 
cascading process (Glass & Witzum, 2001). The evolution of atherosclerotic lesions 
progess through a multi-step process including: endothelial injury, monocyte migration, 
lipid accumulation, smooth muscle cell proliferation and cap formation, lipid core 
formation, plaque vascularization, plaque remodeling, and plaque progression (Gotto & 
Pownall, 2003). This can be further broken down into the following three distinct stages: 
the fatty streak, the fibrous plaque, and plaque progression.  
 The fatty streak is characterized by the accumulation of intercellular lipids and 
foam cells within the intimal lining of the artery and is the hallmark of both early and late 
developing atherosclerotic lesions (Glass & Witzum, 2001). The formation of the fatty 
streak is initiated by impairment of the endothelium leading to inflammation within the 
vessel wall. Cardiovascular risk factors such as dyslipidemia, hypertension, and smoking 
contribute to the inflammatory process and oxidative stress (Ross, 1999; Schlächinger & 
Zeiher, 2002). The resultant oxidative process allows monocyte-derived macrophages to 
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invade the intimal lining of the artery.  Monocytes are present in all phases of 
atherogenesis (Ross, 1999; Schlächinger & Zeiher, 2002). Cellular mediators of the 
inflammatory process play a key role in the low density lipoprotein cholesterol (LDL-C) 
particles binding to the endothelium. Once there, circulating LDL-C particles become 
engulfed by the macrophages and transform into foam cells, which contain liquid 
cholesterol esters (Ross, 1999). This process contributes to more inflammation and a 
vicious cycle ensues, as long as the LDL particles are present. 
 The fibrous plaque is characterized by smooth muscle cell migration from the 
medial to the intimal layer of the endothelium (Ross, 1999). Platelets and macrophages 
stimulate the proliferation of smooth muscle cells and allow a fibrous matrix to form. The 
core beneath the cap contains degenerating foam cells, which are full of lipids and 
cholesterol esters. 
Plaque progression leads to the increase in size and density of the lesion as the 
inflammatory process progresses. The progressive stage of the process allows the lesions 
to encroach into the lumen of the vessel, compromising blood flow (Ross, 1999). It is at 
this point that the plaque will calcify or rupture, depending on the morphology of the 
particular lesion.  
The formation and morphology of plaque plays a significant role in the diagnosis 
and treatment of cardiovascular disease. Plaque can be categorized as stable or unstable. 
Stable plaque is morphologically different from unstable plaque. The formation of the 
fibrous plaque and the size of the lipid core are directly related to endothelium function 
and dysfunction. 
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Stable plaque develops a thick, uniform fibrous cap, which is less likely to rupture 
(Ross, 1999). Over time, calcification of the lesions develops and encroachment of the 
vessel lumen occurs.  Conversely, unstable plaque is described as more prone to rupture 
due to a thinner, uneven fibrous cap and larger lipid core (Fayad & Fuster, 2001; Ross, 
1999). As the lesion grows, the vessel lumen may also narrow.  The continuation of 
oxidative stress and inflammation, the same processes that contribute to the cascade of 
endothelial dysfunction, also contribute to plaque destabilization and fibrous cap thinning 
(Ross, 1999; Schlächinger & Zeiher, 2002). Unstable plaque has been linked to acute 
coronary syndrome (ACS), unstable angina, acute myocardial infarctions, and sudden 
cardiac death (SCD).  
Risk Factors 
 The development of coronary artery disease (CAD) has long been linked to 
known risk factors, thus identification of one’s risk factors is key to stemming this tide. 
Large national and international studies have consistently reported that nine potentially 
modifiable risk factors account for greater than 90% of the risk of an acute myocardial 
infarction (MI) (Yusuf et al., 2004). Moreoever, it is estimated that more than 90% of 
CVD events occur in persons with a single risk factor (Vasan et al., 2005). Each risk 
factor contributes to the complex dynamic of endothelial function and dysfunction and 
the subsequent development of CAD (Bonetti et al.; 2003; Corti et al., 2003; Lerman & 
Zeiher, 2005; Ross, 1999). Risk factor reduction has been shown to reduce the incidence 
of cardiovascular disease and is clearly supported by literature. Risk factor reduction 
strategies have confirmed increased stabilization of the endothelium as well as decreased 
morbidity and mortality from cardiovascular disease. Risk factor reduction is significant 
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because many strategies impact more than one risk factor. For example, implementing a 
walking program not only addresses the risk of physical inactivity, but also affects weight 
and obesity. Likewise, smoking cessation would impact the negative effects of smoking 
in addition to high density lipoprotein cholesterol (HDL-C) levels. For the purposes of 
this paper, smoking, obesity, sedentary lifestyle, dyslipidemia, hypertension, and 
depression are discussed related to both endothelial dysfunction and the subsequent 
impact of risk factor modification. 
Smoking 
 While smoking is commonly discussed as the leading cause of lung cancer, it also 
greatly affects the number of deaths related to cardiovascular disease. Globally, smoking 
causes 5 million deaths annually and is expected to climb to at least 8 million by 2030 
(CDC, 2013). Furthermore, smoking triples the risk of dying from heart disease among 
middle-aged men and women and, on average, men die 13 years sooner and women die 
14.5 years sooner than their non-smoking counterparts (AHA, 2013). Both active and 
passive (second-hand) smoking contributes to atherogenesis. In addition, smoking 
contributes to physiologic conditions such as hypertension and decreases high density 
lipoprotein (HDL) cholesterol (AHA, 2013). Furthermore, when smoking is combined 
with other risk factors the synergistic effect substantially raises the risk for CVD.  
 Roth and Shick (1958) described the effects of smoking on the cardiovascular 
system, stating that early investigation of smoking and cardiovascular damage dates back 
to 1848. Since that time, scientists have continued to study and document the deleterious 
effects of smoking on the human body.  Early descriptions of “heart dysfunction” have 
more recently been replaced with scientific knowledge that smoking adversely affects 
11 
vascular endothelial function, which leading to cardiovascular disease (Newby et al., 
2001; Ross, 1999; U.S. Department of Health and Human Services, 2004). Smoking 
disrupts endothelial homeostasis and hemostasis leading to atherothrombosis (Newby et 
al., 2001). In addition, smoking is not only associated with CAD, but also with sudden  
cardiac death (SCD). The incidence for SCD is related to impaired hemostasis, 
endothelial dysfunction, and atherothrombosis (Newby et al., 2001). 
 Crichley and Capewell (2003) conducted a systematic review to determine the 
effects of smoking cessation on cardiovascular risk. A total of 20 prospective cohort 
studies were used from a screening of 665 publications. The authors included studies that 
reported all-cause mortality data, patients diagnosed with CHD, and those with a follow-
up of at least two years. Conclusions from this review state that smoking cessation is 
correlated with a substantial decrease in all-cause mortality among persons with CHD. 
The World Health Organization (WHO) reported a dramatic 50% reduction in CHD risk 
one year after quitting smoking. In addition, smoking cessation decreases the risk of 
dying prematurely (CDC, 2013). 
Obesity 
Obesity is a complex risk factor for CAD. Although it is an independent CVD risk 
factor, it is also closely related to other risk factors such as physical inactivity, 
hypertension, lipid abnormalities, elevated C-reactive protein (CRP) and insulin 
resistance.  Since 1993, the prevalence of obesity has steadily increased and forecasts that 
by 2030 more than 51% of the population will be obese (AHA, 2013). Public health 
officials have recognized the detriments on health related to obesity and have stated that 
the continuation of current trends may negate gains made in treatment of heart disease 
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and other chronic diseases (Fontaine, Redden, Wang, Westfall, & Allison, 2003). 
Furthermore, obesity is associated with a shortened lifespan, especially among younger 
adults (Fontaine et al., 2003). 
Obesity is associated with increased coagulopathy, endothelial dysfunction and 
inflammation. Moreoever, there are many metabolic effects that are derived from adipose 
tissue that can mediate the development of atherosclerosis: secretion of tumor necrosing 
factor-alpha (TNF-α), interluken 6, and plasminogin activator inhibitor. Abdominal 
adiposity carries a higher risk than general adiposity (Warziski, Choo, Novak, & Burke, 
2008).  
The contribution of general obesity to atherosclerosis has been debated. While the 
Seven Countries Study showed little correlation between body weight and 
atherosclerosis, both the Framingham Heart Study and the Pathobiological Determinants 
of Atherosclerosis in Youth (PDAY) Study demonstrated a clear association between 
obesity and atherosclerosis (Grundy, 2002). Grundy proposed that variability among 
groups may help to explain the differences. For example, the PDAY study found that 
obesity was associated with atherosclerosis in adolescent and young men, but not in their 
female counterparts (McGill et al., 2002). Similarly, McKeigue and colleagues (1993) 
found that moderate weight gain increased the risk for CHD in South Asians. Further 
explanation may lie within the endothelial dysfunction mechanisms specific to obesity. 
Grundy (2002) suggested that obesity acts as a mediator through emerging risk factors 
including insulin resistance, C-reactive protein, and plasminogen activator inhibitor-1. 
Therefore it may be a stronger and more complex risk factor than originally thought. 
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Hotamisligil, Shargill, and Spiegelman (1993) were among the first to establish the 
link between obesity and factors affecting endothelial dysfunction, namely tissue necrosis 
factor-alpha (TNF-α). They used rodent models to identify how obese animals differed 
from the lean control models. At this time, TNF-α was already known to affect serum 
triglycerides and very low density lipoproteins (VLDLs). The results of their study 
indicated that the obese animals produced a minimum of five to ten times the amount of 
TNF-α mRNA than the lean control animals. Since this landmark study, the relationship 
between obesity and endothelial dysfunction continues to be supported and informed 
(Dandona, Aljada, Chaudhuri, Mohanty, & Garg, 2005; Rutter, Meigs, Sullivan, 
D’Agostino, & Wilson, 2004; Ziccardi, et al., 2002). 
Since obesity contributes to other traditional risk factors, such as hypertension, 
hyperlipidemia, and increased glucose values, weight loss also has a dramatic effect on 
these variables. Anderson, Konz, Frederich, and Wood (2001) conducted a meta-analysis 
of eleven studies and concluded that the effect of weight loss systematically modifies risk 
factors for CHD, thereby reducing overall risk from CHD. While modification of this 
factor has the potential to greatly impact overall cardiovascular risk, the high rate of 
recidivism with weight loss programs poses a significant challenge.  
Sedentary Lifestyle 
 Sedentary lifestyle has been identified as a cardiovascular risk factor since the 
1970s. It is closely related to the risk factors of obesity and hypertension. In addition, 
sedentary lifestyle has an impact on the lipid profile, especially high density lipoprotein 
cholesterol (HDL-C). Given these factors, physical inactivity, like obesity, has the 
potential to not only impact these related risk factors, but overall cardiovascular risk. 
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Trends have shown that with the advances in modern technology and changes in 
transportation modes American have adopted a more sedentary lifestyle. Most American 
adults are not physically active on a regular basis. In fact, more than 50% of adults in the 
United States do not engage in enough physical activity to gain any health benefits 
(CDC). This resultant lack of physical activity is associated with an increased risk for 
CVD and all-cause mortality (Blair & Church, 2004).  
 While there is an established relationship between sedentary lifestyle and 
cardiovascular health, exact pathways and mediating mechanisms continue to be explored 
(Mora, Cook, Buring, Ridker, & Lee, 2007). Novel risk factors such as homocysteine, 
creatinine, C-reactive protein (CRP), and other inflammatory biomarkers are examples of 
potential mediating mechanisms that may explain the role sedentary lifestyle plays in 
reducing CVD.   
 Physical activity is related to increased health benefits. Not only can enough 
physical activity help to achieve or maintain a healthy weight, but it can also help lower 
blood pressure, triglycerides, insulin resistance and glucose intolerance, and enhance 
HDL cholesterol levels (CDC, 2008). At the cellular level, increased physical activity has 
an antioxidant effect, thereby stabilizing the endothelium (Harrison et al., 2006). Harrison 
and colleagues (2006) reported that increased blood flow, produced by increased activity, 
within the vasculature provides laminar shear stress. In turn, nitric oxide production 
increases which results in decreased inflammation in the endothelium. Chronic or 
habitual physical activity, therefore, provides a lasting and protective effect on the 
endothelium. 
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 The level of physical activity needed to provide health benefits is referred to as dose 
response. This is important because many people have limitations that allow for only low 
to moderate levels of physical activity. The level of physical activity does not need to be 
strenuous or intense to provide health benefits (Church, Earnest, Skinner, & Blair, 2007).  
Current recommendations suggest adults need to accumulate 150 minutes per week of 
moderate level aerobic exercise such as walking, bicycle riding, water aerobics, or 
playing doubles tennis. This prescription can be completed in 10 minute intervals if 
preferred (CDC, 2013).  
Dyslipidemia 
 The traditional components of the lipid profile have been studied at length. Low 
density lipoprotein cholesterol (LDL-C) has been shown to contribute to plaque 
development, while high density lipoprotein cholesterol (HDL-C) has been shown to be 
atheroprotective. Research data has consistently shown through major trials such as The 
Helsinki Heart Study, Multiple Risk Factor Intervention Trial (MRFIT), and the Seven 
Countries Study that when these components are maintained at recommended levels, the 
endothelium remains healthier and poses less risk for the development of CVD and CVD 
related mortality. More recently, focus has shifted to more specific subcomponents of the 
lipid profile, such as apolipoprotein subgroups. However, since the focus of this paper is 
to provide an overview of risk factors, only the traditional components will be discussed.  
 LDL-C plays a significant role in the development of atherogenesis via the 
oxidative process. Oxidation of LDL particles stimulates the release of a host of negative 
factors such as interleukin-6 and tumor necrosis factor-alpha from the endothelial cells 
and macrophages. This contributes to stimulating the inflammatory process, causing 
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further endothelial dysfunction. In addition, LDL-C contributes to direct injury of the 
endothelial lining and underlying vascular smooth muscle (Ross, 1999; Vogel, 1999). 
Very low density lipoprotein cholesterol (VLDL) also contributes to oxidation and 
inflammation within the endothelium (Libby, Ridker, & Masseri, 2002).  
 A large body of studies from epidemiological, angiographic outcomes trials, and 
randomized controlled trials consistently support the evidence that lowering LDL 
cholesterol has a positive effect on CVD prevention. This evidence served as the basis for 
The National Cholesterol Education Program (NCEP) first issued in 1985. This program 
and the two subsequent panels provide clear directives and strategies for reaching 
primary prevention goals. Strategies for improving the lipid profile include lifestyle or 
behavioral changes and medication therapy (ATP III, 2004). NCEP refers to the non-
pharmacologic measures as Therapeutic Lifestyle Changes (TLC). The TLC diet consists 
of limiting total fat intake to 25-35% of diet (with up to 20% of this from 
monounsaturated fat), saturated fat to less than 7% of total calories, 20-30 grams of high 
fiber foods, increased levels of fruits and vegetables and addition, of plant sterols. This 
diet is supported by the American Heart Association to decrease the risk of CVD (AHA, 
2013). For primary prevention, this diet should be monitored for six weeks, and if not at 
goal, another six week trial should be prescribed. After those efforts, pharmacological 
therapy is recommended to treat any persistent dyslipidemia. Medications  that lower 
both LDL-C and total cholesterol while increasing HDL-C have consistently shown 
reduction in mortality related to CVD. In particular HMG CoA reductase inhibitors, or 
statins reduce endothelial inflammation through decreased oxidative stress (Libby et al., 
2002; Vogel, 1999).  
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  Hypertension   
Approximately 77.9 million Americans over the age of 20 have high blood pressure  
(AHA, 2013). This startling statistic translates to slightly more than one in every three 
adults. While the etiology for the majority of hypertension is unknown, the disease can be 
easily identified through screening and treated in a variety of ways. Hypertension is not 
only one of the major risk factors for CVD, but is also a co-morbid condition with serious 
health consequences. Hypertension has been studied in many epidemiological studies 
such as the Framingham Heart Study, followed by an extensive number of randomized 
control trials that showed that antihypertensive drug therapy works to reduce the risk of 
CVD events.   
         Hypertension causes vascular damage including impaired endothelium-dependent 
vasodilation, decreased production of nitric oxide, increased resistance in the coronary 
vasculature and atherosclerotic narrowing of the coronary arteries. With hypertension, the 
endothelium is subjected to increased shear stress that also results in inflammation (Libby 
et al., 2002). Libby and colleagues suggest that the inflammatory process may be the link 
between hypertension and CVD. Angiotensin II, which is part of the physiologic process 
of hypertension not only causes vasoconstriction, but also instigates endothelial 
inflammation. 
 Lifestyle modifications are an essential component of prevention and treatment of 
hypertension. These treatments include dietary management, weight loss, and exercise. 
Dietary Approaches to Stop Hypertension (DASH) eating plan is one of the most 
successful adjuncts to decreasing blood pressure. The original DASH study and the 
second DASH study both demonstrated that adherence to this program resulted in a 
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decrease in blood pressure (Bacon et al., 2004). The Premier study, which utilized the 
DASH eating plan and other lifestyle modifications, showed similar findings (Lien et al., 
2007). The DASH eating plan utilizes a modest amount of sodium and increased amounts 
of fruits and vegetables, and is recommended by the American Heart Association and the 
National Heart, Lung, and Blood Institute.   
Pharmacologic treatment of hypertension is guided by the Joint National Committee 
guidelines (JNC). The most recent guidelines recommend a variety of medications 
including thiazide diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin 
II receptor blockers (ARBs), beta blockers, and calcium channel blockers based on 
compelling indications. ACE-I and ARBs interrupts the pathways that lead to the 
inflammatory process (Libby et al., 2002). Furthermore, ACE inhibitors affect 
fibrinolysis and coagulation, further stabilizing the endothelium. Consequently, research 
has demonstrated that these two classifications of medications used to treat hypertension 
have demonstrated a decrease in both cardiovascular related events such as myocardial 
infarction and mortality related to CHD.  
Depression 
 Psychosocial components are becoming more widely recognized as risk factors for 
CVD. Initially, the “type A” behavior was considered as a risk factor. More recently, 
other psychosocial components such as depression, anxiety, and personality traits have 
been recognized as more significant contributing factors to CVD (Elovainio et al., 2005; 
Frasure-Smith & Lespérance, 2006; Rosansky & Kubzansky, 2005). In fact, the 
prevalence of depression is nearly three times higher in those with CVD (Thombs, 2005). 
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While there are various psychosocial factors discussed in the literature, this paper will 
focus on depression. 
It is important to distinguish between depression and the presence of depressive 
symptoms. Rozanski, Blumenthal, and Kaplan (1999) describe depression as the presence 
of depressed mood and a marked decrease in all activities that persists for at least two 
weeks. In addition, this mood alteration is also accompanied by at least two of the 
following symptoms: “changes in appetite, sleep disturbance, fatigue, psychomotor 
retardation or agitation, feelings of guilt or worthlessness, problems concentrating, and 
suicidal thoughts” (p. 2193). Depressive symptoms may have components of clinical 
depression, but lack sufficient magnitude to be classified as such. Rozanski and 
colleagues outlined the presence of a threefold higher depression rate among those with 
CAD. In addition, these authors also highlight that the risk for CAD is associated with the 
degree of depressive symptoms, suggesting that depression manifests itself on a 
continuum.  
 Depression and the presence of depressive symptoms affect endothelial function in 
three different ways. First, increases in cortisol results in the promotion of central 
adiposity, insulin resistance and development of diabetes (Rozansky, Blumenthal, 
Davidson, Saab & Kubzansky, 2005).  Second, increased platelet reactivity and 
hypercoagulability develops which contributes to prothrombotic properties in the 
endoethelium (Matthews, Schott, Bromberger, Cyranowski, Everson-Rose, & Sowers, 
2007; Miller, Rohleder, Stetler, & Kirschbaum, 2005; Rozansky et al., 2005). Lastly, 
inflammation increases within the endothelium and is demonstrated, in part, by increases 
in C-reactive protein, interleukin-6, and tumor necrosing factor (Barr-Taylor et al., 2006; 
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Rozansky et al., 2005). Thus, strong evidence demonstrates the relationship between 
depression and depressive symptoms and endothelial dysfunction that leads to the 
development of CVD. Biobehavioral mechanisms are also responsible for the link 
between depressive symptoms and depression to cardiovascular disease. Both have been 
shown to contribute to behaviors leading to other risk factors for CVD. This complexity 
poses a challenge for adherence to both treatment modalities for depression and other 
underlying risk factors for CVD (DiMatteo, Lepper & Croghan, 2000).  
 Similar to other risk factors, depression and manifestation of depressive symptoms 
can be successfully treated with both behavioral and pharmacological interventions 
(Blumenthal et al., 2007). Pharmacological treatments for depression have been studied 
both for safety and efficacy, with several classes of antidepressants, most notably 
selective serotonin reuptake inhibitors (SSRIs), and found to be quite effective. 
Psychosocial and behavioral interventions have not been explored in as much depth. 
Types of psychosocial intervention have included: one on one counseling, group 
counseling, educational programs, and physiologic stress management to name a few.  
Further research should be conducted in the area of psychosocial and behavioral 
intervention to elucidate the effectiveness of these techniques (Frasure-Smith & 
Lespérance, 2006; Rosansky & Kubzansky, 2005). While there is evidence to support 
psychosocial and behavioral therapy to treat depression and depressive symptoms, 
combination with pharmacological treatment is recommended for the maximum benefit.   
Summary 
 Risk factor reduction has been shown to reduce the incidence of CVD and is clearly 
supported by research. Healthcare providers are being challenged to find ways to assist 
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the public to identify and modify their personal CVD risk factors. Many evidence-based 
strategies and therapies are currently available. But the greatest challenge is assisting 
individuals to “perceive” that they are at risk in the first place. To help persons address 
the development of CVD, measuring cardiovascular risk is thus necessary. 
Measuring Cardiovascular Risk 
 Measuring risk for developing cardiovascular disease (CVD) or having a cardiac 
event, such as a myocardial infarction, is an evolving science. While the risk factors for 
cardiovascular disease and their subsequent contribution to disease progression have been 
extensively studied and well-documented, it remains difficult to precisely predict the 
likelihood of a cardiovascular event. Epidemiologic research has shown that reliance on 
one single risk factor can be misleading. Rather, quantitative multivariable risk 
assessments confer a more accurate prediction, especially since most of the standard risk 
factors tend to synergistically affect each other as discussed earlier in this paper (Kannel, 
2005). Therefore, multivariable cardiovascular risk assessment has become a necessity.  
Several methods are available to mathematically estimate risk, including the 
Framingham Risk Score (FRS), coronary artery calcium (CAC) score and intravascular 
ultrasound (IVUS). While each method contributes a greater understanding of actual risk 
for a cardiac event and possesses individual strengths and weaknesses, no one method 
completely or accurately calculates risk for a cardiac event. The FRS will be discussed in 
this paper, since it is the method employed in this study. In addition, the Heart Health 
Score will also be discussed as a tool commonly used for health screenings among the lay 
population. 
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Framingham Risk Score 
 The Framingham Risk Score (FRS) is one of the most widely used methods for 
predicting and calculating risk for a future cardiovascular event. This method evolved 
from the Framingham Heart Study, which began in 1948, and ultimately identified risk 
factors for CVD. A mathematical calculation integrates age, gender, smoking history, 
 blood pressure, and cholesterol as well as blood glucose or a history of diabetes in 
persons without a history of CAD to demonstrate the multiplicative and cumulative 
aspects of atherogenesis (Greenland, LaBree, Azen, Doherty, & Detrano, 2004). Based 
on the presence of these risk factors, a 10-year risk of having a cardiovascular event is 
calculated. However, this method has both strengths and weaknesses. 
 A positive attribute of this method is the inclusion of multiple or “global” risk 
factors. The presence of CVD is most frequently attributed to risk factor combinations 
closely associated with one another. For example, persons who smoke and also have 
dyslipidemia will be at higher risk for CVD. By addressing the multiplicity of risk factors 
through the FRS mathematical equation, a more comprehensive view of true risk is 
examined.  
The FRS provides a 10-year, gender specific projected risk of having a 
cardiovascular event. In addition, risk results are stratified with a percentage. A low risk 
is correlated with a calculated risk of less than 10%. A moderate risk is correlated with a 
risk between 11% and 20%. High risk is correlated with a calculated risk of greater than 
20%. This level of risk is used to determine which patients require more intensive 
management of LDL cholesterol, as outlined by the ATP III recommendations (Grundy et 
al., 2004). 
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Risk stratification may act as a motivational factor to inspire behavior changes in at 
risk individuals. However, there are limitations to projecting risk. For example, how 
much projected risk for a cardiovascular event in the next ten years would it take to 
motivate a person to stop smoking, exercise more, lose weight, or become more 
physically active? Logically, it would seem that the higher the projected risk, the more 
motivated a person would be to make positive behavior choices. But theoretically, 
motivation could also depend on how that person “perceives” their risk. Do people 
consider “time” when formulating risk perception? Does projecting risk out to a 10-year 
period negatively affect how risk is perceived? Is 10 years too long of a projection? 
Would a shorter time frame be more of a motivating factor? These and other questions 
bring to light the challenges of using the FRS. 
This tool is indicated for primary prevention screening. Those individuals who 
already have known CVD, or who have a CVD “risk equivalent” such as diabetes, 
peripheral artery disease, abdominal aortic aneurysm or symptomatic carotid artery 
disease are already at 20% risk of a cardiac event in 10 years, so calculation of personal 
risk factors is not necessary for prediction.   
Heart Health Score 
Wellsource© is a company that provides health appraisal programs to organizations 
and has been in business for more than 30 years. Wellsource© offers a wide range of 
wellness programs and is commonly used in the cardiac rehabilitation setting as well as 
corporate wellness programs. Wellsource© compiles individual risk profiles based on 
self-report and physiological data and also offers a variety of online educational resources 
for customer use (Wellsource, 2013).   
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   The Heart Health Score (HHS) is derived from a combination of physiologic and 
self-report data and is based on the NCEP III revised guidelines taking into account both 
the severity and amount of major versus moderate risk factors. In addition to using the 
same variables as the Framingham risk calculation, it considers fitness level as well as 
personal and family history of cardiovascular disease and reflects current risk as opposed 
to future projected risk (Wellsource©, 2012). A computer program generates a “Heart 
Health Score” (HHS) in one of four categories: 
 “Excellent” or “Ideal risk” (score of 75-100), defined as no risk factors other than 
age; 
  “Doing Well” or “Low Risk” (score of 50-74),defined as having 1 to 3 moderate 
CHD risks factors not including age, or having a personal history of CHD when 
blood lipids are “not known” 
 “Needs Improving” or “Moderate Risk” (score of 25-49), defined as having only one 
major CHD risk factor not including age or family history or having 4 or more 
moderate CHD risk factors (counting age and family history as moderate risk 
factors), and 
 “Caution” or “High Risk” (score of 0-24 defined as having moderate CHD risk blood 
lipids AND 2 or more major CHD risks OR having two or more major CHD risks not 
including age OR having one major CHD risk, plus the age major risk AND Low 
fitness OR having blood lipids or triglycerides within “Ultra-high” category. 
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Risk Perception 
 Risk perception is a complex concept comprised of several interrelated concepts.  
A cross-disciplinary literature review was conducted using the term “risk perception” in 
the areas of business, law, medicine, psychology, sociology, and nursing using: ABI 
inform, Criminal Justice Periodicals Index, Medline, PsychINFO, Social Science 
Abstracts and CINAHL data bases. The search was limited to English only. Both a 
computerized and hand-search of current literature was performed to elicit relevant 
current information on risk perception.  Main themes were identified in each discipline 
after reviewing the literature on risk perception (see Table 1). These themes were used to 
identify additional literature on optimism, optimistic bias, and negative emotions such as 
anger, hostility, uncertainty, anxiety, and depression. While risk perception, optimism, 
and optimistic bias are recognized in many disciplines, including medicine, there is little 
literature regarding risk perception directly relating to cardiovascular disease. However, 
there is a connection between these concepts that will be demonstrated throughout the 
paper. A relationship between negative emotions and CVD has been demonstrated in the 
literature and will also be explored in this paper. 
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Table 1. Risk Perception Literature Search 
Search 
terms used 
Discipline searched: 
Data base used 
Main themes 
Risk 
perception 
Business: 
ABI Inform 
Consumer marketing strategies, Risk versus benefit 
 Law: 
Criminal justice periodicals 
Gun policy, crime deterrents, violence in prison, sexual 
violence, burglary, criminal decision making, fear of 
crime, HIV, date rape 
 Medicine: 
Medline 
HIV/AIDS, blood transfusions, cancer, spinal cord 
injury, immunization, surgery and treatment options, 
informed consent 
 Nursing: 
CINAHL 
Breast cancer, colon cancer, tanning, genetics, 
HIV/AIDS, pain, peripheral vascular disease, infectious 
disease, asthma, tanning, genetics, vaccination, and 
pregnancy 
 Psychology: 
PsychINFO 
Reasons for perception, differences in perception, 
comparative vs real risk 
 Sociology: 
Social science abstracts 
Population risk, risks important to people, social theory 
and social support 
 
 Literature from the areas of business, law, medicine, nursing, psychology and 
sociology addresses different, but important aspects of risk perception.  The business 
literature focuses on consumer marketing strategies and ways that consumers make 
decisions about purchases and investments. These decisions are made using a risk versus 
benefit analysis. While this decision-making process may appear to be specific to 
purchases, it is really a part of human psychology that examines how persons make 
decisions regarding behaviors and actions. In contrast, the law literature draws on the 
concept of fear, such as being a target of crime or the risk of contracting the human 
immunodeficiency virus (HIV) in prison. While both the medical and nursing literature 
address risk perception by examining specific disease processes, such as HIV and 
different types of cancer, the medical literature also includes decision-making about 
treatment options and specific processes such as informed consent. In contrast, the 
nursing literature examines beliefs about a disease process and/or behaviors that either 
lead to or prevent a disease process. Breast and colon cancer literature are the most 
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prevalent disease processes in the nursing literature. Psychology literature examines 
reasons and differences in perception of risk, while the sociology literature focuses on 
theories that attempt to explain behavior and behavior choices. Both the psychology and 
sociology literature use theory and empirical findings to explain how persons make 
decisions involving risk. For example, one area of study is public perception of fear 
involving violence. This fear has been linked to the media’s sensationalizing crime and 
violence through newspapers and increased television programming of both drama and 
reality police shows demonstrating violence. However, this paper will focus primarily on 
business and healthcare concepts. 
Literature on Risk Perception 
 Current business literature relevant to this paper on risk perception addresses: 
consumer-marketing strategies, risk benefit ratio, and risk factors. In business literature, 
risk perception is used as a consumer-marketing tool and is viewed from a consumer 
psychology standpoint.  Consumer psychology evaluates the reasons a consumer will or 
will not buy a product or service. While consumers use a risk versus benefit process to 
make a decision with regards to purchases, the decision making process is driven by the 
potential to encounter potentially negative outcomes.  Risk perception arises from the 
potential for unanticipated and uncertain consequences related to purchasing of products 
(Dholakia, 2001). The marketing of products is based on the strategies to reduce 
consumer risk perception related to the product or service. Risk perception has been an 
integral part of economic growth, however, in order for it to be successfully utilized, it 
must first be understood. 
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 Ropeik (2002) reviewed articles spanning over 20 years to compile a list of 14 risk 
perception factors (see Table 2). Each factor explains a different aspect of consumer 
decision-making and acts as motivational factors to influence behavioral responses.  Each 
of the fourteen factors will be discussed with an example related to healthcare. 
Table 2. Risk Perception Factors 
Risk Perception Factors in Consumer Purchasing 
Number Perception factor Label Definition 
1 Trust versus Lack of Trust Factor The more trust there is in those informing us about a 
risk, the less fear there will be of that risk.   
2 Imposed versus Voluntary Factor There is increased fear of a risk that is imposed than 
a risk that is chosen.   
3 Natural versus Human-made Factor Exposure to natural risk, sun exposure is less feared 
than nuclear exposure. 
4 Catastrophic versus Chronic Factor Most often, people are more afraid of things/events 
that kill a large number of people at once, suddenly 
and violently, than things such as heart disease.  
Although heart disease kills more people annually, it 
is individual and more dispersed. 
5 Dread Factor The worse the outcome from a risk, the more a 
person is afraid of it.  It is postulated that cancer has 
a high dread factor.   
6 Hard to Understand Factor The harder a potential risk is to understand the higher 
the fear of that risk. 
7 Uncertainty Factor When science provides the answers to problems with 
technology, fear about the technology will decrease.   
8 Familiar versus New Factor The first time encounter to a new risk increases the 
fear of that risk. However, after a person lives with 
the risk, the fear will eventually begin to decrease.  
9 Awareness Factor Increased media coverage of a risk has a positive 
influence on risk perception. 
10 A Known Victim Factor Personal knowledge of someone who has been 
affected by a risk will lead to increased fear of that 
risk  
11 Future Generations Factor When children are involved, the fear of a risk is 
increased. 
12 Does it Affect Me?  A person perceives risk more personally than they do 
for society. 
13 Risk versus Benefit Factor The more a person perceives a benefit from a 
potential hazard, the less likely a person will be 
afraid of the risk.  This can be specifically applied to 
medication and treatment therapies. 
14 Control versus No Control Factor If a person feels that he or she can control the 
outcome of a hazard or risk, the less likely that 
person will be to be afraid of that risk 
Note: From “Understanding Factors of Risk Perception,” by D. Ropeik, 2002, Nieman Reports, 4, p.52. 
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The trust versus lack of trust factor (#1) addresses the trust that the consumer places 
on the person(s) informing the consumer. Specifically, the more trust there is in the 
person(s) informing the consumer about a risk, the less fear the consumer will have about 
the presented risk. Conversely, if there is a lack of trust in the person informing the 
consumer, the consumer is more likely to be fearful of the risk. An example related to 
healthcare is receiving advice on decreasing cholesterol in one’s diet from a dietician or 
nurse versus a lay person in the supermarket. While a friendly face in the vegetable aisle 
may be accurate in providing information, a person would trust information given to them 
by a healthcare professional.  
The imposed versus voluntary factor (#2) posits that an imposed risk is more feared 
than a risk taken voluntarily.  For example, while smokers realize that there is a health 
risk associated with tobacco consumption they are often not fearful enough to stop 
smoking.  However, if consumers were told they would be exposed to an unhealthy 
smoking environment every day in the workplace, they would be more fearful of the 
health consequences (exposure on the job does not involve addiction and also removes all 
control).  
The natural versus human-made factor (#3) examines risk based on whether or not 
the risk is human-made or naturally occurring. A simple example is fear of cancer. While 
the sun exposes people to a form of radiation and an increased potential for skin cancer, 
consumers are more afraid of getting cancer from a nuclear exposure or manufacturing 
exposure, which are human-made processes.  
The catastrophic versus chronic factor (#4) bases the fear of risk on the numbers of 
people that are harmed at one given time. Consumers tend to be more afraid of those 
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events that kill large numbers of people catastrophically than things that kill people 
annually. While it is known that cardiovascular disease kills more Americans annually in 
the United States, there is a greater fear of dying in a plane crash because this 
catastrophic incident can kill hundreds of people at one time. 
The dread factor (#5) posits that the worse the perceived outcome from an event, 
the more fear that is associated with the event. Cancer has a high dread factor.  This may 
explain the misconception that American women have regarding breast cancer.  Studies 
have shown that more women are afraid of dying from breast cancer than from 
cardiovascular disease, when scientific evidence clearly demonstrates that more women 
die annually from cardiovascular disease than from breast and colon cancer combined 
(NHLBI, 2006). Perhaps death from breast cancer is perceived as being more painful than 
with cardiovascular disease. In addition, the dread may be related to whether death is 
quick or drawn out. Finally, breast cancer is often viewed as disfiguring.  
The hard to understand factor (#6) states that fear about a risk increases as difficulty 
in understanding the risk increases. Disease processes are complex and difficult to 
understand, which provokes fear in patients. From laboratory results to a spectrum of 
procedures such as percutaneous transluminal angioplasty, persons possess a fear of 
things that they do not understand. However, fear associated with these processes can be 
lessened when the healthcare provider is able to educate the patient about signs and 
symptoms, diagnostic procedures, treatment regimens, and recovery processes.  
The uncertainty factor (#7) is related to science and technology. This factor states 
that fear regarding specific technology will decrease if science explains problems with 
that particular technology. There has been an increase in health-related technology over 
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the last decade. Magnetic resonance imaging (MRI) was originally termed nuclear 
magnetic resonance imaging (NMRI). Although there were no instances that this test was 
harmful in studying brain function, the change in name gained the confidence of the 
public (Goldberg, 2007). It can be explained to the patient that, unlike x-rays, the MRI 
does not expose patients to any form of radioactivity or radiation.   
The familiar versus new factor (#8) established that repeated exposure to a risk 
results in decreased fear regarding the risk over time. For example, air travel is feared by 
many people. However, those who frequently travel by air (repeated exposure) do not 
view this mode of transportation as an unnecessary risk. Traveling by automobile actually 
carries more risk for injury and death than does air travel, however, due to familiarity 
with auto travel, most people do not fear driving in a car at all. In healthcare, new 
treatment regimens such as chemotherapy may be fearful to people. However, after a 
patient has gone through one or two rounds of chemotherapy, the anxiety about the 
treatment regimen decreases.     
The awareness factor (#9) is related to the amount of media coverage that is focused 
on the risk. Increased media coverage of a given risk will increase the fear of that risk 
(Ropeik, 2002; Sjöberg, 2000). This is similar to the media coverage prevalent today to 
market drugs and to advertise drug recalls. When Vioxx was publicly linked to an 
increase in cardiac deaths, there was a frenzy of people calling their physicians about 
continued use of Vioxx and similar non-steroidal anti-inflammatory medications 
(Mukherjee, Nissen, & Topol, 2001).  
The known victim factor (#10) supports that personal knowledge of someone who 
has been affected by a risk will influence fear about the risk. Knowing either a friend or 
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relative with cancer raises awareness about the symptoms, treatments, and certainly the 
effects of the disease (Katapodi, Lee, Facione, & Dodd, 2004). Those who know 
someone with cancer often take primary prevention measures such as screenings very 
seriously. In addition, these same persons often take part in raising awareness in the 
community in events such as walk-a-thons.  
The future generations factor (#11) states that fear will increase if children are 
involved in the risk. For example, while parents may not be overly concerned about 
second-hand smoke exposure for themselves, they are more concerned if their children 
are exposed to this hazard or risk. Another example is the fear of vaccines causing or 
being related to autism (Woo, Ball, Bostrom, Shadomy, Ball, Evans, et al., 2004). Parents 
go to great lengths to keep children safe from perceived hazards.  
The “does it affect me” factor (#12) states that a person often perceives a risk 
differently for others than they do for themselves and it can be explained by people 
thinking “it cannot happen to me” or “this is something that happens to others”. This 
factor, also referred to as comparative risk, is especially pertinent because when people 
perceive less risk for themselves than for others, risk prevention may not be seriously 
considered (Weinstein, 1982). 
The risk versus benefit factor (#13) is associated with a person weighing risks and 
benefits of a risk or behavior. If the benefits of a behavior outweigh the risks, the person 
is less likely to be afraid of the risk or behavior. For example, a person may have a belief 
that taking medication is unnecessary, unnatural, costly, and can cause side effects. The 
person is prescribed a medication to treat high blood pressure. If a healthcare provider 
was able to demonstrate that this medication could decrease the chance for stroke and 
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heart attack while also decreasing recent symptoms of impotence, the person may be 
more likely to see the benefits of treatment and decide that the risk of taking medication 
is worth it. 
Lastly, the control versus no control factor (#14) states that if a person perceives 
that they can control the outcome of a risk, the person will be less afraid of that risk. 
Conversely, if a person perceives that they will have little or no control over a risk, the 
person will be more afraid of the risk. Risky sexual practice and the potential contraction 
of human immunodeficiency virus (HIV) is one example. Stolte, Dukers, Geskus, 
Countinho, & de Wit (2004) conducted a study and observed a correlation between 
homosexual men who believed that highly active antiretroviral therapy (HAART) would 
prevent the contraction of HIV and unprotected anal sex. 
These fourteen factors all contribute to different aspects of risk perception and have 
relevant implications for the healthcare environment. Each of these factors serves as a 
basis to understand perception by the consumer and may act as a motivator that will 
influence consumer behavior. The risk perception factors may be one way for healthcare 
providers to understand how health behavior decisions are made. Furthermore, by 
studying these factors, healthcare providers may be able to tailor interventions based on 
how each person may view risk in a given situation.  
Additional literature on risk perception will be examined using subcategories 
including demographic variables and risk awareness and knowledge. Both optimism and 
optimistic bias will be explored as terms closely related to risk perception. 
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Demographic Variables Affecting Perception 
 Consumer-marketing strategies in the business literature concluded that consumers 
are not only influenced by the motivating factors outlined by Ropeik (2002), but vary by 
personal characteristics such as age, gender, income, education, marital status, parental 
status (Grobe, Douthitt & Zepeda, 1999; Sjöberg, 2000), and also by the context of the 
perceived risk (Grobe et al.; Sjöberg, 2000). Age has been established as a variable or 
mediator that affects perception of risk (Cohn, Macfarlane, Yanez, & Imai, 1995). 
Therefore, conducting research in different populations may elucidate effective strategies 
that will increase awareness of risk in different age samples.  
 Grobe and colleagues investigated the influence of personal characteristics (age, 
gender, household size, socioeconomic status, and education level) on risk perception of 
recombinant bovine growth hormone (rbGH) using Weinstein’s Self-Protective Theory. 
This theory posits that personal susceptibility and severity affect the way an individual 
perceived risk. A nationwide telephone survey was conducted on 1,910 (56.1% of the 
sample) primary food shoppers regarding recombinant bovine growth hormone (rbGH) in 
milk. Data was analyzed using Chi Square analysis. The study concluded that perceived 
health risks from rbGH were dependent on individual perceived exposure (χ2= 0.98, p = 
0.05), fear of risks in general (χ2 = 0.48, p = 0.05), household size (χ2 = 0.12, p = 0.05), 
and socioeconomic status (χ2= 0.125, p = 0.05). Furthermore, level of education ( χ2= -
0.024, p = 0.05, χ2= -0.093, p = 0.05, χ2= 0.050, p = 0.05) male gender (χ2= -0.052, p = 
0.05), and increased age (χ2 = 0.001, p = 0.05) were associated with higher level of 
awareness about rbGH. This finding is particularly poignant since awareness is not only 
essential for understanding information, but also for processing it as a risk or threat. 
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Additional information regarding awareness and knowledge will be discussed in a later 
section of this paper. Lastly, feeling a lack of control in life was associated with increased 
concern regarding rbGH, but not enough to exhibit self-protective behaviors. However, 
self-protective behaviors increased when the exposure could affect the family members. 
Thus, responsibility for others may act as a motivating factor to lessen exposure to a risk 
or threat.   
 Limitations of this study are due to the nonexperimental study design. While survey 
research can provide descriptions and breadth, it can lack depth. Thus, it may serve as a 
foundation for future studies on the topic. Strength of the results from survey research 
can vary based upon the expertise of the researcher(s) in sampling, survey construction, 
interviewing, and data analysis. In this study, the researchers stated that questions were 
compiled from risk perception theories and results from focus group research. However, 
it is not stated whether the questionnaire was piloted prior to use or if it was tested for 
construct, face, or content validity. Furthermore, the authors did not report reliability or 
validity data from this study. Such information would be useful for further research in 
this area.  
Risk Benefit Ratio 
Risk benefit ratio has been identified in the business (Dholakia, 2001; Ropeik, 
2002), psychology (Simonet & Wild, 1997; Weinstein, 1988; Weinstein, Marcus, & 
Moser, 2005), and sociology (Wilkinson, 2001) literature. The risk benefit ratio posits 
that persons make decisions based on the risk versus the benefit in a given situation, 
whether it involves a purchase or behavior choice, supporting that health behavior 
decisions are made consciously and not haphazardly. Before making a decision to 
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incorporate a lifestyle change, a person carefully weighs the benefits and risks of the 
behavior. While consumer psychology tends to evaluate risk as a condition that arises 
from a potentially negative outcome, behavioral based disciplines such as psychology, 
sociology, medicine, and nursing take into account both potential positive and negative 
outcomes that guide individual decision making processes (Dholakia, 2001). In effect, the 
perception factors defined by Ropeik (2002) can be viewed as motivational factors that 
could influence behavior regarding the risk.  The conclusions drawn from the business 
literature may be helpful in planning education strategies for the public in matters of 
disease risk and prevention. Consumers of healthcare are influenced by the same 
motivational factors (table 2) as consumers of products and services in the business 
industry. However, little is known about how healthcare consumers use a risk benefit 
ratio that may influence decision making lifestyle behaviors. Instead, the healthcare 
discipline utilizes health behavior models and theories that attempt to explain behavior 
choices.  
Risk Awareness and Knowledge 
 The concept of risk perception has not been used consistently in the healthcare 
literature.  While some studies state that risk perception is being measured or use the term 
“perception of risk” in their title, it is commonly awareness or knowledge about risk 
factors that is being measured and reported (King et al., 2002; Oliver-McNeil & Artinian, 
2002). For example, in an article titled Perception of risk for coronary heart disease in 
women undergoing coronary angiography, King and colleagues surveyed a convenience 
sample of 450 women undergoing coronary angiography to examine the relationship 
between a woman’s recollection of being told that she was at risk for CHD and the 
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presence of personal risk factors. The mean age of the participants was 64.5 years and 
ranged from 32-93 years. The sample was 94% white/Caucasian, 5.8% African 
American, and 0.2% Hispanic, thus not ethnically/racially diverse. However, the authors 
reported the sample as representative of the community, having a similar percentage of 
those with hypertension, diabetes, and physical inactivity. Results found that 83.6% had 
three or more risk factors, 12.2% had one or two risk factors, and 0.9% had no risk 
factors. Furthermore, only 35% of the women recalled being told that they were at risk 
for CHD, even though 84% reported having three or more risk factors. Using a 
multivariate regression analysis, age (95% CI = 0.96-0.99; p= 0.03), education (95% CI = 
1.03-1.79, p= 0.03), and being told by provider about high cholesterol level (95% CI = 
1.01-2.45, p= 0.05) were the only significant variables that predicted recollection of being 
told about personal risk for CHD.  Results from this study highlight the importance of 
providing accurate information about risk factor for CHD. However, while awareness 
about risk factors plays a significant role in the formation of risk perception, risk 
awareness and risk perception are two separate and distinct concepts. 
In critiquing this study, it is noted that threats to internal validity are addressed by 
using two trained nurses to conduct the structured interviews and following a set 
procedure for data collection. In addition, all but two of the participants were interviewed 
in person in the same hospital setting. This study included a large cohort of women with a 
wide range of ages. While the mean age was 64.5 years, there were participants as old as 
95. At first glance, it appears that a participant at the age of 95 would be an outlier in the 
sample. It would have been helpful to provide the reader with the number of participants 
within a given age range. In addition, data analyzed by age category may provide 
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information about how knowledge and awareness about CVD changes with life stage and 
life experience. Due to the survey design of this study, causality and relationships cannot 
be assigned. However, this study can act as a basis for future research on this topic. 
Perception of risk for CHD cannot be formed without awareness and knowledge of 
risk factors for CHD.  For example, if a person does not know what factors contribute to 
the development of CVD (knowledge), then it would be difficult to become aware of the 
potential risk to health. Risk knowledge can arise from several sources including: media 
such as television, radio, internet, and printed sources; and dialogue with those who can 
provide accurate and candid information, whether they are healthcare professionals or 
well-informed lay persons. In addition to general knowledge, individualized information 
about personal risk factors such as blood pressure readings or lipid profile results further 
contribute to risk awareness and the subsequent formation of risk perception.  Accurate 
perception of a risk is not necessarily guaranteed, even if complete and thorough 
knowledge is given and awareness of the risk is raised because the individual must be 
able to process the information to perceive a threat to well-being. The key to risk 
perception is how a person cognitively processes the information and subsequently is able 
to internalize and personalize the threat. Both internal and external influences affect how 
an individual processes a risk.   
Lefler (2004) completed an integrative review of 11 studies including both men and 
women to examine why women do not perceive they are at risk for a myocardial 
infarction (MI) or heart attack. Lefler listed the following as some of the major findings 
from the studies: women were unaware that heart disease was the number one killer of 
women and believed that it is a male disease; women often underestimate the significance 
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of chest pain; women’s symptoms for MI are often different that for their male 
counterparts; women reported paternalistic attitudes from physicians about symptoms; 
women often felt uninformed about heart disease; women often use print media as a 
primary source of health information; fewer physicians discussed heart disease with 
women; primary care providers often did not discussed disease prevention; and lower 
perceived risk was commonly reported by women, African American, those with lower 
levels of education, and younger patients. She concluded that there are gender differences 
that affect perceived risk of a heart attack. Moreover, she concluded that there is a need to 
involve the patient, family, and community to provide knowledge and reinforce behavior 
changed that will positively impact the lives of women. While Lefler did include both 
qualitative and quantitative studies that increased the richness of the findings, no audit 
trail was provided other than which search terms and databases were investigated. In 
addition, findings from quantitative studies were not supported by either significance 
levels or indication of sufficient power within the studies. Furthermore, there was no 
evidence presented about the strengths and limitations of the studies. Therefore, without 
this information, the conclusions drawn by Lefler may be weak and have limited 
application in practice.  
Terms Related to Risk Perception 
Both optimism and optimistic bias are terms closely associated with risk perception. 
When examining studies that involve risk perception, one or both of these related terms 
are often measured. In some cases, while optimism or optimistic bias is measured, results 
are reported as risk perception. Both optimism and optimistic bias will be examined in 
more detail later in this paper. But first the following meta-analysis is presented as a 
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poignant example of how risk perception was studied in the breast cancer literature and 
how the term overestimation (optimistic bias) was reported in many of the studies. 
Katapodi and colleagues (2004) conducted a meta analysis on 42 studies related to 
risk perception and breast cancer screening using clearly described research methods. In 
addition, search terms, limitations, inclusion and exclusion criteria, and coding/analysis 
of data were provided in detail. Effect sizes were calculated using Hedge’s G statistic in 
which g = 0.20 were considered small, g = 0.50 were considered moderate, and g = 0.80 
were considered large. Odds ratios were also calculated along with a 95% confidence 
interval. The use of Hedge’s G statistic is appropriate for the calculation of effect sizes in 
meta analysis. Thus, those studies with a small effect size have a stronger instrument to 
measure perceived risk. There is a large amount of variation is the type of instrument 
used to measure perceived risk. In this analysis, the authors noted that perceived risk was 
measured in a variety of ways, ranging from a single question to an eight-item panel of 
questions. In addition, both subjective and objective risk can be measured verbally on a 
Likert-type scale, or numerically as a percentage. Furthermore, Katapodi reported that in 
these studies, questions were formulated as subjective risk (the risk an individual 
assigned to him/herself based on variables such as knowledge and personal risk factors), 
or comparative risk (the risk an individual assigns to him/herself while comparing their 
risk against others), or both (see Appendix A). Most often, the comparison included 
demographics such as age group, gender, socioeconomic status, education level, and 
race/ethnicity. The table in this analysis clearly shows that the concept of risk perception 
has not been consistently defined and measured which poses a threat to reliability and 
validity of individual study results. For example these authors explain that while single-
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item scales can be administered easily due to brevity and have adequate face validity the 
major limitation is limited discriminatory capacity. In addition, since the data is most 
often classified as interval level data, there is an increased risk for limited reliability due 
to measurement error. Lastly, single item scales have commonly been used to measure 
more than one construct leading to measurement errors.  
Unlike the study conducted by Grobe and colleagues (1999), these researchers 
found conflicting results on the influence of demographic characteristics on breast cancer 
and perceived risk. Although seven of the studies concluded that younger women were 
more likely than older women to perceive higher risk for developing breast cancer, the 
effect size was small and the confidence interval was low (total N= 38,000, g = 0.13, 
95%, CI 0.13-0.14). Katapodi and colleagues (2004) ultimately concluded that no 
relationship exists between age and increased perceived risk due to the small effect size 
for these seven studies and insufficient data to calculate an effect size for the remaining 
five studies. This conclusion limits the application of the findings.  
This meta analysis is important to include for several reasons. To begin with, after 
searching the literature, this was one of the studies that ultimately revealed that risk 
perception is being measured in a variety of ways. In addition, risk perception is often 
reported as optimistic bias. Lastly, the analysis found gaps in the breast cancer literature 
that not only lays the groundwork for future research in breast cancer, but also in the 
areas of cardiovascular disease.  
Literature on Optimism 
The relationship between the concepts of optimism and risk perception was 
identified by this author after reviewing several studies that discussed risk perception, but 
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measured optimism (Facione, 2002; Katapodi, et al., 2004). Optimism, dispositional 
optimism, or “overestimation” can be defined as either a state or trait of personality or 
character in which a person views the word positively. It is thought that optimistic 
individuals make the best of things and are able to cope with adversity; hence they may 
make better choices related to healthy behaviors (Scheier & Carver, 1992).  
Optimism has been most often measured with the Life Orientation Test (LOT) 
(Scheier & Carver, 1985) or the Life Orientation Test-Revised (LOT-R) (Scheier, Carver 
& Bridges, 1994). The original LOT is a twelve-item self report of both positive and 
negative outcome expectancies measured on a five point Likert response scale (Appendix 
B). There are four filler items, four positively phrased items, and four negatively phrased 
items on the instrument. Acceptable reliability and validity has been established and 
published in a variety of health related areas. 
The concept of pessimism is commonly integrated within the same literature and is 
often explained as the opposite of optimism. Research has been conducted to further 
elucidate the relationship between optimism and pessimism (Kubzansky, Kubzansky, & 
Maselko, 2004). In some instances, pessimism has been more significantly correlated to 
health than optimism (Carver, Lehman, & Antoni, 2003; Brenes, Rapp, Rejeski, & 
Miller, 2002). However, there is some discussion among researchers whether optimism 
and pessimism are two separate constructs rather than opposite measures of a single 
construct (Brenes et al., 2002; Kubzansky et al. 2004; Scheier et al., 1994). Thus, it is 
difficult to discuss one concept without the other. In fact, more recent literature has 
discussed the concepts as optimism-pessimism rather than separate terms (Carver et al., 
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2003). Even though there is not complete agreement regarding the relationship between 
these terms, there is evidence to suggest that both constructs affect health. 
Kubzansky and colleagues (2004) explored whether optimism and pessimism, as 
measured on the LOT and LOT-R, are measures of the same construct. The study was 
designed to examine three versions of the LOT instrument: the original LOT, a half-
reversed version of the LOT, and finally, a fully-reversed version of the LOT. In the half-
reversed version the framing was reversed on half of the questions, while maintaining the 
intent of the item. The fully-reversed version reversed the framing of all questions. In 
reversed items, positively phrased items are changed to negatively phrased items. For 
example, if the original items states “In uncertain times, I usually expect the best,” the 
reversed item would state, “In uncertain times, I rarely expect the worst.” Thus, the 
connotation opposes the meaning of the statement but the intent of the item is the same. 
To ensure item meanings were intact, pilot testing was performed on the two reversed 
versions of the instrument. In addition, both versions kept the same order as the original 
LOT and the filler items were left unchanged. One version of the LOT was administered 
along with health-related measure for trait anxiety, trait anger, symptom measures, 
general health status and health behaviors. In addition, external health behavior 
information was obtained from the university health services for each of the 429 
participants, including information on gastrointestinal problems, back and neck injuries, 
asthma, skin rashes, and regular preventive vaccine acquisition, to name a few.  
Optimism and pessimism independently predicted anxiety, anger, and depressive 
symptoms (p<0.01), suggesting that optimism and pessimism are separate constructs. 
These researchers posit that negative emotions may act as a mediator between optimism 
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and pessimism. In addition, they suggest that positive expectations may play a role in 
how persons cope with adverse conditions such as illness. Finally, further investigation 
into the conceptual nature of optimism and pessimism has been suggested to explore the 
concepts of risk persistence, risk behaviors, risk tolerance, denial, and coping styles. 
Optimism has been the focus of studies that examine human immunodeficiency 
virus and disease progression (Ironson, Balbin, Stuetzle, Fletcher, O’Cleriegh, 
Laurenenceau et al., 2005), immune function (Sergerstrom, Taylor, Kemenym & Fahey, 
1998; Von Ah, Kang & Carpenter, 2007), breast cancer and social interaction (Carver et 
al., 2003; Von Ah et al., 2007), and carotid artery disease progression (Matthews et al., 
2004; Matthews et al., 2006). While it makes logical sense to think that a positive outlook 
on life can affect overall physical health and functioning, there is objective evidence to 
support this position.  
Immune Function. Optimism has also been shown to affect the immune system of 
healthy individuals. Sergerstrom et al. 1998) studied 50 first year law students with 
confirmed healthy immune systems to determine if optimism is associated with mood, 
coping, and immune function in response to stress. Immune measures included CD4+ 
cells (helper T), CD3+, CD8+ cells (cytotoxic C), CD19+ cells (B), CD3+, CD3-CD16+56+ 
cells (NK), and natural killer cell cytotoxicity (NKCC). Strict methods of collection, 
handling, and processing of the samples were described adding to internal validity of the 
study. Dispositional optimism (trait optimism) was measured using the LOT, which has 
already been described. To capture situational optimism, a 10-item scale was specifically 
developed for this study based on a previous study examining optimism with HIV. 
Reported reliability was α = 0.86 at Time 1 and   α = 0.91 at Time 2. The correlation 
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between dispositional and situational optimism was 0.30 suggesting sufficient ability to 
discriminate between the two concepts. The Coping Operations Preference Enquiry 
(COPE) measured several factors including problem solving, mental accommodation, and 
avoidance. The Profile of Moods State (POMS), a well-established instrument to assess 
mood, was used to measure mood state over the past week. It assesses 65 different moods 
using a 5-point Likert type scale. Measures assessed for the previous week included: 
amount of exercise, average amount of sleep, and intake of caffeine, alcohol, nicotine, 
and/or drugs. Demographic characteristics were collected. Lastly, each participant was 
asked to describe extremely stressful recent school related experiences using a 7-point 
Likert type scale. The instruments were not included in the publication therefore, it is not 
possible to examine how these concepts were explored. 
Self-reported optimism and situational optimism, related to college life as first year 
law students, were measured at baseline and mid-semester. Situational optimism, in this 
study, was defined as the outlook a student had related to school related stress. Results 
indicated situational optimism was associated with less perceived stress (r = -0.28, p< 
0.05) and less avoidance coping (r = -.27, p< 0.05). In addition, both dispositional and 
situational optimism were associated with less mood disturbance at both Time 1 (r = -.25, 
p< 0.05; r = -.28, p< 0.01) and Time 2 (r = -.33, p< 0.01; r = -.39, p< 0.01) respectively. 
Lastly, situational optimism was significantly associated with levels of CD4+ cells (helper 
T cells) (r = 0.35, p< 0.05).  
Results from this study suggest that individuals who are more optimistic are less 
likely to perceive stress and have less mood disturbances. While only situational 
optimism was significantly associated with increased helper T-cells it may be that 
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individuals are able to remain optimistic while enduring the stress of a situation that has 
limits. For example, students often feel stressed before a paper is due or before an exam. 
However, the student is able to endure this stress without deleterious effects because it 
occurs during a relatively short period of time (days to weeks depending on the student’s 
schedule and classes). However, if an individual is enduring stress over a long period of 
time, it may not be possible for the body to react in a protective manner. Since there is 
evidence to support that CVD is related to an inflammatory response, which is part of 
immune functioning, further research regarding optimism should be included in the area 
of CVD. This study provides a strong foundation for more research in this area. Not only 
can other age groups be studied, but also different ethnicities, and those with different 
disease processes.  
A more recent study conducted on 54 women newly diagnosed with breast cancer 
found optimism to moderate the immune response while it did not have a direct effect on 
natural killer cell activity (NKCA) in this sample (Von Ah, Kang, & Carpenter, 2007). 
These researchers posit that in some instances optimism may be more of a state 
previously thought. In addition, Von Ah and colleagues suggest that not only does more 
research need to be done in this area, but specifically longitudinal studies to determine 
how psychosocial factors influence immune response in breast cancer.  
Social Interaction. Carver and colleagues (2003) examined social interaction 
among women with breast cancer using a cross-sectional design. The authors 
hypothesized that pessimism would be correlated with less social interaction in these 
participants. The sample consisted of 235 women with a first experience with cancer who 
were otherwise physically and psychologically healthy. The participants were recruited at 
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three, six, or twelve months post-surgery; had either Stage 0, 1, or 2 cancer; and ranged in 
age from 27 to 87 years. Women with more advanced cancers were excluded from the 
study. The sample ethnicity was: 63.4% Caucasian/White, 11% African American, 25.5% 
Hispanic. Instruments included both the LOT-R to measure “optimism-pessimism” with a 
reported α = 0.75 for this study. Social disruption was measured using two subscales of 
the Sickness Impact Profile (SIP). The first scale assessed impact on social activities (α = 
0.86), while the second examined recreation and pastime activities (α = 0.70). In addition, 
emotional distress was measured with small sets of adjectives that respondents rated 
according to severity. For example, distress was measured as anxiety using “tense, 
nervous, and anxious”. Furthermore, the sets were also combined to yield a composite 
index by averaging responses with a correlation of 0.43. Lastly, fatigue was measured by 
using three descriptors from the fatigue scale (“tired, worn out, and exhausted”) of the 
Profile of Moods State (POMS) with a reported α =0.90 when the responses were 
averaged across items. These sets of adjectives were described as having adequate 
measures of reliability and had been used in earlier breast cancer research. In addition, 
the researchers did not explain why the entire fatigue scale from the POMS was not used. 
Perhaps it was for brevity and to lessen the burden on the participant. However, the use of 
only a few adjectives to measure a significant part of the study poses a threat to internal 
validity and may negatively impact the findings.  
Regression analysis found that optimism was inversely related to social disruption 
(β = -.25, t(231) = 4.16, p< 0.001), distress (β = -.41, t(231)= 6.97, p< 0.001), and fatigue 
(β = -.29, t(231) = 4.59,  p< 0.001); thus higher levels of optimism were correlated to less 
social disruption, distress, and fatigue. While treatment for breast cancer does imply a 
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certain amount of social disruption, it appears that optimism may play a role in the 
recovery and resultant positive social interaction for those with breast cancer. While it is 
not known whether the same would be found for those at risk for cardiovascular disease, 
further research may help to further define the relationship between optimism and 
pessimism, negative emotions and health outcomes. One possible explanation is that 
optimism acts as a mediator for more positive health outcomes.     
 Disease Progression. Evidence supports the premise that optimism may slow 
disease progression. For example, Ironson and colleagues (2005) examined the effect of 
optimism on human immunodeficiency virus (HIV) disease progression. The sample of 
177 participants had CD4 counts between 150 and 500, were HIV positive with at the 
beginning of the study, denoting they were all in the “midrange” of the illness. The 
sample was 70% male and diverse, with 31% Caucasian, 36% African American, 28% 
Hispanic, and 5% reported as other ethnicity/race. Disease progression markers, 
psychosocial measures and adherence to the medication regimen were measured 
longitudinally every six months over a two and a half year period. Psychosocial measures 
included: optimism, depression, coping, and perceived stress. The LOT-R, which was 
previously discussed, was used to measure optimism. The Beck Depression Inventory 
(BDI), a well-established instrument, was used to measure depression. The Coping 
Operations Preference Enquiry (COPE) was used to measure coping ability. Lastly, the 
Perceived Stress Scale (PSS) was used to measure degrees of perceived stress. While 
these measures were very briefly discussed, no reliability or validity data was provided. 
However, these instruments are used widely with established reliability and validity data 
supporting the integrity of internal validity. The researchers explained that the statistical 
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method of hierarchical linear modeling (HLM) was specifically chosen to predict CD4 
and viral load at each point in time, rather than predicting data at a single point in time. 
HLM is an appropriate method, given the nature of the data and design of the study. After 
controlling for significant covariates of: viral load intercept (intercept, age, gender, 
cocaine use), viral load slope (average slope, education, sexual orientation, optimism), 
antiretroviral 1 (average increment), and antiretroviral 2 (average increment), optimism 
measured at baseline predicted the change in CD4 and viral load over the 2 year time 
period. So, while the group as a whole lost CD4 cells due to the disease process (as 
expected), results showed that optimistic individuals showed less disease progression 
through an increase in CD4 cells (0.19, t = 2.08, p= 0.04) and a slower increase in viral 
load (-0.001, t = –2.007, p= 0.04). 
 This was an in depth, highly structured study that serves as a foundation to support 
the impact that optimism has on the immune function in those with HIV. While it is not 
known whether optimism has any effect on the development and/or progression of CVD, 
further study in this area could elucidate this relationship. If the results could be 
replicated in CVD, even more could be understood about immune response and the 
development and progression of CVD leading to new prevention and treatment measures 
to prevent or halt the progression of disease.  
 There are few studies that examine optimism and the development and progression 
of CVD. However, two studies most relevant to this paper correlate increased optimism 
and life engagement with decreased levels of CVD. Matthews, et al., (2004) measured 
carotid intimal thickness, a surrogate marker for atherosclerosis, in a prospective, 
longitudinal study of 209 middle-aged healthy women. The women were part of the 
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Healthy Women Study (HWS) and were premenopausal at enrollment. Data was 
collected on demographics, blood glucose and cholesterol levels, body mass index, blood 
pressure, optimism, and depressive symptoms. Carotid intimal thickness, a surrogate for 
atherosclerosis, was measured via ultrasound scans using certified readers with pre-study 
interrater reliability for establishing intima medial thickness (IMT) with an intraclass 
correlation of 0.86. Carotid scans were performed at 10 and 13 years into the study when 
women were 5 and 8 years postmenopausal.   
 The Life Orientation Test (LOT) was used to assess optimism-pessimism and was 
administered upon entry into this part of the study and at the time of the first carotid scan. 
Blood draw parameters were given for all laboratory assessments. Body mass index 
(BMI) and blood pressure (BP) procedures were described. Self-reported measured 
included: current medication therapy for hypertension, hyperlipidemia, and hormone 
replacement; smoking history and alcohol intake. In addition, the Paffenbarger Activity 
Questionnaire (PAQ) was used to collect data on leisure time activity spenditure. Lastly, 
The Beck Depression Inventory (BDI) was used to measure depression. However, 
information on the timing of the PAQ or BDI measures was not specified. Sound 
measures to collect data supporting internal validity of the study. 
 Multiple linear regression analysis and univariate analyses of covariance 
(ANCOVA) were used to analyze the data. Results showed that women who remained 
optimistic for the longest periods of time had less disease progression (p < .001) and 
those who reported higher pessimism scores were more likely to have greater increases in 
carotid intimal medial thickness (p < .007). Pessimism scores collected at study entry 
were related to an increase in mean IMT (β = 0.17, t = 2.71, p< 0.007). After being 
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placed in quartiles based on the distribution of pessimism scores, significant linear effects 
of pessimism were seen on the percentage of increase in both mean (linear contrast, F = 
3.29, p< 0.002) and maximum IMT (linear contrast, F = 2.85, p< 0.25). The lowest 
quartile (most optimistic) showed that this group had less progression than the other three 
groups for both mean (F = 15.4, p< 0.001) and maximum IMT (F = 5.6, p< 0.02). 
Optimism and pessimism scores remained stable over the 10.4 years of follow-up 
(Pearson R = 0.71, p < .0001). 
 These results bring new information about optimism and cardiovascular disease 
progression. Findings from this study should leave researchers thinking that more needs 
to be done to examine the relationship between optimism, pessimism and the 
development and progression of CVD.  Several limitations must be examined in light of 
the findings. To begin with, the subjects were all female. In addition, the study population 
was homogenous, with 90% of the participants being white. Additional study, including a 
broader range of ethnicities and with men is necessary to examine whether similar results 
could be replicated. Lastly, the sample was comprised of healthy individuals, thus it is 
not known whether similar results would be found in those with established CVD or in 
those with co-morbid states such as hypertension, or diabetes.   
 The second study, conducted by Matthews et al. (2006), found similar findings 
among 155 healthy women who completed instruments to measure cognitive affect and 
optimism before and after an electron beam tomography scan (EBCT) to measure aortic 
and coronary calcification. Similar to the previous study, the participants were part of the 
larger Healthy Women Study. This study is a continuation of the first study by Matthews 
et al. (2004), thus the women were now post-menopausal with a mean age of 65.1 years.   
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 EBCT was used to measure calcification in the aorta and coronary arteries. The 
Agatston scoring method was used contributing to reliable and valid score reporting. 
Coronary and aortic calcium scores showed moderate association (Spearman’s p = 0.40, 
p< 0.001). In addition to assessment of cardiovascular risk factors, several psychological 
attribute tests were administered to identify optimism, depression tendencies, self-esteem, 
and hostility. Elements of each measure including number of items, rating/scoring 
system, sample items, and alpha coefficients were described and presented as a table. All 
instruments reported alpha coefficients of 0.70 or higher. Similar to the previous study, 
the use of well-established instruments supports strong internal validity. However, there 
was no discussion as to which instrument measured which construct. Therefore, unless 
the reader is familiar with the name of the scale, it might prove difficult to fully 
understand the reported findings. For example, after scanning the references, it was 
determined that the LET is the Life Engagement Test. However, it was necessary to read 
that article to learn that the LET measures life engagement and life satisfaction and was 
explicitly designed for researchers in the fields of behavioral medicine and health 
psychology (Scheier, Wrosch, Baum, Cohen, Martire, & Matthews et al., 2006). So, 
while the LET does not measure optimism specifically, it was tested and was moderately 
correlated (r = 0.39 to r = 0.61, p = 0.01) with measures of optimism in eight separate 
studies. In fact, one of the eight studies is this very study (Matthews et al., 2006). The 
introduction of the LET without using the LOT does pose some questions since Dr. 
Scheier was key in the development of both instruments. Is it possible that since the LOT 
is correlated with optimism, researchers are now beginning to focus on engagement in 
life as a measure of positive emotion, namely optimism?  
53 
 Findings from both studies may have a tremendous impact on the way we view 
emotional attributes and their impact on the development and progression of CVD. 
However, this impact must be tempered due to study limitations. Similar to the 2004 
study, the non-diverse sample was comprised of middle-aged, highly educated white 
women. Only one participant had less than some college education. Thus, findings from 
neither study can be generalized to all women. Additional research is needed to establish 
whether similar relationships exist in different ethnicities and in men. While the clarity of 
the measures used in the study and some of the findings were difficult to interpret, brief 
reporting in both areas may be due to journal publication limitations and, therefore, may 
not a true reflection of study strength or design. 
 Clearly, these two studies were conducted with attention to detail in many areas and 
measures were taken to support strong internal validity such as the use of well-
established instruments, the appropriate use of statistical regression to identify 
relationships, and strict data collection protocols. Both studies support a relationship 
between psychological factors and the development of CVD. Therefore, further research 
on the impact of psychological variables needs to be conducted on both men and women 
and in different ethnicities. As was seen in these two studies emotions played a 
significant role and should be investigated further.   
 Positive and Negative Emotions. While optimism has been studied with regards to 
other positive emotions such as resilience (Bowen, Morasca, & Meischke, 2003), 
pessimism has been examined in relationship to negative emotions such as depression, 
depressive symptoms, Type A personality, and anger; as well as other emotional factors 
such as social support, coping, and helplessness (Blumenthal, Burg, Barefoot, Williams, 
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Haney, & Zimet, 1987; Ironson et al., 2005; Sergerstrom et al.,1998; Shnek, Irvine, 
Stewart, & Abbey, 2001). The literature explaining negative emotions will be examined 
later in this paper. 
Bowen and colleagues (2003) analyzed the relationship among resiliency variables 
and optimism in 357 women with a family history of breast cancer using a cross sectional 
design. While optimism was measured using the LOT-R, resiliency was measured using 
the Life Ladder Scale and the Life Attitude Profile-revised (LAP-R). The Life Ladder 
Scale was described as measuring comparative levels of past, present and future thriving 
and the LAP-R was reported to measure meaning and purpose in life as well as the 
motivation to find meaning and purpose in life.  In addition, data was gathered using the 
MOS Social Support Survey; the SF-36 sub-scales of mental health, physical functioning, 
and perceived health; the Cancer Worry Scale; and the subscales of depression and 
anxiety from the Brief Symptom Inventory. Subjective risk perception was obtained by 
asking the participant to rate their chance of getting breast cancer on a scale from zero to 
100. Lastly, quality of life (QOL) was asked as a single item “Overall, how would you 
rate the quality of your life?” using an 11-point Likert scale. Even though some 
information about these instruments and measures was reported, there were areas that 
were difficult to understand. For example, the authors mention using the MOS Social 
Support Survey, but fail to define MOS, which may assist the reader to understand more 
about the measure. In addition, reliability and validity were not presented for all 
measures, which may affect the strength of study results and contribute to Type I error. 
Optimism was not correlated with any of the resilience variables and LOT-R values 
were lower than in previously reported studies, which may explain why the LOT-R did 
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not load high enough on exploratory factor analysis (EFA) to be considered a measure of 
resiliency. However, the researchers did suggest that the LOT-R be used in further 
studies since it was very close to meeting the criteria. The specific statistics for the EFA 
cannot be discussed because they were not included in the publication. Using multiple 
regression analysis, independent predictors of resilience included: age (β = 0.92, p<0.01), 
perceived risk of breast cancer (β = 1.73, p< 0.01), mental health (β = 0.38, p< 0.01), and 
general health (β = 1.3, p<0.01). It is interesting that perceived risk of breast cancer was 
an independent predictor of resilience and supports the intricate relationship between 
these closely linked concepts. However, limitations of this study should be considered. 
Similar to many studies in breast cancer research, this sample consisted of mostly 
Caucasian (93%) and well-educated women with 65.8% completing at least four years of 
college. Without representation from other ethnicities, it is difficult to say whether or not 
similar findings would be replicated. In fact, studies of African American and Chinese 
American women have reported an association with fatalism and breast cancer, which 
definitely would impact resilience. The concept of fatalism will be discussed later in this 
paper. In addition, there may be significant gender differences regarding resilience and 
optimism. Thus, further study is warranted to explore the relationship between optimism 
and resiliency in more diverse populations. 
 Summary. Overall, there has been extensive work completed on many aspects of 
optimism, including influence on health and health related behaviors. However, limited 
exploration has been completed in the areas of CVD. Specifically, only two studies 
examine the development and progression of cardiovascular disease. Results from both 
studies demonstrate the importance of investigating this area more fully with CVD. 
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Additional research should include more diverse samples to see if findings can be 
replicated.  
 The long-term challenge may be figuring out if individuals can be “taught” to be 
more optimistic. Certainly individuals that already possess trait optimism have a head 
start. However, it may not be completely unrealistic to teach state optimism. Behavior 
modification techniques, such as meditation and reframing, have proven to be successful 
in managing stress and adverse visceral reactions. 
Literature on Optimistic Bias 
 Optimistic bias or unrealistic optimism is demonstrated when individuals believe 
that their own risk is less than that of their peers (Weinstein, 1987). Work conducted on 
risk perception relative to health and illness has shown that Americans tend to be 
optimistically biased about their susceptibility to disease and illness (Facione, 2002; 
Kreuter & Strecher, 1996; Weinstein, 1982, 1987).   
   Optimistic bias has been used to measure individual behaviors such as smoking 
(Ayanian & Cleary, 1999; Hahn, Rayens, Hopenhayn, & Christian, 2006; Strecher, 
Kreuter, & Kobrin, 1995; Weinstein et al., 2005), but has also been used to examine the 
Health Belief Model (Clarke, Lovegrove, Wiliams, & Machperson, 2000), susceptibility 
to health problems (Kruger & Burrus, 2004; Strecher et al., 1995; Weinstein, 1982), 
intent to change behavior (O’Brien, Fries, & Bowen, 2000) and breast cancer (Facione, 
2002; Katapodi et al., 2004). 
 Personal Characteristics. Researchers have found that, similar to risk perception, 
personal characteristics also influence optimistic bias (Avis, Smith, & McKinlay, 1989; 
Ayanian & Cleary; 1999; Hahn et al., 2006). For example, Ayanian and Cleary examined 
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smokers’ perception of risk for heart attack and cancer using both a telephone interview 
and a self-administered survey. The sample included 737 current smokers and 2,294 
former smokers. 
 Increased perceived risk for heart attack was correlated with age greater than 65 
years (O.R. = 0.2, 95% CI = 0.1-0.8, p < .05), less education (O.R. = 0.5, 95% CI = 0.2-
1.1,  p < .05), lighter smokers (less than 20 cigarettes per day) (O.R. = 3.0, 95% CI = 1.5-
5.8, p < .05), and self-reported fair or poor physical health (O.R. = 1.6, 95% CI = 1.0-2.7, 
p < .05). Perception of an increased risk of cancer was correlated age greater than 65 
years (OR 0.2, 95% CI 0.1-0.5, p < .05), less education (OR 0.5, 95% CI 0.2-0.9, p < 
.05), lighter smokers (less than 20 cigarettes per day) (OR 1.8, 95% CI 1.0-3.3, p < .05), 
Increased perceived risk for heart attack was correlated with age greater than 65 years 
(O.R. = 0.2, 95% CI = 0.1-0.8, p < .05), less education (O.R. = 0.5, 95% CI = 0.2-1.1,  p 
< .05), lighter smokers (less than 20 cigarettes per day) (O.R. = 3.0, 95% CI = 1.5-5.8, p 
< .05), and self-reported fair or poor physical health (O.R. = 1.6, 95% CI = 1.0-2.7, p < 
.05). Perception of an increased risk of cancer was correlated age greater than 65 years 
(OR 0.2, 95% CI 0.1-0.5, p < .05), less education (OR 0.5, 95% CI 0.2-0.9, p < .05), 
lighter smokers (less than 20 cigarettes per day) (OR 1.8, 95% CI 1.0-3.3, p < .05), 
In examining the results, it may appear unusual that increased perceived risk for 
heart attack and cancer occurred in only the light smokers (less than 20 cigarettes per 
day). However, this difference may be due to the fact that these individuals may have 
been heavy smokers at one time and cut down knowing there was a risk associated with 
heavy smoking. In addition, the number of light smokers may be skewed due to the self-
reported nature of the data. While the results of this study highlight personal 
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characteristics that contribute to perceived risk for heart attack and cancer, the use of self 
-reported data can introduce bias and can threaten internal validity.       
Avis, Smith, and McKinlay (1989) investigated influences on perceptions of heart 
attack risk in a random sample of 732 men and women, ages 25-65 years. Using logistic 
regression, the study found elevated perceived risk for heart attack was seen with 
increased age (O. R. = .90, 95% CI = .87, .92), self-reported poor health (O.R. = 1.80, 
95% CI = 1.25, 2.58), and death of a parent caused by heart disease (O.R. = 2.72, 95% CI 
= 1.52, 4.87). Both increased age and self reported poor health were findings similar to 
those found by Ayanian and Cleary (1999). However, these values were reported without 
a reference to a p value, thus increasing the risk for a Type I error when interpreting the 
results. It is possible that the journal did not require this information to be reported nearly 
19 years ago. However, this foundational study is important since it examined personal 
characteristics that affect risk perception. In addition, these researchers found that 42 % 
of the respondents underestimated their risk, 18% overestimated their risk, and 40% 
estimated their risk accurately when compared to an estimate provided by the RISKO 
tool, which is based on objective data regarding risk factors for CVD such as blood 
pressure and cholesterol. An overwhelming 60% of respondents inaccurately perceived 
their estimated risk for a heart attack. This is an important message because if individuals 
do not form an accurate perception of risk, there is little chance improvement in health 
behaviors will occur.  
Individual Behaviors. Optimistic bias research centered around individual 
behaviors and/or risk factors includes areas such as: seat belt use, binge drinking, condom 
use, vaccine effectiveness, food safety, bicycle helmet use, dietary choices, and traffic 
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accidents, to name a few. Since the purpose of this paper is not to explore optimistic bias 
specifically as related to individual behaviors, this area will not be explored in depth.  
However, one example will be discussed to demonstrate the difference with this 
application. Using grounded theory method, Wolburg (2001) studied risk perception of 
binge drinking among 81 college students at a small Midwest university.  Focus group 
data gathering took place prior to in depth interviews by paid volunteer participants. 
Results of the study revealed the following items as potential risks encountered while 
drinking: drunken driving, illegal activities such as fake identification and underage 
drinking, sexual experience including rape, passing out/losing control, fights, vandalism, 
physical illness, physical injuries, emotional consequences such as guilt or humiliation, 
drug use with alcohol, academic failure, financial consequences, and parent knowledge.  
The study concluded that students who feel personally vulnerable to threats/risks are 
more likely to understand the real risks in binge drinking. The prevailing attitude of most 
college students was that getting sick from drinking was the worst outcome to expect and 
most do not care if they get sick from drinking because they feel it is a part of college life 
(Wolburg).  Most students conveyed that they feel “invincible” and free from 
consequences; therefore they do not feel vulnerable to the risks of binge drinking.  
The results of this study are important for two reasons. First, because it 
demonstrated that these college age students participated in risky behavior such as binge 
drinking, despite identifying potential risks such as physical and social consequences. 
Second and perhaps more importantly, although this study has found this behavior to be 
true with college binge drinking, it may also carry over into health behaviors that affect 
the development of CVD such as smoking, unhealthy eating, and physical inactivity. This 
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study may have biased results based on the self-reported nature of the topic and use of 
volunteer subjects. It is possible that many participants may have purposely given 
misinformation about this controversial topic. Both biases may threaten the internal 
validity of the study.  
Screening Behaviors. Facione (2002) examined screening behavior for breast 
cancer in 770 women ages 19-99 years (mean age 46.18 years). The sample was diverse 
with 26.7% African American, 33.3% Latino, and 33% White. Only 8.3% had less than a 
high school education. This was a secondary analysis of data collected from a previous 
survey study. Instruments used in the study included: the Life Orientation Test (LOT) 
used to measure the trait of optimism; Breast Cancer Fatalism used to examine attitudes 
about developing and surviving breast cancer; Breast Cancer Symptom Knowledge 
(BCSK) used to evaluate knowledge about breast cancer; and the Reynolds Form of the 
Crowne-Marlow Scale used to analyze social desirability response bias. Satisfactory 
validity and reliability measures were provided for each instrument used in the study 
supporting internal validity. Facione hypothesized that women with more knowledge 
about symptoms of breast cancer and the disease process would show less optimistic bias 
about their personal risk and make more realistic judgments about their own risk. Results 
confirmed this hypothesis and showed women with a college education scored higher on 
the BCSK (mean 9.44, SD 3.44) than women without a college education (mean 7.04, SD 
4.31) and that higher education levels were significantly related to less optimistic bias on 
the BCSK scale (Chi square = 7.28, p= 0.007). In this study, LOT scores (trait optimism) 
did not significantly differ between those perceiving themselves to be at lower risk for 
breast cancer (mean 5.31, SD 1.84) and those perceiving themselves to be at higher risk 
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(mean 5.46, SD 1.70, t = .996, p = 0.314). Thus optimism did not influence their personal 
perception of breast cancer risk. Similar findings were described for the measure of 
fatalism in this study. However, 75.8% of the women gave comparative risk estimates 
lower than that of other women. Both the survey design and the use of a convenience 
sample may have produced biased results. However, the findings from this study may be 
cursory in helping to explain the delay in screening for breast cancer and related 
symptoms. Thus, communicating relative risk to women could ultimately influence 
preventive health practices for breast cancer.  
 This study is a good example of how both survey research and a secondary analysis 
of data is useful to researchers in examining strategies to influence health behaviors. 
While bias may be present, there is still enough evidence to further investigate how 
individuals perceive risk. The strength of this study was using established instruments 
with strong reliability and validity data. In addition, demographic data supported that 
level of education may be a powerful predictor of optimistic bias.  
 Susceptibility. Weinstein, Marcus, and Moser (2005) conducted a telephone 
interview with 6,369 participants and found that smokers underestimate their risk for lung 
cancer both relative to other smokers and to non-smokers. These findings support work 
completed by other researchers such as Ayanian & Cleary (1999) that was previously 
discussed. Strecher, Kreuter, and Kobrin (1995) examined perceived risk and optimistic 
bias for heart attack, cancer, and stroke in smokers and nonsmokers.  In contrast to 
previous studies, Strecher and colleagues found that smokers estimated their risk for each 
disease higher than non-smokers. However, the smokers in this study underestimated the 
degree of health-related problems caused by smoking. Thus, smokers knew that smoking 
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had negative effects, but underestimated the severity of the consequences. This may 
explain why smokers continue to smoke, even though they know they are putting 
themselves at risk for cardiovascular disease and cancer. However, the difference in 
methods between these studies is that Strecher and colleagues conducted personal 
interviews with subjects. The technique may be partially responsible for personal bias in 
reporting risk.  Weinstein believes that the specific questions asked have more influence 
on response than the type of interview. However, any type of telephone interviewing and  
voluntary participation may contribute to bias in the data collection affecting internal 
validity of the study. 
 Summary. Optimistic bias has been studied in many disease processes. Research 
has shown that personal characteristics such as age, gender, and education play a role in 
how individuals perceive risk. In addition, research conducted with breast cancer patients, 
in particular, demonstrated that optimistic bias is not only influenced by personal 
characteristics, but may also play a role in preventative screening behaviors. Because this 
concept has not been studied in CVD, it is not known how optimistic bias affects 
preventive health behaviors related to this disease process or risk perception for CVD. 
Understanding this relationship could potentially influence interventions that will 
effectively decrease the development and progression of CVD. The impact of primary 
prevention not only affects disease development and progression, but ultimately impacts 
healthcare resources. 
Literature on Negative Emotions 
 While the purpose of this paper is not to specifically discuss negative emotions, 
psychosocial components are becoming more widely recognized as risk factors for CVD, 
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hence it is necessary to address this area of literature. In addition, research related to 
optimism has suggested that the opposite of optimism may be depression and not 
pessimism. Research in this area is ongoing to determine this relationship. Initially, “type 
A” behavior was examined and attributed as a risk factor. More recently, however, other 
psychosocial components such as depression, anxiety, hopelessness, and worry have been 
recognized as contributing factors to CVD (Elovainio et al., 2005; Ferketich, 
Schwartzbaum, Frid, Melvin, & Moeschberger, 2000; Matthews, Nelesen, & Dimsdale, 
2005; Matthews, Owen, Edmunsowicz, Lee, & Kuller, 2006; Shnek et al. 2001; Weber-
Hamann et al., 2002). These components are often referred to collectively as negative 
emotions. It is important to examine how pessimism is related to other negative emotions.  
Rozanski, Blumenthal, and Kaplan (1999) describe depression as the presence of 
depressed mood and a marked decrease in all activities that persists for at least two 
weeks. In addition, this mood alteration is also accompanied by at least two of the 
following symptoms: “changes in appetite, sleep disturbance, fatigue, psychomotor 
retardation or agitation, feelings of guilt or worthlessness, problems concentrating, and 
suicidal thoughts” (p. 2193). Depressive symptoms may have components of clinical 
depression, but lack sufficient magnitude to be classified as such. Rozanski and 
colleagues outlined the presence of a threefold higher depression rate among those with 
CAD. It is important to distinguish between depression and the presence of depressive 
symptoms because research demonstrates that CAD is associated with the degree of 
depressive symptoms present (Matthews, Nelesen, & Dimsdale, 2005). These findings 
suggest that depression manifests along a continuum. Shnek and colleagues (2001) 
examined the relationship between psychological factors and depressive symptoms in 
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post-myocardial infarction patients using repeated measures at one-month post discharge 
and one-year follow-up. Regression analysis was run controlling for confounding 
variables of depressive symptoms, helplessness, self-efficacy, and cognitive distortions; 
optimism was the only variable negatively correlated with depressive symptoms (ΔR2 
0.34, p< 0.001) at time 2. This supports work initially completed in this area by Scheier 
and Carver (1985) conceptualizing optimism as a stable trait that is not affected by health 
status, mood or circumstances.  
 Gender. There is evidence to suggest that there are gender differences in how 
negative emotions manifest as part of the atherogenic process. For example, Elavainio et 
al. (2005) reported findings from the Young Finns study showing that higher levels of 
depressive symptoms, measured using a modified version of the Beck Depression 
Inventory, were correlated with increases in carotid intimal medial thickness in men, even 
after adjusting for age and cardiovascular risk factors in adolescence and childhood (β = 
0.08, F[1, 405], 9.24, p< 0.003). The Young Finns Study examined both men and women 
(n= 1126) over a 21-year period, capturing adolescence through young adulthood. The 
researchers suggest that one possible explanation for the expressed difference between 
genders is that women develop atherosclerosis later in life. However, further studies 
between men and women may help to explain the intricacies of these differences. More 
recent studies have indicated that negative emotions may also contribute to the 
development of atherosclerosis in middle-aged women (Matthews, Raikkonen, Sutton-
Tyrrell, & Kuller, 2004; Matthews, Owens, Edmunsowicz, Lee & Kuller, 2006). These 
studies were previously discussed in the section on optimism. 
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 Race/Ethnicity. In addition, there is evidence to support a link between 
race/ethnicity and depressive symptoms. Results from the Coronary Artery Risk 
Development in Young Adults (CARDIA) Study followed a cohort of 5,115 participants 
ages 18-30 for 15 years (Knox, Barnes, Kiefe, Lewis, Iribarren, Matthews, et al. (2006). 
This prospective study included African American men and Caucasian men and women. 
Measures of depressive symptoms were obtained with the Center for Epidemiology 
Studies Depression Scale (CES-D) instrument, a 20-item self-reported measure using a 4- 
point Likert scale. Reliability and validity measures have been reported widely for this 
well-established instrument.  
 Results found African American women had more episodes of depression (n = 625) 
compared to African American men (n = 367), Caucasian men (n = 276), and Caucasian 
women (n = 413). In addition, there was a significant association between diabetes and 
reported episodes of depression in African American men and women in both unadjusted 
(β = 0.09, SE = 0.02, p< 0.0001) and adjusted (β = 0.06, SE = 0.02, p< 0.0008) regression 
models. A significant inverse correlation between physical activity and depressive 
episodes was seen across all groups: African American men and women: β = -32.16, SE 
= 8.21, p = 0.0001; Caucasian men and women: β =   -27.26, SE = 8.27, p = 0.001). A 
positive correlation between smoking and depressive episodes was seen across all groups: 
African American men and women: β = 0.09, SE = 0.02, p = 0.0001; and Caucasian men 
and women: β = 0.07, SE = 0.02, p = 0.003). Similarly, a positive correlation was also 
seen between BMI and depressive episodes across groups: African American men and 
women: β = 0.18, SE = 0.18, p = 0.0001; and Caucasian men and women adjusted: β = 
0.54, SE = 0.19, p = 0.006). This study showed both differences and similarities between 
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African Americans and Caucasians regarding depressive symptoms and risk factors for 
CVD. This is an important first step in tailoring treatment options that not only affect 
depression, but also CVD. If, in fact, African Americans experience more depression, 
could this also be considered a comorbid state for this population? Further study may 
help to explain more about the relationship between negative emotion and the 
development and progression of CVD in various ethnicities.  
        Socioeconomic Status. Socioeconomic status is also a factor related to the presence 
of depression, anxiety and CHD. Thurston, Kubzansky, Kawachi, and Berkman (2006) 
examined data from the First National Health and Nutrition Survey (NHANES I) to see if 
depression and anxiety mediate the relationship between low socioeconomic status (SES) 
and CHD using regression analysis and proportion hazard ratios. In this analysis, the 
researchers considered negative affect to be the presence of depressive and anxious 
symptoms. However, specific indicators of these symptoms were not outlined in the 
paper. Increased risk of CHD was associated with high levels of depressive symptoms 
(RR = 1.57; 95% CI, 1.29-1.92) and symptoms of anxiety (RR = 1.60; 95% CI, 1.34-
1.90); as well as moderate levels of depressive symptoms (RR = 1.20; 95% CI, 1.05-1.37) 
and symptoms of anxiety (RR = 1.18; 95% CI, 1.03-1.36). Although these researchers 
reported that women had higher reports of depressive symptoms than men, after adjusting 
for age, the difference was marginal (p<0.05). While both depressive symptoms and 
anxiety are correlated to increased risk for CHD and lower SES, data did not support the 
hypothesized mediating effect. 
Fatalism. While fatalism has not been examined closely in cardiovascular research, 
the concept is worth exploring for two reasons. First, literature on fatalism in breast 
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cancer research has examined fatalism along with optimism, optimistic bias, and risk 
perception to examine risk perception with respect to that disease process. Second, and 
perhaps most important in this review, is that fatalism is present in several groups that 
have already been identified as high risk to develop CHD, namely African Americans, 
and Hispanics (Facione, Giancarlo, & Chan, 2000; Franklin, Schlundt, McClellan, 
Kinebrew, Sheats, Belue, et al., 2007; Kwok & Sullivan, 2006; Simon, 2006). Thus, a 
brief review of fatalism will be discussed.  Fatalism can be defined as a predetermined 
health outcome controlled by a higher power and not the individual (Franklin et al., 
2007). Fatalism is often associated with religious or cultural beliefs among Chinese 
Americans (Franklin et al., 2007; Faccione et al., 2000), African Americans (Franklin et 
al., 2007), and Hispanics (Simon, 2006). Fatalism has been shown to hinder both 
screening and treatment in breast cancer, thus there is increasing interest to study its 
effect on daily health behaviors.  Whether or not fatalism can be considered a negative 
emotion related to cardiovascular disease still needs to be determined, however, 
exploring pre-existing concepts from related disease processes such as breast cancer may 
help to increase knowledge about primary prevention for cardiovascular disease.   
There is an ever-increasing body of research that supports the relationship between 
negative emotions and the development of CHD. Furthermore, continued study of 
negative emotions may help to elucidate their role in personal health behavior choices 
and strategies to treat those with depression and depressive symptoms. It is important to 
continue to explore the relationship between negative emotions and health status. 
 Summary. In summary, the literature on risk perception, optimism, optimistic bias, 
and negative emotions clearly shows that these areas overlap conceptually. However, 
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since these concepts have not been used or measured consistently, gaps in the both the 
literature and research are present.  Health behavior choices, whether positive or 
negative, are conscious decisions made by individuals.  Investigators want to know how 
factors such as risk perception, optimism, optimistic bias, and negative emotions 
influence a person to choose health behaviors that will influence health status or disease 
progression. Findings from such research may be helpful in planning primary prevention 
strategies, such as tailored interventions, that could ultimately impact the onset of 
cardiovascular disease. 
Chapter Summary 
 The evidence reviewed in this chapter presents some concerns that need to be 
addressed. While the author addresses many critiques during the review of specific 
studies, there are a few global areas of concern. To begin with, none of the studies 
discussed power analysis or effect size in relation to the sample size. In addition, most 
samples were nonrandom convenience samples that increased the risk for bias. Second, 
with few exceptions (Clarke et al., 2000; Facione, Giancarlo, & Chan, 2000; Hahn et al., 
2006, Meischke, et al., 2000; Scheier et al., 2006; Weinstein, 1982) studies did not use or 
discuss theoretical frameworks or models to guide the study. The two theoretical 
frameworks most frequently cited in these studies were the Health Belief Model or the 
Stages of Change Model.  
 While each study has made a contribution in understanding how risk perception, 
optimism, optimistic bias, and negative emotions affect health and health related 
outcomes, more research is needed for a number of reasons. First, there has been 
inconsistency in the terms used. For example, risk perception has often been used when 
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knowledge and awareness is being studied. In addition, comparative and subjective risk 
can and have been measured in many different ways. These inconsistencies present a 
problem when comparing study results and making conclusions regarding the findings. 
Adding to this concern is the use of many different instrument measures. While some 
instruments such as the LOT are well-established, some of the studies have used only 
parts of scales or descriptive words to gather data (Carver et al., 2003). Moreover, much 
of the work has been limited to cancer research. The knowledge gained from these 
studies needs to be replicated in the area of CVD. Furthermore, both genders need to be 
studied. Both breast cancer research and foundational research in CVD conducted by 
Matthews et al., (2004) and Matthews et al., (2006), has focused only on women. It is 
necessary to see if research including both genders would produce similar results.  
 In conclusion, knowledge about risk factors, alone, is not enough for individuals to 
make decisions about health behaviors. More understanding is needed on how 
psychological variables such as risk perception, optimism, optimistic bias, and negative 
emotions govern an individual’s consciousness to make decisions regarding health 
behavior. Future work examining the relationship of risk perception and related concepts 
with CVD disease development and progression is necessary in order to make an impact 
on morbidity and mortality rates.  
 
 
   
 
 
CHAPTER THREE 
 
 METHODS 
 
The previous sections have described several factors that are conceptually related 
to risk perception. Psychological variables such as optimism, life satisfaction and 
depressive symptoms may play an important role in how persons perceive risk. In 
addition, other influences, such as demographic and personal variables, may also be 
helpful when examining risk perception.  The relationships between and among these 
variables will help to establish how risk perception is formed and may be an important 
component in understanding the decision-making process that leads to behavior changes. 
Therefore, the purpose of this study is to examine the concept of risk perception in 
cardiovascular disease. The primary aims are to: 1) examine the accuracy of one’s 
perceived risk for CVD; and 2) examine the relationship between perceived risk and key 
sociodemographic and psychological variables thought to influence risk perception. 
Hence, the study will be framed by the following research questions: 1) Do persons 
perceive their risk for cardiovascular disease accurately? 2) How do the 
sociodemographic variables of age, gender, socioeconomic status, level of education, 
family history of CVD, and knowledge of someone with CVD contribute to risk 
perception? 3) How do the psychological variables of optimism, life satisfaction, and 
depressive symptoms contribute to risk perception? 
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Study Design and Rationale 
This study used a cross-sectional descriptive correlational design to explore the 
relationship between perceived versus calculated risk, the demographic variables that 
may affect perceived risk and the relationship between optimism, optimistic bias, and 
depressive symptoms and how each contributes to perceived risk. For the remainder of 
this study, the term psychological variables will refer to optimism, optimistic bias, life 
purpose, and depressive symptoms. The conceptual framework developed by the author 
supports this design and the proposed study questions (Appendix C). In addition, the 
review of literature also confirms the importance of examining the relationship between 
risk perception, demographic variables, and psychological variables. 
Setting: Health Screenings 
The study was conducted at monthly Health Screenings (called CV Health Risk 
Appraisals) in a multi-hospital system that serves racially and ethnically diverse 
populations in Northwest Indiana and neighboring Illinois. The three hospitals in this 
system have a capacity of over 750 beds. The Community Hospital is located in Munster, 
Indiana; St. Mary Medical Center is located in Hobart, Indiana; and St. Catherine 
Hospital is located in East Chicago, Indiana.. 
The three hospitals host the Health Screenings each month on different days of 
the week and at a variety of times to allow people of all ages to attend.  These screenings 
include the following measures: systolic and diastolic blood pressure, body mass index, 
fasting blood sugar, measures for determining metabolic syndrome, lipid levels (total, 
HDL, LDL cholesterol, and triglycerides), and a heart health profile. The heart health 
profile ascertains family history of heart disease and dyslipidemia, as well as personal 
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history of diabetes, disylipidemia, hypertension, and stroke. Other measures include: 
intake of saturated fat, dietary sodium, and alcohol; exposure to secondhand smoke; 
weekly exercise patterns; and coping status. Lastly, women are asked to report use of 
birth control pills and hormone replacement therapy. 
Recruitment  
Pre-registration is required to attend a health screening even. Health screening 
events are advertised throughout the institutions in the hospital system. Those interested 
in attending a screening must call to reserve a spot and are given a designated time to 
arrive on the day of the screening along with instructions for fasting prior to the 
screening. The number of participants who attend the monthly health screenings varies, 
but average attendance is 10 and 20 individuals. Attendance is affected by the time and 
day of the screening as well as weather conditions. 
The researcher planned to recruit participants from those already attending the 
screening event. Since the average attendance is 10-20 people per event, additional 
methods were used in an effort to recruit a sufficient number of participants for this 
study.  The first supplemental method was to advertise the research study at each of the 
hospitals and their associated outpatient clinical facilities. Approved study fliers were left 
and replenished in waiting rooms at these facilities which included: wellness centers, 
outpatient physical therapy and rehabilitation departments, and outpatient diagnostic 
centers. The second method was to advertise in the community at area churches and 
community centers that offer instructional classes. Similarly, approved study flyers that 
explained the purpose of the study were sent to these facilities to be posted in a visible 
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area. In addition, contact information for the researcher was made available. See 
Appendix D for Flyers.  
All departments who had staff working at the coronary risk appraisals were sent 
information about the participation and recruitment for the study. The researcher met 
with the screening coordinator prior to the start of the initial data collection to discuss the 
purpose of the study, approved recruitment procedure, and the informed consent process. 
Before each screening, the researcher talked to staff working at the screening to reinforce 
that any questions about the study be referred to the researcher for clarification.  
The researcher was present at all screenings during the study period to advertise 
and recruit.  The researcher sat in a designated recruitment area to discuss the purpose of 
the study, obtain informed consent, and complete the data collection booklet. The 
screening event areas were all located in well-marked areas in each hospital and easily 
accessible to participants. 
Sample 
A nonprobability convenience sample meeting both inclusion and exclusion 
criteria were enrolled in the study. The types of people who typically attend the 
screenings are: both insured and uninsured people seeking an economical way to get 
laboratory testing related to cardiac wellness; the ”worried well”- people who are well, 
but worry about their health status and frequently seek out health screenings; and those 
referred by their physicians for annual laboratory work. 
The inclusion criteria for participation were: men and women over the age of 40 
years, who are able to participate in the informed consent process and could read, speak, 
and understand English. The preselected age range was based on the 2012 AHA Heart 
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Disease and Stroke statistics that states that average age of onset for the initial major 
cardiovascular event is 70.4 years for women and 64.5 years for men (American Heart 
Association 2012 update). The age range has been selected to capture both men and 
women who have not experienced a cardiovascular event nor who have been diagnosed 
with cardiovascular disease. 
The exclusion criteria for participation included: self-report of diagnosed 
cardiovascular disease; inability to participate in the informed consent process and 
inability to read, speak or understand English; those who have been diagnosed with 
clinical depression or are taking medications to treat depression; and those who have 
undergone percutaneous coronary transluminal angioplasty (PTCA) or coronary artery 
bypass graft surgery (CABG).  
The number of pre-registered persons for each screening was communicated to 
the researcher so that an appropriate amount of material was brought to each screening. 
Each person who arrived for the screening was given a study flyer which included the 
description and purpose of the study (Appendix D). Those interested in participating in 
the study were referred to talk with the researcher and were screened for inclusion and 
exclusion criteria. Those meeting the stated eligibility criteria were encouraged to ask 
questions about the study. After all questions were answered, the participant was asked to 
sign duplicate informed consent and HIPAA documents (Appendices E and F, 
respectively).  
Data Security 
Each participant was assigned a study number to de-identify the data and protect 
the anonymity of the participant. A directory of study numbers and corresponding 
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participant names is kept in a locked file cabinet in the researcher’s home office. 
Completed questionnaire booklets were transported directly from each data collection site 
to the researcher’s home. De-identified data was entered into a password protected 
database on a laptop computer.  
                                           Measurements 
The outcome variable in this study is risk perception, while the independent 
variables included: demographic variables, health history, actual/predicted cardiac risk, 
and psychological variables (life satisfaction, and optimism, and depression).  Each 
variable and related measurement tools are discussed next. Instruments with acceptable 
reliability and validity were selected to measure these variables. See Table 3 for an 
overview.  
Table 3. Measurement Instruments   
Variables  Measurement 
Outcome:  
Risk Perception 
 
Dependent:  
Demographics & Health History 
 
• CRIP Instrument 
 
 
• Demographic Study Questionnaire 
• Wellsource© Health History Form 
  
Life Satisfaction • Life Engagement Test (LET) 
Optimism • Life Orientation Test Revised (LOT-R) 
Depression • Patient Health Questionniare-8 (PHQ-8) 
Actual/Predicted Cardiovascular Risk • Framingham Risk Score (estimate of 10 year risk for 
CVD)  
• Heart Health Score(Wellsource©) (estimate of level 
of coronary risk)  
 
Risk Perception 
Risk perception is relatively new to the area of cardiovascular research.   The 
Cardiac Risk Perception (CRIP) instrument (Barnhart, 2009) was used in this study 
(Appendix G). The CRIP is a six point Likert-based instrument composed of 19 questions 
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encompassing the domains of perceived vulnerability, worry, self-efficacy, & perceived 
health status through both comparative and subjective risk statements. Scoring entails 
adding the total responses once the worry and self-efficacy questions are reversed (# 5, 7, 
11, 14, 16), with higher scores indicating increased risk perception. The Likert response 
range is: Strongly Disagree/ /Disagree/ /Somewhat Disagree/ /Somewhat Agree/ /Agree/ / 
Strongly Agree. The CRIP has undergone vigorous pilot testing in several populations 
involving postmenopausal women, persons with diabetes, and mixed genders. Reported  
Cronbach’s alpha = 0.78 in a recent study (Barnhart, 2008). The time needed to complete 
the instrument is approximately 10 minutes. 
Demographic Variables and Health History 
The demographic study questionnaire consisted of demographics such as: age, 
gender, marital status, socioeconomic status, and number of children as well as  questions 
that examined  health maintenance behaviors. Examples included: How often do you see 
your primary care provider? How often do you visit your dentist? These questions were 
structured to elicit ordinal or continuous level of measurement (See Appendix H). In 
addition, health history information   was gathered using the Wellsource© Heart Health 
Profile. Wellsource© is a company that provides health appraisal programs widely used 
for more than 30 years. The Wellsource© program reports a combination of ordinal and 
continuous measurement data and will be discussed in the section on projected cardiac 
risk.  
Psychological Variables 
The psychological variables assessed in this study included: optimism, life satisfaction, 
and depressive symptoms. These types of variables may lead to misleading results during 
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this current economic climate. Therefore, a number of single question items were also 
added to the Health History Questionnaire to help determine if the presence of any 
depressive symptoms are situational and related to the current economic 
environment or whether they are more dispositional in nature.  Each of these instruments 
are discussed in this section.  
Optimism. The Revised Life Orientation Test (LOT-R) was used to measure 
optimism. Although there are several versions of this instrument, this study used the 
modified version of the tool (Appendix B) (Scheier, Carver, & Bridges, 1994). The life 
orientation test-revised (LOT-R) is a LIKERT scale based instrument consisting of ten 
questions. In the revised version, there are four filler questions (#2, 5, 6, 8), three 
positively worded questions (#1, 4, 10), and 3 negatively worded questions (#3, 7, 9). The 
coding of the LOT-R (with a total possible score of 24) is positively worded so that high 
values imply optimism, while low values imply pessimism (Scheier et al., 1994). 
Reported Cronbach’s alpha for the LOT-R = .90, making the instrument highly reliable 
and valid for measuring optimistic bias (Scheier et al., 1994). This instrument has been 
used widely to measure optimism in areas previously discussed such as: immune 
response (Sergerstrom, Taylor, Kemeny, & Fahey, 1998), cancer, cardiovascular disease 
progression (Matthews 2004), and arthritis (Brenes, Rapp, Rejeski, & Miller, 2002).Time 
to complete this instrument is approximately five minutes.  
Life Satisfaction. Life satisfaction was measured using the Life Engagement Test 
(LET). The LET is a five point Likert scale based instrument consisting of six questions 
(Appendix I). Three items (# 2, 4, and 6) are positively framed, while the other three 
items (# 1, 3, and 5) are negatively framed. The LET is scored in a two-step process. 
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First, three questions (# 1, 3, and 5) are reverse coded and then the scores are summed. 
The higher the summary score, the higher the reported purpose in life. Reported 
Cronbach’s alpha for the LET in initial testing ranged from .72 to .80, making the LET 
reliable, especially for a newer instrument. Purpose in life has been shown to affect how 
persons make decisions about health behaviors and also has been correlated with 
development of CVD in a longitudinal study (Matthews, Owens, Edmundowicz, Lee & 
Kuller, 2006). Although this variable is relatively new in cardiovascular research, it may 
be directly related to both optimism and depressive symptoms. Time needed to complete 
this instrument is approximately 3-5 minutes.  
Depression. The PHQ-8 (Appendix  J) is a self-reported depression screening 
instrument using the first eight questions of the Patient Health Questionniare-9 (PHQ-9). 
Comparative analysis of the PHQ-9 with the PHQ-8 indicated similar operating 
characteristics with respect to predictability of depression severity (Kroenke, Spitzer, & 
Williams, 2001).  The PHQ-8 omits the ninth item asking about “thoughts that you would 
be better off dead or of hurting yourself in some way”. The use of this alternate form is 
supported for use in populations or samples in which one or more of the criteria are met: 
there is a low or negligible risk of suicide; depression is being assessed as a secondary 
outcome and not the focus of the research; and data is collected using self-report 
measures (Kroenke & Sptizer, 2002). 
The questions are scored on a 0-3 Likert scale with 0 = not at all, 1 = several days, 
2 = more than half the days, and 3 = nearly every day. The scoring for the PHQ-8 is 
summative with a score ranging from 0 –24. Current literature supports a score of > 10 on 
the PHQ-8 as being positive for symptoms of depression (Kroenke, Strine, Spitzer, 
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Williams, & Mokdad, 2009). In addition, reported reliability for the PHQ-9 is 0.89 in a 
study of 3,000 primary care patients and 0.86 in the OB-GYN study of 3,000 women. 
Calculated Cardiovascular Risk 
       Framingham Risk Score. The Framingham Risk Score is a calculation that projects 
one’s 10-year risk for a cardiac event, and has been widely used and reported in the 
literature.  Calculated cardiovascular risk is based on physiological measures and self-
reported health behaviors obtained at the coronary risk appraisal.  This calculation used 
the following variables: age, gender, total and HDL cholesterol, systolic blood pressure, 
smoking history and diabetic history.   
Calculations were performed using  a gender appropriate tool and risk scores  
were  categorized as low, medium, and high (Appendix K). Those participants with 
coronary risk equivalents (diabetes, stroke, and peripheral artery disease) were scored as 
>20% risk of developing CHD over the next 10 years. The researcher completed the 
calculations of the scores using the online risk calculator. This score serves as a surrogate 
for “actual/predicted risk for heart disease”. During the calculation of the Framingham 
Risk Scores, the researcher noted little variability in the scores. Therefore, it was decided 
to also include the Heart Health Scores (HHS) in data analysis. Though the HHS is a 
similar concept, it does not project future  risk, rather it reflects current risk based on the 
number and severity of risk factors.    
Heart Health Score. The Heart Health Score is based on a scoring strategy using 
the NCEP III revised guidelines based on the severity and amount of the risk factors and 
includes the same variables: age, gender, lipid profile, systolic blood pressure, BMI, 
smoking history and diabetic history listed for the Framingham Risk Score, but the HHS 
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also adds fitness level and personal and family history of cardiovascular disease 
(Wellsource©, 2012). The Wellsource© program assigns a score based on the number 
and severity of risk factors (major versus moderate) present.  A computer program 
generates a “Heart Health Score” (HHS) in one of four categories: 
 “Excellent” or “Ideal risk” (score of 75-100), defined as no risk factors other than 
age; 
  “Doing Well” or “Low Risk” (score of 50-74),defined as having 1 to 3 moderate 
CHD risks factors not including age, or having a personal history of CHD when blood 
lipids are “not known” 
 “Needs Improving” or “Moderate Risk” (score of 25-49), defined as having only one 
major CHD risk factor not including age or family history or having 4 or more 
moderate CHD risk factors (counting age and family history as moderate risk factors), 
and 
 “Caution” or “High Risk” (score of 0-24 defined as having moderate CHD risk blood 
lipids AND 2 or more major CHD risks OR having two or more major CHD risks not 
including age OR having one major CHD risk, plus the age major risk AND Low 
fitness OR having blood lipids or triglycerides within “Ultra-high” category. 
The score is part of a report generated from the Wellsource© computer program and was 
provided to the researcher by the coordinator of the screening.  See Appendix L. 
                          Knowledge and Attitude Questions 
Chapter two highlighted that the concept of risk perception has not been used 
consistently in the healthcare literature. Examples were provided that illustrated that 
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while some studies stated that risk perception was being measured or used the term 
“perception of risk” in their title, it was found that awareness or knowledge about risk 
factors was really being measured (King et al, 2002; Oliver-McNeil & Artinian, 2002). 
Knowledge and awareness are thought to be related to CVD and is therefore foundational 
to the formation of personal risk perception. Thus, in addition to answering the aims of 
the study, questions that gathered information on worry about disease, knowledge related 
to CVD, being informed about heart disease, risk factors to CVD, and risk factor 
modification strategies were also included. In addition, permission was obtained to 
include specific questions from the American Heart Association 2009 telephone survey 
tool (Mosca, Mochari-Greenberger, Dolor, Newby and Robb, 2010). 
Data Collection Procedure 
The usual health risk appraisal screening procedure required individuals to pre-
register for the event.  When participants arrived at the screening, the study was briefly 
explained and if they were interested in participating in the study, they were told to report 
to a specific area in the room after their testing was completed. Participants were given a 
15 question Wellsource© Heart Health form to complete prior to having blood pressure, 
height, and weight taken and recorded by an exercise physiologist. Next, blood was 
drawn by a qualified hospital phlebotomist in order to generate laboratory results for a 
fasting blood sugar and lipid profile.  Each sample was coded with the patient’s name and 
patient identification number. The collected blood was later sent to the hospital 
laboratory where it was analyzed according to hospital policy and standardized 
procedures. The researcher did not interfere with nor was involved in the blood sampling 
procedures or blood analysis process.  
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Persons interested in participating in the study returned to the researcher’s table to 
complete the informed consent process and obtain the study booklet containing a unique 
participant number. The researcher was available to clarify study information and to 
answer any questions. Granola bars were available to participants while they completed 
the booklet. The researcher verified that all items had been answered prior to giving a 
$10.00 gift card to the participant.  
Approximately one week after the screening, the Health Screening Appraisal 
coordinator received a report containing all laboratory results. She entered the laboratory 
results into a Wellsource© computer program to generate a personalized report for each 
participant. The reports were then mailed to each participant via the United States postal 
service. Each report provided a composite “overall” heart health score determined by the 
number of risk factors present and offered a detailed explanation of the test results. For 
example, the lipid profile was broken down into desirable, borderline, and high risk 
results, while also displaying the participant’s results. After results were reported, 
suggestions were provided on how to effectively modify any results that needed 
improvement. For each category, the report outlined whether the participant is “doing 
well” or “needs improvement”. The researcher contacted the coordinator to acquire a 
copy of the Wellsource© report and laboratory data for each participant in the study. A 
Framingham Risk Score was calculated by the researcher from this report and the 
physiological measures taken at the screening.  
                       Power Analysis Calculation of Sample Size 
The sample size proposed for this study was estimated using power analysis in an 
effort to decrease the chance of making a Type II error and increase the likelihood of 
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finding statistically significant results erroneously rejecting the null hypothesis. The 
power analysis was calculated framed by the research questions. Regardless of these 
questions, the alpha (α) and beta (β) levels were set at 0.05 and 0.80 respectively. 
The first research aim examined if persons perceive their risk for the development 
of CVD accurately. This aim correlated actual/predicted risk scores measured by a 
Framingham Risk Score (FRS) and Heart Health Score (HHS) with risk perception 
scores, as measured by the CRIP. Using a moderate effect size (r = 0.30) with α = 0.05, β 
= 0.80, the sample estimate was 67 participants (Hulley, 2001). A second calculation was 
performed using a method proposed by Cohen (1992). Using a moderate effect size of 
0.30 and α = 0.05, the sample estimate was 85 participants.  
The second  and third research aims examined the contributions of psychological 
variables and possible confounders to risk perception: How do optimism (LOT-R), life 
purpose (LET), and depressive symptoms (PHQ-8) contribute to the formation of risk 
perception (CRIP)? The literature suggests 10-15  participants per independent variable 
in a regression analysis. Therefore, based on three independent variables  (optimism, life 
purpose, and depressive symptoms) and six possible confounding variables (age, gender, 
level of education, socioeconomic status, family history, and personal knowledge of 
knowing someone with CVD), the estimated number of participants needed for this study 
was between 90 (nine variables x 10 = 90) and 135 (nine variables x 15 = 135).  A third 
method outlined by Cohen (1992) was also examined. Using a moderate effect size 
statistic (0.15), α = 0.05, β = 0.80, and nine variables, the sample estimate would be 111.  
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Data Analysis 
Data analysis was conducted using International Business Machines Statistical 
Software Package for Social Sciences (IBM SPSS) version 20 (2012). Alpha and Beta 
levels were set at 0.05 and 0.90 respectively for all statistical analyses to limit the 
possibility of a Type II error. Data were manually screened for data entry errors including 
missing or potentially erroneous data.  Identified errors were corrected and frequencies 
were run again prior to continuing further data analysis. Data were cleaned using the 
process of running frequencies. 
Data were analyzed for normality, outliers, and extreme scores that could 
influence data interpretation and study outcomes. Descriptive statistics are provided for 
the sample and displayed in tabular form. Data obtained from the CRIP, LOT-r, LET, and 
PHQ 8 as well as data on the Framingham Risk Scores (FRS) and Heart Health Scores 
(HHS) were analyzed for normal distribution by examining histograms, measures of 
central tendency, skewness and kurtosis. The reliability of each instrument was examined 
for internal consistency using Cronbach’s alpha. 
Aim 1: Examine the Accuracy of Perceived Risk 
The prevalence of both self-reported and physiological risk factors was examined 
to offer a baseline view of risk factors present in the sample. Then, the relationship 
between the prevalence of known risk factors and risk perception was explored using 
nonparametric correlation analysis. Next, Pearson correlation analysis was used to 
examine the relationship between the scores from both the FRS and HHS.  Again, using 
Pearson correlation analysis the relationship between calculated cardiovascular risk (FRS, 
HHS) and risk perception (CRIP) was explored. Finally, a Chi-squared test was used to 
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determine whether there was a significant difference between FRS and HHS on risk 
perception scores. 
Aim 2:  Examine the Relationships between Perceived Risk and 
   Sociodemographic/Psychological Variables 
Relationships between sociodemographic variables (age, gender, level of 
education, socioeconomic status, and income), psychological variables (LOT-r, LET, & 
PHQ-8) and risk perception were examined using multiple regression analysis including 
only those variables that were significantly correlated with risk perception. A backwards 
stepwise method was employed since the model used to support this study is new and 
untested and therefore will help to account for suppressor effects and reduce the risk of 
making a Type II error (Field, 2009).   
                            Institutional Review Board Approval 
This study was approved by three independent review boards located at: Loyola 
University, Purdue University (the researcher’s faculty appointment), and The 
Community Healthcare System (the research setting). Institutional review boards were 
not only designed to ensure participant safety, but also to evaluate the risks and benefits 
as well as the overall strength of study design thus supporting ethical integrity, sound 
study design, and feasibility. The study did not begin until approval was gained from all 
three review boards.  
 
 
  
CHAPTER FOUR 
RESULTS 
The overall purpose of this study was to examine the concept of risk perception in 
cardiovascular disease using two specific aims: 1) To examine the accuracy of one’s 
perceived risk for CVD; and 2) To examine the relationship between perceived risk and 
key sociodemographic and psychological variables thought to influence risk perception. 
This chapter provides the study results beginning with a discussion of the sample 
characteristics and key variables.  The results are reported according to the specific aims 
of the study.  
Sample 
Participants were recruited at health screenings hosted by a multi-hospital system 
in the Midwest. Over a 14 month period, a total of 296 individuals were pre-registered for 
the screenings that the researcher attended, however, 71 (24%) did not show up. Of the 
225 individuals present at the screenings, 63 (27%) did not meet one or more of the 
inclusion criteria and 48 (21%) declined participation in the study.  Therefore, 114 
participants were enrolled in the study. However, while matching laboratory data with the 
data collection booklets during the data entry process, one participant was excluded 
because she came to two separate screenings but used different names in the consent 
process.  Thus a total of 113 participants who met enrollment criteria completed the 
study. 
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Sample Characteristics 
 The mean age of the sample was 58 years, 69% were female, 70% were White 
Caucasian (non-Hispanic), and 58% were married. The sample was well-educated, with 
42.5% having a 4 year college degree or higher; 28% having vocational training, an 
Associate degree or some college; and 21% having a high school diploma. Most 
participants were employed full or part-time (63%) with reported annual household 
incomes almost evenly split between less than or greater than $50,000.  The majority of 
the participants (91.2%) reported having private insurance, with only 8.8% having no 
health care coverage. Table 4 provides information on the overall sample characteristics. 
Because the study took place at four sites in a multihospital system, it was 
expected that the study sample would resemble the racial and ethnic composition of the 
surrounding communities. Based on the most recent United States Census Bureau 
estimates, the population in Lake County, Indiana was 490,093 and included: 62.8% 
Caucasian, 25.5% African American, 14% Hispanic or Latino, 1.1% Asian, and 0.3% 
American Indiana or Alaskan Eskimo (United States Census Bureau, 2009).  The study 
sample did closely resemble these statistics with the exception of the African American 
representation.  See Table 4. 
 
 
 
 
 
 
 
 
 
 
 
 
88 
Table 4. Sample Characteristics 
Characteristic N Percent 
Age    Mean (Standard Deviation) 
          Median (Range) 
Gender 
          Male 
          Female 
Race/Ethnicity 
         Hispanic/Latino Culture 
         Black/African American (Non-Hispanic)    
         Caucasian/White (Non-Hispanic)   
         Asian (Pacific Islander) 
         Other: American Indiana 
Marital Status 
         Married 
         Living in a marriage-like relationship 
         Divorced or Separated 
         Widow/Widower 
         Never Married 
Education 
         No formal Schooling 
         Less than 9th Grade 
         9th -12th Grade (no diploma) 
         High School Diploma or GED 
         Vocational School, Some College or Associate Degree  
         College Graduate degree or higher 
Total Annual Household Income 
         Under  $20,000  
          $20,000 to less than $35,000 
          $35,000 to less than $50,000 
          $50,000 to less than $75,000 
          $75,000 to less than $100,000 
          $100,000 to less than $150,000 
          $150,000 to less than $200,000 
Employment Status 
          Full or Part-time 
          Retired 
          Homemaker 
          Other: Currently Unemployed 
Health Insurance  
          Primary Coverage 
          No Primary Coverage 
          Secondary Coverage 
113 
 
 
35 
78 
 
14 
15 
80 
3 
1 
 
65 
4 
21 
11 
12 
 
2 
2 
5 
24 
32 
48 
 
12 
21 
28 
20 
16 
10 
6 
 
71 
29 
7 
6 
 
103 
10 
11 
58.02 (+ 9.8) 
57.80 (40-83) 
 
31.0% 
69.0% 
 
12.4% 
13.3% 
70.8% 
2.7% 
0.9% 
 
57.5% 
3.5% 
18.6% 
9.7% 
10.6% 
 
1.8% 
1.8% 
4.5% 
21.1% 
28.3% 
42.5% 
 
10.6% 
18.6% 
24.8% 
17.7% 
14.2% 
8.8% 
5.3% 
 
62.8% 
25.7% 
6.2% 
5.3% 
 
91.2% 
8.7% 
9.6% 
 
Knowledge and Awareness Survey 
 
 As discussed earlier in chapter 3, questions taken from an American Heart 
Association questionnaire were used to determine participants’ overall awareness, 
knowledge and perceptions about heart disease that were expected to influence their risk 
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perception. Prior studies used these questions to describe their sample of interest using 
descriptive statistics.  No “total” or “subscale” scores can be derived from these 
questions. Therefore, the data is reported here as background information to provide 
evidence of how educated and aware the sample was about heart disease and CVD risk. 
Awareness and Perception about CVD 
 When asked to “select the greatest single health problem today from a pre-
determined list, participants responded as follows: heart disease/heart attack (34.5%), 
obesity (25.7%), and cancer-in general (23%). Participants were also asked to identify the 
leading cause of death for both men and women. Heart disease/heart attack was 
overwhelmingly identified as the leading cause of death for men (77.9%) and women 
(63.7%). See Table 5. 
Table 5. Awareness and Perception about CVD 
   N (%) 
Greatest health problem?  
 Heart disease/ heart attack 
 Obesity 
 Cancer-in general 
 
N=39  (34.5%) 
N=29  (25.7%) 
N=26  (23.0%) 
Leading cause of death for men? 
 Heart disease/ heart attack 
 Cancer- in general 
 Lung cancer 
 
N=88  (77.9%) 
N=11  (9.7%) 
N=  5  (4.4%) 
Leading cause of death for women? 
 Heart disease/ heart attack 
 Cancer- in general 
 Breast cancer 
 
N=72  (63.7%) 
N=21  (18.6%) 
N=15  (13.3%) 
 
Knowledge of Heart Disease 
When asked about how well informed participants were about heart disease, more 
than half or 67 (59.3%) reported being moderately informed, followed by 32 (28.3%) 
being well informed, and nine (8%) being very well informed. Despite only five (4.4%) 
participants stating that they were not at all informed about heart disease, it is surprising 
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that 14.1% of the participants either strongly or somewhat agreed with the statement 
“There is nothing you can do to prevent yourself from getting heart disease”. In addition, 
19 participants (16.8%) strongly agreed and 45 (39.8%) somewhat agreed with the 
statement “When you think about heart disease, you most often think of someone having 
a heart attack and dying quickly”. See Table 6. 
Table 6. Knowledge of Heart Disease 
How informed are you about heart disease? 
 Very well 
 Well 
 Moderately 
 Not at all 
 
N= 9 (8.0%) 
N= 32 (28.3%) 
N= 67 (59.3%) 
N= 5 (4.4%) 
There is nothing you can do to prevent yourself 
from getting heart disease 
 Strongly agree 
 Somewhat agree 
 Somewhat disagree 
 Strongly disagree 
 
 
N=  5 (4.4%) 
N=11 (9.7%) 
N=24 (21.2%) 
N=73 (64.5%) 
When thinking of heart disease, you think of 
someone having a heart attack and dying quickly?  
 Strongly agree 
 Somewhat agree 
 Somewhat disagree 
 Strongly disagree 
 Do Not Know 
 
 
N=19 (16.8%) 
N=45 (39.8%) 
N=24 (21.2%) 
N=22 (19.5%) 
N=  2 (2.7%) 
 
Perceptions of Heart Disease Risk Factors and Prevention   
Knowledge related to risk factors and risk factor modification were asked using 
two multiple response questions from the American Heart Association. The first question 
was: “Based on what you know, what are the major causes of heart disease?” The 
participants were asked to “select all that apply” from the following list: family history of 
heart disease, being overweight, drinking alcohol, high cholesterol, low levels of 
estrogen, exercise, stress, aging, diabetes, high blood pressure, high triglycerides, 
menopause (in women), smoking, and racial heritage. The majority of participants 
correctly identified high cholesterol (100%), family history (97.3%), being overweight 
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(95.6%), stress (92.0%), high blood pressure (89.4%), and lack of exercise (83.2%) as 
contributing to heart disease. However, many participants did not identify significant 
factors such as: low levels of estrogen (86%), menopause (84.3%), drinking alcohol 
(70.2%), racial heritage (64%), aging (60.5%), diabetes (53.5%), high triglycerides 
(36.8%), and smoking (28.9%).   
 The second question asked participants to identify activities from a list that they 
believed could prevent or reduce the risk of getting heart disease. The majority of the 
participants identified losing weight (99.1%); getting physical exercise (96.5%); reducing 
stress (95.6%); maintaining healthy cholesterol (93.8%); quitting smoking (92.9%); 
maintaining blood pressure levels (91.2%); reducing dietary sodium (86.7%), dietary 
cholesterol intake (80.5%), and  dietary animal products (74.3%), as well as taking 
aspirin regularly (60.2%) as strategies that prevent or reduce the risk of getting heart 
disease. Conversely, only a minority of the sample identified taking special vitamins like 
C, D, & E (28.1%) or multivitamins with folic acid (26.3%); aromatherapy (17.5%); and 
hormone replacement therapy (11.5%) as being activities that could prevent or reduce the 
risk of getting heart disease.  See Table 7. 
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Table 7.Perceptions of Heart Disease Risk Factors and Prevention 
What are major causes of disease? (Check all that 
apply). 
 high cholesterol 
 family history 
 being overweight 
 stress 
 high blood pressure 
 lack of exercise 
 
 
N=113 (100%) 
N=110 (97.3%) 
N=108 (95.6%) 
N=104 (92.0%) 
N=101 (89.4% 
N=  94 (83.2%) 
What specific activity could reduce risk of getting 
heart disease? (Check all that apply). 
 losing weight 
 getting more physical exercise 
 reducing stress 
 maintaining healthy cholesterol level 
 quitting smoking 
 maintaining a healthy blood pressure 
 reducing dietary sodium intake 
 reducing dietary cholesterol intake 
 reducing dietary animal products 
 taking aspirin regularly 
 
 
 
N=112 (99.1%) 
N=109 (96.5%) 
N=108 (95.6%) 
N=106 (93.8%) 
 
N=105 (92.9%) 
N=103 (91.2%) 
N=98 (86.7%) 
N=91 (80.5%) 
N=84 (74.3%) 
N=68 (60.2%) 
 
 
Sources of Information about Heart Disease 
 
Information regarding sources for heart disease awareness was asked through two 
questions. An overwhelming majority (101 participants/88.6%) reported seeing, hearing, 
or reading information about heart disease within the last 12 months.  While the majority 
of participants (101/88.6%) either strongly or somewhat agreed with the statement “You 
are comfortable talking with your doctor about preventive and treatment options 
regarding your health”,  only 41 (36%) responded that any of their physicians ever 
discussed heart disease with them when discussing their overall health. 
Worry about Heart Disease 
One question focused on whether people worry about getting twelve commonly 
occurring conditions and diseases. The question was worded as: “How much do you 
worry about getting each of the following health conditions?”   The rating scale choices 
included “worry a lot”, “worry a little”, “do not worry at all” and “don’t know”.  The 
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health conditions were listed in the following order and included: cancer-in general, heart 
disease or heart attack, AIDS, breast cancer, lung cancer, drug addiction/alcoholism, 
violent crime, stroke, Alzheimer’s disease, diabetes, osteoporosis, and obesity.  
Looking only at the “worry a lot” category, participants reported worrying the 
most about heart disease or a heart attack (31%) followed by obesity (27.4%) and cancer-
in general (19.5%). When combining the categories of “worry a lot” and “worry a little”, 
participants had more worry related to heart disease or a heart attack (83.2%) and cancer-
in general (83.2%), than for stroke (77.8%), obesity and diabetes (62.8%), breast cancer 
(60.2%), and other non-cardiac conditions.  See Table 8.  
Table 8. Worry about Heart Disease 
Worry “a lot” about Getting Specific Diseases  
 Heart disease or heart attack 
 Obesity 
 Cancer in general 
N=35 (31.0%) 
N=31 (27.4%) 
N= 22 (19.5%) 
Combined: Worry “a lot” and Worry “a little” 
about Specific Diseases 
 
 Heart disease or heart attack 
 Cancer in general 
 Stroke 
 Obesity 
 Diabetes 
 Breast cancer 
N=94 (83.2%) 
N=94 (83.2%) 
N=88 (77.8%) 
N=71 (62.8%) 
N=71 (62.8%) 
N= 68 (60.2%) 
Note: Only responses with the highest frequencies are reported here. 
 
Data Analysis for Study Instruments 
   
Data obtained from the CRIP, LOT-r, LET, and PHQ 8 as well as data on the 
Framingham Risk Scores (FRS) and Heart Health Scores (HHS) were analyzed for 
normal distribution by examining histograms, measures of central tendency, skewness 
and kurtosis. The reliability of each instrument was examined for internal consistency 
using Cronbach’s alpha. 
94 
Data for each of the instruments fell within the prescribed possible scoring range. 
Overall, the data (n =113) were found to have a normal distribution based on frequency 
distributions and analysis of histograms. However, it should be noted that the Heart 
Health Score had a large standard deviation and standard error indicating a larger 
variability than the scores calculated using the Framingham Risk Calculator. See Table 9. 
Table 9. Distribution Statistics of the Sample for Study Instruments 
Variable n Participant Range 
(Tool Range) 
Mean SD Standard 
Error 
Risk Perception (CRIP) 113 16-91 (16-96) 50.2 13.7 1.29 
Optimism (LOT-r) 113 3-24 (0-24) 16.45 4.55 0.43 
Life Satisfaction (LET) 113 15-30 (6-30) 25.23 3.53 0.33 
Depression (PHQ-8) 113 0-12 (0-24) 3.27 3.1 0.29 
Framingham Risk Score (FRS) 113 <1-25% (0-25%) 7.12 6.88 0.44 
Heart Health Score (HHS) 113 4-86 (0-100) 41.09 27.99 2.63 
 
Variables were also assessed for the presence of both skewness and kurtosis. Both 
skewness and kurtosis can be positive or negative. In a normal distribution, both 
skewness and kurtosis should be zero. Skewness indicates asymmetry related to 
distribution of the variable around the mean. Positive skewness occurs when the majority 
of the distribution of the variable falls to the left of the mean and negative skewness 
occurs when the majority of the distribution of the variable falls to the right of the mean 
(Field, 2009). The CRIP, LOT-r, and LET were all negatively skewed, while the PHQ-8 
was positively skewed. In addition, the skewness scores were close to zero indicating a 
normal distribution. Kurtosis indicates the shape of the distribution where positive values 
indicate a “pointy” distribution and negative values indicate a “flat” distribution (Field, 
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2009). CRIP, LOT-r, and PHQ 8 had a positive kurtosis, while LET, HHS, and FRS 
values had negative kurtosis. Similar to the skewness scores, the values were close to 
zero indicating a normal distribution. See Table 10.   
Table 10.  Skewness and Kurtosis of the Sample on Study Instruments (N=113) 
Variable Skewness Kurtosis 
Risk Perception (CRIP) 0.65 0.81 
Optimism (LOT-r) -0.33 0.03 
Life Satisfaction (LET) -0.55 -0.16 
Depression (PHQ-8) 1.14 0.84 
Framingham Risk Score (FRS) 0.89 -0.55 
Heart Health Score (HHS) 0.09 -1.69 
 
Aim 1- To Examine the Accuracy of Perceived Risk 
 
 As background to reporting the results on risk perception, it is important to point 
out that perception of risk for CHD cannot be formed without awareness and knowledge 
of risk factors for CVD (as described earlier). If a person does not know what factors 
contribute to the development of CVD (knowledge), then it would be difficult to become 
aware of the potential risk to health. However, accurate perception of a risk is not 
necessarily guaranteed, even if complete and thorough knowledge is given and awareness 
is raised, because the individual must be able to process the information to perceive a 
threat to well-being.  This section begins with a report on the perceived risk as measured 
by the Coronary Risk Individual Perception (CRIP) instrument, presentation of data 
relating to the number and type of cardiac risk factors reported in this study, predicted 
cardiac risk using both the Framingham Risk Score (FRS) and the Heart Health Score 
(HHS) and the relationship of these variables to overall risk perception. These 
instruments were discussed in chapter 3.  
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Analysis of Risk Perception 
Coronary Risk Individual Perception (CRIP) Scale. The construct of risk 
perception was operationalized with the 16-item, Likert scale response, Coronary Risk 
Individual Perception (CRIP) Scale. Five items, numbers 5, 7, 11, 12, and 14, were 
reverse coded before tabulating the score. CRIP scoring is the simple sum of the item 
scores and can range from 16-96. There are no subscales. Higher total scores on the CRIP 
indicate higher levels of perceived risk for coronary heart disease. The mean score for the 
sample was 50.2 (+ 13.7) with a range from 16-91. Table 11 displays mean and percent 
scores for the individual items with the reverse coding adapted for clarity in reading 
tables. Internal consistency was examined using Cronbach’s alpha and was 0.90. Barnhart 
(2009) reported a mean score of 53.9 + 10.3 with an internal consistency of 0.76. (See 
Table 11). 
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Table 11. CRIP Item Response (N=113) 
 Mean 
(SD) 
SD 
n/% 
D 
n/% 
SomD  
n/% 
SomA  
n/% 
A 
n/% 
SA 
n/% 
  1 2 3 4 5 6 
1. I’m as healthy as anybody I 
know.                            
3.87 
(1.28) 
9 
8% 
33 
29.2% 
31 
27.4% 
16 
14.2% 
23 
20.4% 
1 
0.9% 
2. Compared to others my age 
and sex, I am at lower risk of a 
stroke. 
3.79 
(1.33) 
12 
10.6% 
25 
22.1% 
30 
26.5% 
24 
21.2% 
18 
15.8% 
4 
3.5% 
3. I am at low-risk of a heart 
attack. 
3.51 
(1.35) 
10 
8.8% 
17 
15% 
29 
25.7% 
29 
25.7% 
21 
18.6% 
7 
6.2% 
4. In general, my health is very 
good. 
4.37 
(1.22) 
18 
15.9% 
42 
37.2% 
30 
26.5% 
14 
12.4% 
5 
4.4% 
4 
3.5% 
5. Following a low-fat diet takes 
too much effort. 
2.92 
(1.36) 
19 
16.8% 
29 
25.7% 
24 
21.2% 
27 
23.9% 
10 
8.8% 
4 
3.5% 
6. Compared to a year ago, my 
health is better now. 
3.62 
(1.32) 
10 
8.8% 
16 
14.2% 
39 
34.5% 
27 
23.9% 
12 
10.6% 
9 
8% 
7. I worry that I might die from a 
heart attack. 
2.94 
(1.46) 
26 
23% 
20 
17.7% 
19 
16.8% 
37 
32.7% 
4 
3.5% 
7 
6.2% 
8. I’m at low risk of having a 
stroke. 
3.42 
(1.32) 
9 
8% 
15 
13.3% 
25 
22.1% 
 38 
33.6%  
18 
15.9% 
8 
7.1% 
9. Compared to others my age 
and sex, I am at lower risk of a 
heart attack.  
3.59 
(1.38) 
11 
9.7% 
17 
15% 
35 
31% 
24 
21.2%  
 
17 
15% 
9 
8% 
 
10. Compared to others my age 
and sex, I am in good health. 
4.16 
(1.25) 
14 
12.4% 
34 
30.1% 
41 
36.3% 
9 
8% 
11 
9.7%  
4 
3.5% 
11. I worry about having a heart 
attack. 
3.16 
(1.48) 
22 
19.5% 
16 
14.2% 
22 
19.5% 
35 
31% 
10 
8.8% 
8 
7.1% 
12. I worry that I might die from 
a stroke.  
3.14 
(1.38) 
16 
14.2% 
19 
16.8% 
36 
31.9% 
25 
22.1% 
9 
8% 
8 
7.1% 
13. I think my personal efforts 
will help control my risk of 
having a heart attack. 
4.62 
(1.08) 
23 
20.4% 
44 
38.9% 
35 
31%  
6 
5.3% 
2 
1.8% 
3 
2.7% 
14. I worry more about having a 
heart attack than a stroke. 
3.44 
(1.50) 
18 
15.9% 
10 
8.8% 
28 
24.8% 
28 
24.8% 
19 
16.8% 
10 
8.8% 
15. I don’t mind the effort it 
takes to exercise. 
4.15 
(1.50) 
22 
19.5% 
36 
31.9% 
21 
18.6% 
13 
11.5% 
14 
12.4% 
7 
6.2% 
16. I have a low lifetime risk of a 
heart attack.  
3.24 
(1.43) 
9 
8% 
14 
12.4% 
 26 
23% 
22 
19.5% 
31 
27.4%  
11 
9.7% 
Note: SD = Strongly Disagree, D = Disagree, SomD = Somewhat Disagree, SomA = Somewhat Agree, A = Agree, and 
A = Strongly Agree 
  
Prevalence of CVD Risk Factors. The risk factors identified in the study were a 
combination of self-report and physiological measurements. Self-reported measures 
included: gender/age (females >55 years, males >45 years); family history (mother, father 
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or sibling) of cardiovascular disease (myocardial infarction, stent placement, coronary 
bypass surgery or stroke); and personal history of hypertension, smoking, diabetes, and 
physical activity.  As shown in Table 12, the sample was relatively young (mean age 58 
years) and healthy.   The most common risk factor was positive family history reported 
by 42% of the sample, while 12% reported they had diabetes, 12% had hypertension, and 
9% reported being a current smoker. For levels of physical activity, 62% reported low 
levels of activity performed per week. 
Table 12. Self-Report Measures 
Self-Report Measures:  n (%) 
Age *  Mean (SD)   58.02(+9.81) 
Family History* Yes 
No 
48(42.5%) 
65(57.5%) 
Hypertension* Yes 
No 
14 (12.4%) 
99 (87.5%) 
Current Smoker* Yes 
No 
11(9.7%) 
102(90.3%) 
Diabetes* Yes 
No 
14(12.4%) 
99(87.6%) 
Physical Activity (min/week)*   < 100   
100-150  
> 150 
70(61.9%) 
28(24.8%) 
15(13.3%) 
 
Physiological measurements obtained during the screening included: fasting lipids 
(HDL-C, LDL-C and triglycerides), fasting blood glucose, body mass index (BMI), and 
blood pressure.    Based on lab results, 80% of the sample had glucose levels at goal, 40% 
has systolic blood pressures below 120 mm/Hg; 69% had LDL-C levels below 130 
mg/dL; 76% had normal triglyceride levels, and 86% had good levels of HDL-C 
(>40mg/dL).  However, 74% of the sample was either overweight or obese (BMI> 25).  
(See Table 13).   
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Table 13. Self-Report Physiological Measurements 
Physiological Data:    
HDL-C (mg/dl)+ 
High density lipoprotein cholesterol 
                    
 
< 40 
 41-59 
> 60 
Mean (SD)    56.68(+16.86) 
16(14.2%) 
57(50.4%) 
40(35.4%) 
LDL-C (mg/dl)+ 
Low density lipoprotein cholesterol 
 
                   
 
< 100 
100-129 
130-159 
160-189 
> 190 
Mean (SD)  118.37(+33.40) 
35(31.0%) 
43(38.1%) 
16(14.2%) 
13(11.5%) 
6 ( 5.3%) 
Triglycerides (mg/dl)+ 
 
                   
                    
 
< 150  
150-199 
200-499 
> 500 
Mean (SD)  121.71(+75.61) 
86(76.1%) 
16(14.2%) 
10 (8.8%) 
1(0.9%) 
Fasting Blood Glucose  (mg/dl)+ 
                  
 
 
<100 
100-125 
>126 
Mean (SD)    92.38(+15.16) 
91(80.5%) 
19(16.8%) 
3(2.7%) 
BMI (kg/m2)+ 
Body mass index 
 
< 25 
> 25 
> 30  
Mean (SD)        29.01(+5.8) 
29(25.7%) 
37(32.7%) 
47(41.6%) 
Systolic BP (mmHg)+  
< 120 
120-139 
140-159 
> 160 
Mean(SD)  123.23(+17.16) 
45(39.8%) 
49(43.4%) 
14(12.4%) 
5(4.4%) 
Diastolic BP (mmHg)+  
< 80 
80-89 
90-99 
> 100 
Mean (SD)    79.38(+11.72) 
43(38.1%) 
48(42.5%) 
13(11.5%) 
9(8.0%) 
BP Classification+, n (%) Normal 
Prehypertension 
Hypertension, Stage 1 
Hypertension, Stage 2 
27(23.9%) 
53(46.9%) 
22(19.5%) 
11(9.7%) 
   Note: “*” indicates a self-reported measure, “+” indicates a physiological measure  
 
Because the results of the physiologic measurements were not known to 
participants until after the screening results were later mailed to them, the risk factors 
used in the initial interpretation of perception of risk for CVD were the self-reported risk 
factors. Each of these approaches (using self-report vs. lab results) is prone to error. 
Using hypertension as an example, participants may have hypertension but deny it when 
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completing the study survey; or participants may self-report having hypertension, but 
then have a normal blood pressure reading due to the therapeutic effect of their 
medications; or participants may have an elevated blood pressure reading during the 
screening, but interpret it as a false finding, believing they don’t have this problem. Since 
this study is focused on “awareness” of one’s risk, only the self-reported risk factors were 
used for overall prevalence.  The number of risk factors ranged from zero to five with a 
mean of 3.7 (SD +1.4) and a mode of two (n=42) accounting for 37.2 % of the sample. 
See Table 14 Note: Age/gender were combined as one risk factor (females > 55 years, 
males > 45 years). 
Table 14. Prevalence of Self-Reported Risk Factors (N=113) 
Number of Risk Factors N (%) 
0 3 (2.7) 
1 19 (16.8) 
2 42 (37.2) 
3 29 (25.7) 
4 13 (11.5) 
5 7 (6.2) 
Note: Age/gender was considered one (1) risk factor for this calculation 
 
Risk Factor Prevalence and Risk Perception 
 
The prevalence of risk factors was significantly correlated with higher levels of 
risk perception as measured by the CRIP (r = .444, p< .01) indicating that those with 
more risk factors had higher levels of risk perception and accounting for nearly 20% of 
the variance in CRIP scores. In addition, multiple regression analysis was conducted to 
see if these risk factors predict CRIP scores and is reported later.  
Heart Health Score (HHS). This score was derived from a combination of 
physiologic and self-report data from the Wellsource© screening tool.  The Heart Health 
Score is based on a scoring strategy using the NCEP III revised guidelines based on the 
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severity and amount of the risk factors and reflects “current” heart health status. All 
scores were examined for normal distribution as previously discussed. Scores ranged 
from 4-86; the mean score was 41.09 with a standard deviation of 27.99 indicating 
greater variability of scores. Lower HHS scores indicate an increased level of risk with 
the presence of more risk factors.  
 Six participants (5.3%) were categorized as in “Excellent” health (score of 75-
100), 44 (38.9%) were categorized as “Doing Well” (score 50-74), 20 (17.7%) were 
categorized as “Needs Improving” (score 25-49), and 43 (38.1%) were categorized as 
“High Risk” (score 0-24).  
Framingham Risk Score (FRS). The construct of calculated risk was 
operationalized using the FRS. This tool is somewhat different from both the 
“prevalence” of risk factors and the HHS scores, in that the FRS is projecting a 10-year 
risk for CVD.  It is based on current risk factor status using mostly physiological 
measures which may have been unknown to participants until after the screening scores 
were reported. Scores are based on variables including age, gender, total and HDL 
cholesterol, smoking history, systolic blood pressure, and pharmacological treatment of 
hypertension. Scores were computed using an online risk calculator found on the 
National Heart Lung and Blood Institute website 
(http://hp2010.nhlbihin.net/atpiii/calculator.asp). All scores were examined for normal 
distribution as previously discussed. Calculation of the FRS is a two-step process. First, 
total points for risk factors are determined using a gender specific tool. Point totals using 
the ranges for men and women are reported in Table 14.     
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The second step in the calculation is to convert the total points to the 10-year risk 
score. Scores ranged from <1% -25%. Framingham scores were relatively low (X=7.12, 
SD 6.88) classifying the majority of the participants in the “low risk” category. 
Combining both genders, 76 (67.25%) were categorized as low risk (score less than 
10%), 22 (19.46%) were categorized as intermediate risk (score 10-20%), and 15 
(13.27%) were categorized as highest risk (score greater than 20% or having a coronary 
risk equivalent). Fourteen of the 15 participants in this category had diabetes, a coronary 
risk equivalent considered to be a risk score of >20%. These scores were included in the 
subsequent statistical analyses. (See Table 15). 
Table 15. Frequency of Participants Total Points and 10 year Risk Scores for Men and Women 
using the Gender-Specific Framingham Risk Score Calculation (N=113) 
Range of  
Point Totals 
for Men 
Men 
Participant 
total scores 
(n= 35) 
Men 
Participant 10 
yr risk score 
Range of 
Point Totals for 
Women 
Women 
Participant 
total scores 
(n= 78) 
Women 
participant 10 
yr risk score 
<0 0 <1% <9 13 <1% 
0 0 1% 9 1 1% 
1 0 1% 10 9 1% 
2 0 1% 11 5 1% 
3 1 1% 12 7 1% 
4 0 1% 13 5 2% 
5 0 2% 14 5 2% 
6 3 2% 15 1 3% 
7 1 3% 16 6 4% 
8 0 4% 17 6 5% 
9 0 5% 18 2 6% 
10 1 6 19 5 8% 
11 5 8% 20 3 11% 
12 7 10% 21 1 14% 
13 4 12% 22 3 17% 
14 4 16% 23 0 22% 
15 0 20% 24 0 27% 
16 1 25% 25 or > 0 >30% 
17 or > 0 >30%    
Known 
Diabetes (risk 
equivalent) 
8 > 20% Known 
Diabetes (risk 
equivalent) 
6 
 
 
> 20% 
Note: Light Gray= low risk, White= intermediate risk, and Dark Gray= high risk 
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Comparison of HHS and FRS  
 A comparison of the HHS and FRS scores revealed a difference in categorization 
of the participants (See Table 16). The HHS categorized more participants in the “high 
risk” range and “intermediate risk”/”needs improving” range. Conversely, the FRS 
categorized more participants in the “low risk range”. This disparity in classification of 
risk may lie in the way the scores are calculated or in the fact that the HHS scores reflect 
current risk while the FRS reflects a projected longer term risk.      
Table 16. Comparison of HHS and Framingham Scores (N=113) 
Category FRS 
  N (%) 
HHS 
N (%) 
“Excellent” ----  6   (5.3%) 
Low risk/ “Doing well” 76 (67.2%)  44 (38.9%) 
Intermediate risk/ “Needs Improving” 18 (15.9%) 20 (17.7%) 
High risk 19 (16.8%)   43 (38%)  
 
Analysis of the Relationship between CRIP scores and HHS and FRS  
 
 Correlational analyses were used to examine the relationship between CRIP 
scores and both the Heart Health and the Framingham Risk Scores. Results showed a 
significant inverse relationship between HHS scores and CRIP scores (r = -.400, p < .01) 
indicating that those with increased risk (using HHS) exhibited increased levels of 
perceived risk and accounts for 16 % of the variance in the CRIP scores. There was a 
non-significant relationship between perceived risk and “projected” cardiac risk using the 
FRS (r = .034, p = .719) indicating that perceived risk is not related to a long-term 
projected risk score. 
A Chi-Square test was used to determine whether there was a significant 
difference between FRS and HHS on risk perception scores. Using the mean score of 50 
obtained from this sample on the CRIP as the cut off point for the two levels and the 
104 
categorized FRS and HHS (Table 16), there was no significant difference between risk 
perception (CRIP) and Framingham risk scores (FRS), χ2 (2) = 3.33, p = .189. However, 
there was a significant difference between risk perception (CRIP) and heart health scores 
(HHS), χ2 (2) = 14.61, p = .001. Persons with lower risk scores (using HHS) were more 
likely to have lower risk perception scores (using CRIP) whereas persons with increased 
risk (using HHS) were more likely to have higher risk perception scores (using CRIP). 
The effect size was .36. See Figure 1. In order to meet the assumption of having a 
minimum of an expected count of 5 in each category, the “excellent” and “doing well” 
categories were combined for this analysis.    
Figure 1. Chi Square Analysis of HHS with Risk Perception Scores      
  
Summary of Aim One  
Aim 1 was to examine the accuracy of one’s perceived risk for CVD. As stated 
throughout this paper, perception of risk for CVD is based on awareness and knowledge 
of risk factors for CVD. Overall the sample demonstrated at least a moderate knowledge-
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base of heart disease and the major risk factors associated with it. They recognized heart 
disease as the leading cause of death for men and women, and could identify the key 
prevention steps to reduce such risk. The majority had seen information on heart disease 
in the prior 12 months.  More than half the sample admitted to “worrying a little” about 
getting heart disease or having a heart attack, with 30% admitting to “worrying a lot”.  In 
reviewing the self-reported risk factors, 42% had a positive family history, 12% had 
diabetes, 12% had hypertension, but most were physically inactive.   Physiological 
measurements obtained during the screenings also revealed a relatively healthy group, 
with the majority of participants at goal for glucose, LDL-C, HDL-C and triglyceride 
levels.  However, the majority of participants were found to be overweight or obese. 
Overall, 80% had 2 or more self-reported risk factors, and 43% had three or more. 
Perceived individual risk scores for CVD as measured by the CRIP fell into the 
middle range. The participants did seem to accurately perceive their risk for CVD. The 
prevalence of risk factors (self-reported) was significantly correlated with higher levels of 
risk perception as measured by the CRIP (r=.44, p < .01).    
HHS scores showed that more than 55% of the participants were categorized as 
either “Needs Improving” or “High Risk”, indicating the presence of multiple risk 
factors. HHS scores were also statistically correlated with risk perception (r=.40, p< .01). 
In addition, Chi Square analysis showed a significant difference between increased risk 
(using HHS) and increased risk perception scores (using CRIP). Framingham Risk 
Scores, a measure of projected future cardiac risk, were not correlated with risk 
perception. 
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Aim 2-Examination of the Relationship between Perceived Risk and Key 
Sociodemographic and Psychological Variables 
 Psychological variables such as optimism, optimistic bias, life satisfaction and 
depressive symptoms may play an important role in how persons perceive risk. In 
addition, other influences, such as demographic and personal variables may also be 
helpful when examining risk perception.  Therefore the second aim of this study was to 
examine the relationship between perceived risk and key sociodemographic and 
psychological variables thought to influence risk perception.  This section begins with the 
report on the sociodemographic variables. 
Sociodemographic Variables 
The sociodemographic variables of age, gender, socioeconomic status, level of 
education, family history of CVD and knowledge of someone with CVD were discussed 
earlier in this chapter as part of the sample characteristics. As previously shown in Table 
4, the sample can be described as: middle-aged (M=58.02 + 9.8) with a range from 40 to 
80 years; mostly female (69%); and well educated with approximately 70% having 
vocational training, an associate degree or higher. Income was almost evenly split 
between less than or greater than $50,000. Less than half of the sample reported knowing 
a relative with CVD (42.5%) or friend with CVD (36.3%). 
Psychological Variables  
Psychological variables include: optimism (measured by the LOT-r), life 
satisfaction (measured by the LET), and depressive symptoms (measured by the PHQ-8). 
These instruments were discussed in detail in Chapter 3 and briefly here. See Table 17.  
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Optimism: Life Orientation Test-revised (LOT-r). The construct of optimism 
was operationalized using the life orientation test-revised (LOT-R). This is a Likert scale-
based instrument consisting of ten questions. In the revised version, there are four filler 
questions (#2, 5, 6, 8), three positively worded questions (#1, 4, 10), and 3 negatively 
worded questions (#3, 7, 9). The coding of the LOT-R (with a total possible score of 24) 
is positively correlated so that high values imply optimism, while low values imply 
pessimism (Scheier, Carver, & Bridges). Reported Cronbach’s alpha for the LOT-R = 
.90. All scores were examined for normal distribution as previously discussed. In this 
study, internal consistency was 0.719; participant scores ranged from 3-24 with a mean of 
16.45 (SD + 4.55) and a median of 16. See Table 18.  Overall, participants in this study 
were optimistic about their life. 
Table 17. Descriptive Statistics for Psychological Variables 
 N LOT-r LET PHQ-8 
Mean (SD) 113 16.45 (4.55) 25.23 
(3.53) 
3.2 
(3.1) 
Range 113 3-24 15-30 0-12 
Possible range 113 0-24 6-30 0-27 
Range for Sample 113 3-24 15-30 0-12 
Internal Consistency 113 .719 .712 .738 
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Table 18. Item Response for Revised Life Orientation Test (LOTr) (N=113) 
 Mean 
(SD) 
Strongly  
Disagree 
N (%) 
Disagree 
 
N (%) 
Neutral 
 
N (%) 
Agree 
 
N (%) 
Strongly 
Agree 
N (%) 
Item Response Score  0 1 2 3 4 
1. In uncertain time, I usually 
expect the best. 
2.90 
(1.06) 
3 
2.7% 
11 
9.7% 
19 
16.8% 
41 
36.3% 
39 
34.5% 
2. It is easy for me to relax.*  2.71 
(1.21) 
4 
3.5% 
19 
16.8% 
10 
8.8% 
52 
46% 
28 
24.8% 
3. If something can go wrong 
for me, it will. 
1.58 
(1.19) 
28 
24.8% 
24 
21.2 
33 
39.2% 
23 
20.4% 
5 
4.4% 
4. I’m always optimistic about 
my future. 
2.89 
(1.02) 
2 
1.8% 
12 
10.6% 
17 
15% 
47 
41.6% 
35 
31% 
5. I enjoy my friends a lot.* 
 
3.58 
(0.63) 
0 
0% 
0 
0% 
9 
8% 
29 
25.7% 
75 
66.4 
6. It’s important for me to keep 
busy.*  
3.36 
(0.83) 
1 
0.9% 
2 
1.8% 
14 
12.4% 
34 
30.1% 
62 
54.9% 
7. I hardly ever expect things to 
go my way. 
1.53 
(1.22) 
32 
28.3% 
21 
18.6% 
34 
30.1% 
20 
17.7% 
6 
5.3% 
8. I don’t get upset too easily.* 2.38 
(1.08) 
5 
4.4% 
21 
18.6% 
28 
24.8% 
43 
38.1% 
16 
14.2% 
9. I rarely count on good things 
to happen to me.  
1.43 
(1.32) 
39 
34.5% 
23 
20.4% 
22 
19.5% 
21 
18.6% 
8 
7.1% 
10. Overall, I expect more good 
things happen to me than bad.  
3.26 
(0.99) 
3 
2.7% 
5 
4.4% 
11 
9.7% 
34 
30.1% 
60 
53.1 
Note:  “*” denotes filler items that are not included for instrument scoring 
.   
Life Satisfaction: Life Engagement Test (LET). The construct of life 
satisfaction was measured using the LET. The LET is a five point Likert Scale instrument 
consisting of six questions (Appendix G). Three items (# 2, 4, and 6) are positively 
framed, while the other three items (# 1, 3, and 5) are negatively framed. The higher the 
summary score, the higher the reported purpose in life. Reported Cronbach’s alpha for 
the LET in initial testing ranged from 0.72 to 0.80.  All scores were examined for normal 
distribution as previously discussed. For this sample internal consistency was 0.712; 
scores ranged from 15-30, with a mean of 25.23 (SD + 3.53) and a median of 25. 
Participants in this study reported increased levels of life satisfaction. See Table 19 for 
individual item scores.  
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Table 19. Item Response for Life Engagement Test (LET) (N=113) 
 Mean 
 
(SD) 
Strongly  
Disagree 
N (%) 
Disagree 
 
N (%) 
Neutral 
 
N (%) 
Agree 
 
N (%) 
Strongly 
Agree 
N (%) 
Item Response Score  1 2 
 
3 4 5 
1. There is not enough 
purpose in my life. 
1.8 
(1.00) 
56  
49.6% 
36 
31.9% 
9 
8% 
11 
9.7% 
1 
0.9% 
2. To me, the things I do are 
all worthwhile. 
3.91 
(1.02) 
6 
5.3% 
6 
5.3% 
10 
8.8% 
61 
54% 
30 
26.5% 
3. Most of what I do seems 
trivial and unimportant to me. 
1.92 
(0.95) 
41 
36.3% 
52 
46% 
11 
9.7% 
6 
5.3% 
3 
2.7% 
4. I value my activities a lot. 
 
4.12 
(0.80) 
3 
2.7% 
2 
1.8% 
6 
5.3% 
69 
61.1% 
33 
29.2% 
5. I don’t care very much 
about the things I do. 
1.59 
(0.73) 
59 
52.2% 
44 
38.9% 
8 
7.1% 
1 
0.9% 
1 
0.9% 
6. I have lots of reasons to 
live.  
4.47 
(0.89) 
4 
3.5% 
1 
0.9% 
4 
3.5% 
32 
28.3% 
72 
63.7% 
 
Depression Screening: Patient Health Questionnaire-8 questions (PHQ-8). 
The construct of depression was operationalized using the PHQ-8. The questions are 
scored on a 0-3 Likert scale with 0 = not at all, 1 = several days, 2 = more than half the 
days, and 3 = nearly every day. The scoring for the PHQ-8 is summative with a score 
ranging from 0 –24. The PHQ-8 divides scores into 4 categories: no depression (scores < 
5), mild depression (scores from 5-9), moderate depression (scores from 10-14), and 
severe depression (scores > 20). However, a score of > 10 on the PHQ-8 is considered as 
being positive for symptoms of depression.  All scores were examined for normal 
distribution as previously discussed. For this study internal consistency was 0.738; scores 
ranged from 0-12 with a mean of 3.27 (SD + 3.1) and median of 2. Categories for this 
tool are based on the following cut-points: <5 = no depression, 5-9 = mild depression, 10-
14 = moderate depression, 15-19 = moderately severe depression, and >20 = severe 
depression. While the majority of the sample reported no symptoms of depression, 
approximately one fifth reported having mild symptoms. None of the participants scored 
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as being moderately severe or severe on the scale indicating that overall, the participants 
in this study were not depressed. See Tables 20 and 21. 
Table 20. Item Response for the Eight item Patient Health Questionnaire (PHQ-8) (N=113) 
Over the last 2 weeks, how often have you been bothered by any of the following:  
 Mean 
(SD) 
Not At 
All 
 
N (%) 
Several 
Days 
 
N (%) 
More 
than 
half the 
days 
N (%) 
Nearly 
Every 
day 
 
N (%) 
Item Response Score  1 2 3 4 
1. Little interest or pleasure in doing things. 1.32 
(0.66) 
87 
77% 
46 
14.2% 
9 
8% 
1 
0.9% 
2. Feeling down, depressed, or hopeless. 1.29 
(0.52) 
84 
74.3% 
25 
22.1% 
4 
3.5% 
0 
0% 
3. Trouble falling or staying asleep, or 
sleeping too much. 
1.74 
(0.91) 
58 
51.3% 
33 
29.2% 
15 
13.3% 
7 
6.2% 
4. Feeling tired or having little energy. 1.84 
(0.83) 
42 
37.2% 
53 
46.9% 
11 
9.7% 
7 
6.2% 
5. Poor appetite or over-eating. 
 
1.55 
(0.83) 
72 
63.7% 
22 
19.5% 
16 
14.2% 
3 
2.7% 
6. Feeling bad about yourself – or that you 
are a failure or have let yourself or your 
family down.  
1.22 
(0.47) 
91 
80.5% 
19 
16.8% 
3 
2.7% 
0 
0% 
7. Trouble concentrating on things, such as 
reading the newspaper or watching TV. 
1.23 
(0.55) 
93 
82.3% 
15 
13.3% 
4 
3.5% 
1 
0.9% 
8. Moving or speaking so slowly that other 
people could have noticed?  Or the 
opposite- being so fidgety or restless that 
you have been moving around a lot more 
than usual.  
1.07 
(0.33) 
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91.2% 
8 
7.1% 
1 
0.9% 
0 
0% 
 
Table 21. Summary Scores on PHQ-8 for Study Sample (N=113) 
Total Scores for 
Sample 
<5 =  
No depression 
5-9 =  
Mild 
depression 
10-14 = 
Moderate 
depression 
15-19 = 
Moderately 
Severe 
Depression 
20 or more = 
Severe 
depression  
 81  
(71.7%) 
24 
(21.2%) 
8 
(7.1%) 
0 
(0%) 
0 
(0%) 
 
Analysis of the Relationship between Predictor Variables and Risk Perception 
 
Multiple regression analysis was performed to determine predictors of risk 
perception (Field, 2009). Thus, this method was used to explore the relationship between 
these potential predictor variables and the outcome variable of risk perception as 
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measured by the CRIP.  The nine assumptions associated with multiple regression 
include: 1) variable types, 2) non-zero variance, 3) multicollinearity, 4) predictors which 
are not correlated with external variables, 5) homoscedacticity, 6) independent errors, 
normal distribution, 8) independence, and 9) linearity. These assumptions were met in 
order to complete the regression analysis.  
Spearman’s rho correlation analysis for ordinal level variables was used to 
examine the relationship between the sociodemographic and psychological predictor 
variables and outcome variable of risk perception. The results are shown in Table 22. The 
reported significant correlations for each of these relationships were small (< .334) and 
indicates that none of  these variables are highly correlated with each other demonstrating 
non-multicollinearity between the variables (Field, 2009). The variables that were 
 significantly related to risk perception (CRIP) were used to perform multiple regression 
analysis in the next section. 
Table 22.  Correlation Matrix of Potential Covariate Predictor Variables and Outcomes Variable 
 2 3 4 5 6 7 8 9 10 
 1. Age -.055 -.315** -.226* -.033 -.200* -.105 -.196* -.324** -.140 
 2. Gender --- -.013 -.155 .005 -.107 .184 .184 -.076 -.021 
 3. Income  --- -.181 -.118 .005 .156 .214* -.048 -.020 
 4. Education    --- -.106 .097 .187* .069 -.008 -.009 
 5. Relative  with 
CVD 
   --- .022 -.062 .027 -.022 -.170 
 6. Friend with CVD     --- -.172 -.145 .148 .194* 
 7. LOTr      --- .256** -.173 -.125 
 8. LET       --- -.188* -.201* 
 9. PHQ8        --- .334** 
10. CRIP         --- 
 Note: * = p< .05; ** = p< .01; CVD = cardiovascular disease; LOTr = Life Orientation Test-revised; LET 
= Life Engagement Test; PHQ8 = Patient Health Questionnaire (eight question); CRIP = Coronary Risk, 
Individual Perception 
Multiple regression analysis was conducted to examine whether specific variables 
contribute to the outcome variable of risk perception. A backwards stepwise method was 
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employed to account for suppressor effects and reduce the risk of making a Type II error 
(Field, 2009). The variables found to be significantly related to risk perception: knowing 
a friend with CVD, life satisfaction, and depression were entered into the regression 
model and produced two models. The final model removed life satisfaction as a 
contributing predictor. Overall, the model explained 11.3% of variance which was found 
to be significant, R2= .113, F(2, 110) = 7.03, p < .01. An examination of individual 
predictors revealed that only depression (β = .278, p = .003) was a significant predictor. 
Having a friend with CVD (β = .163, p = .07) was not found to be significant.  
(Appendix M). 
Summary of Aim Two 
Aim Two was to examine the relationship between perceived risk and key 
sociodemographic and psychological variables thought to influence risk perception.  The 
majority of the sample had high levels of optimism and life satisfaction and low levels of 
depression.  Correlation analysis between the risk perception and the potential variables 
showed that there were three variable associated with risk perception: having a friend 
with CVD, optimism, and depression. These variables were then used to perform multiple 
regression analysis and revealed that depression was the single predictor in the model, but 
accounted for only 11.3% of the variance. Further exploration is needed to identify 
salient variables that may contribute to risk perception.  
CHAPTER FIVE: DISCUSSION 
  Sample and Setting 
 Data collection took place at four separate sites within a single hospital system 
located throughout the county.  Compared to the most recent census bureau statistical 
data noted in Chapter Four, the overall sample of 113 participants was representative of 
the county except for an underrepresentation of African Americans.  This was expected, 
as most African Americans are established patients at other hospital systems that were 
not part of the study and therefore were not recruited to attend the screenings. The sample 
was younger and more educated than had been expected, and were employed either full 
or part time. The majority had primary health insurance.  One would expect that 
participants at a community health screening would be more representative of individuals 
without other sources for preventive health care.  It is likely that those with more 
education understand and value preventive healthcare and thus sought opportunities for 
cardiovascular health screening.  Even though the screening cost was reasonable 
($30.00), it is possible that those unemployed were not able to attend due to financial 
constraints. The screening coordinator did share that insurances with wellness benefits 
cover the cost of the screening, while those without insurance or those without wellness 
benefits paid “out of pocket” for the screening. An interesting comment made by many 
participants was that their primary care providers encouraged them to obtain annual 
laboratory work at such screenings since it was more economical than going through 
traditional hospital or office based laboratory methods. 
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Knowledge and Awareness Survey 
It is reassuring that public health efforts to raise awareness of heart disease were 
effective in this sample of low risk patients.  Most of the sample rated themselves as 
well-informed or moderately informed about heart disease. They correctly identified 
traditional risk factors known to contribute to cardiovascular disease, such as high 
cholesterol, family history, obesity, stress, hypertension, and lack of exercise. Similarly, 
most of the sample reported that heart disease and heart attack were the leading cause of 
death in both men and women.  Overall they were actively engaged in efforts to prevent 
heart disease.  These findings indicate a high level of health literacy and may be related 
to the large number of participants educated beyond the 12th grade level. Health literacy 
is an important determinant of health, and has been defined as the way in which 
individuals are able to obtain, process, understand and communicate about health-related 
information needed to make informed health decisions (Berkman, Davis & McCormick, 
2010).  Most participants reported the source of their cardiovascular health information 
came from reading magazines, brochures, and newspapers, from viewing television, and 
from the internet. Regrettably, only slightly more than one third of the sample reported 
that their physician ever initiated a discussion on this topic.  
 In response to “What is the greatest health concern today?” the sample reported 
“heart disease or heart attacks” followed by “obesity, and “cancer-in general”. Curiously, 
they reported these same categories in response to a question about personal worry 
related to health conditions in their own lives. One would expect that most people have 
some experience and exposure to both heart disease and cancer (e.g., knowing family or 
friends with these conditions) which could increase personal worry/concern. However, it 
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was surprising that obesity caused such a high amount of concern and worry.  Perhaps 
this is due to the more recent attention focused on obesity in America, with more 
individuals finally taking notice of this health problem.  Or it may be related to the high 
number of participants in this sample who were overweight or obese.  They may be 
sensitive to the health issues that obesity poses. 
 While this sample exhibited health literacy in many areas, it is troubling that 
smoking was not identified by the sample as a contributor to CVD. In fact, there were 
curious inconsistencies noted in the smoking and triglycerides categories.  Only 29% of 
the participants thought that smoking contributed to CVD, yet almost every participant 
(93%) answered that quitting smoking would prevent or reduce CVD.  These findings are 
contradictory. This inconsistency was also noted for triglycerides; however, this response 
may be explained by a lack of knowledge that triglycerides are part of the cholesterol 
profile.  
 Mosca et al. (2013) have partnered with the American Heart Association to 
examine changes in awareness of heart disease, especially among women, with the most 
recent telephone survey conducted in 2003. Since the present study had a majority of 
women (69%), some comparisons to the Mosca study will be made here.  Both samples 
rated themselves as well or moderately informed about heart disease. Interestingly, both 
studies reported comparable results related to sources of information about heart disease, 
with 75-88% using the media for information, and only 36-38% having had a discussion 
about heart disease with their health care provider.  While both samples did identify the 
major risk factors for heart disease, the Mosca study had much lower rates (7-36% of 
major risk factors identified) versus this study with ranges of 82-100%. This difference 
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may be related to interview methodologies. This study used a paper survey with the 
various choices listed and asked participants to select “all that apply”; the Mosca study 
asked participants to “spontaneously identify” the causes of heart disease. Only 31% of 
Mosca’s women identified high cholesterol as a cause, with 1% reporting high 
triglycerides as a risk factor.  This study had 100% of participants identifying high 
cholesterol, and 36.8% identifying high triglycerides. It is unclear whether the testing 
format, the span of 10 years since the Mosca study, or the combination of men and 
women participants resulted in the increased awareness of these risk factors. Both studies 
reported similar data for those activities that could potentially reduce one’s risk of getting 
heart disease.  Finally, the Mosca study of only women found cancer rated as the greatest 
health threat (41%) with breast cancer= 35% and cancer in general = 16% as compared to 
this study where 34% selected heart disease/heart attack. Cancer in general was listed as 
the third greatest health threat (23%).  Another major difference was the reporting of 
obesity was high in this study (26%) and only 6% in the Mosca study. These differences 
could be related to the setting in which the current study was conducted—a 
cardiovascular health screening event.  
Discussion of Aim 1   
 Perception of risk requires some awareness and knowledge of risk factors for 
CVD.  As just discussed, this sample reported being well-to-moderately informed about 
heart disease.   In this section we will discuss the actual risk for CVD as related to the 
number and type of cardiac risk factors reported, and the relationship to risk perception 
using the CRIP tool. Further comparisons using both the Heart Health Score (HHS) and 
the Framingham Risk Score (FRS) will also be discussed. 
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Prevalence of CVD risk factors 
The sample was knowledgeable about the causes/risk factors for heart disease in 
general and was also able to self-report personal behaviors and family history known to 
contribute to the development of heart disease.  Overall this sample had a significant 
number of major risk factors, as 37% had two and 43% had three or more. Thus they 
would be expected to have some concerns about their “personal risk” for heart disease.  
This number is comparable to Barnhart’s sample where 51.6% had three risk factors and 
were deemed to be at high risk for CHD.  It is interesting to note that 74% of the sample 
was either overweight or obese (BMI> 25) and 62% reported low levels of activity 
performed per week. The majority of the sample was either overweight or obese with 
12.4% reported being diabetic. The number of persons with normal fasting glucose levels 
and triglyceride levels was only 80% and 76% respectively, suggesting that more of the 
sample either does not know that they are pre-diabetic or diabetic or chose not to report 
being in either category. 
Analysis of Risk Perception- CRIP 
 Risk perception was quantified using the Coronary Risk Individual Perception 
(CRIP) tool. This relatively new instrument was easy to administer and score. During the 
screenings there were no questions from the participants requiring clarification of items. 
Scoring for the instrument is logical with higher scores relating to increased levels of risk 
perception. Many of the item responses fell in “somewhat disagree” (3) and “somewhat 
agree” (4) categories with calculated item means near 3.5. While many scores on 
individual items did fall within this “middle range”, several CRIP items warrant further 
discussion. For example, overall the sample somewhat agreed that their health was very 
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good (item four; X= 4.37) and compared to others their health was good (item ten; X= 
4.16). They felt that personal efforts will help to control the risk of having a heart attack 
(item thirteen; X= 4.62) and they don’t worry about dying from a heart attack (item 7; X= 
2.94). These responses indicate that this sample felt positive and relatively optimistic 
about their health status and risk for a heart attack. While the participants were not made 
aware of the results of the screening lab tests conducted during the health screening, the 
results later did reveal that this was a relatively healthy group, with the majority at goal 
for glucose, LDL-C, HDL-C, and triglyceride levels.  Thus their self-perceptions of 
overall “middle-level risk” were accurate.  
The range of CRIP scores for this study was wide (16-91). A closer examination 
of the score frequencies revealed that the same number (eight) of participants reported 
scores on the low end (scores of 16, 24, 26, 29) as on the high end (scores of 69, 72, 75, 
83, 91). Thus there were no clear outliers. It is interesting that the mean score on the 
CRIP for the sample (X= 50.2; SD 13.7) was similar the one reported by Barnhart and 
colleagues (X=53.9; SD 10.3) (2009). Although there were some differences between the 
two samples with respect to race/ethnicity and education levels (Barnhart sample was 
predominantly Hispanic, uneducated, and poor), one striking similarity was gender; both 
studies were approximately 70% female.  
The data supports the accuracy of the sample’s risk perception.  As in Barnhart’s 
study (2009), a simple index for risk of CHD was derived by summing the participant’s 
number of major risk factors.  The prevalence of these self-reported risk factors was 
significantly correlated with higher levels of risk perception as measured by the CRIP. 
Again—this is not a surprise, in that this sample was well-educated, employed, and had 
119 
primary health insurance.  And they were seeking out a health screening opportunity—
that may have contributed to their accurate risk perception. 
 The small sample size limited the number of analyses that could be made with 
the CRIP.  In Barnhart’s larger study, risk perception was correlated with individual risk 
factors such as diabetes, hypertension, and obesity. Barnhart (2009) used the median 
score (55) to divide her group into high vs low levels of risk perception. The same type of 
analysis was not conducted in this study since it did not match the aims of this study. 
However, additional analysis such as this will be planned for in a secondary analysis of 
data.  
Heart Health Score (HHS). The HHS score reflects risk at the current time and 
is based on both self-reported and physiological measures. The summative scoring 
method is somewhat counterintuitive from other methods, with low scores indicating 
higher levels of risk and high scores indicating lower levels of risk. The HHS not only 
presents a numeric risk, but also a semantic descriptor. Since a large number of the 
sample had multiple risk factors, it was not surprising to see 17% of the sample 
categorized as “Needs Improving” and 38% categorized as “High Risk”.  Thus it was 
logical that the HHS scores were statistically correlated with risk perception on the CRIP 
since they were both measuring similar risk factors.  Likewise the Chi square analysis 
showed a significant relationship between increased risk and increased risk perception 
scores.  
Wellsource© has been a recognized leader in corporate health screenings for more 
than 30 years and it used extensively in cardiac rehabilitation programs as a tracking and 
motivational strategy.  However, it was not possible to make any comparisons of data 
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from this study with other studies, as Wellsource© has not published any results as 
pooled data related to the HHS tool.  The HHS tool has been primarily used to collect 
data from individuals and provide individualized risk scores.  It is possible that due to 
health privacy laws and/or contracts with data sources (hospitals, corporations), 
Wellsource© has chosen not to make pooled data available.   
Despite these limitations, the HHS tool seems useful in assessing patient’s health 
risk.  There is evidence that providing individuals with “current risk” data is more 
advantageous than using “future risk”.  Waldron, Weijden, Ludt, Gaalacher and Elwyn 
(2011) conducted a systematic review of risk communication strategies and found that 
when methods used long-term projected risk (10 years or longer as in the FRS) persons 
had less accurate risk perception and intention to change behaviors. Thus using this 
method may help those with increased levels of risk to perceive risk more accurately and 
plan health behaviors accordingly. Moreover, it may be vital in providing motivation for 
positive health behaviors. 
Framingham Risk Scores (FRS). This scoring method also uses physiological 
measures and current risk factors; but unlike the HHS, it calculates a “projected” 10 year 
risk for CVD and cardiac events.  In addition, the scores are gender-based, with women’s 
cardiovascular risk typically underestimated due to the older age in which they exhibit 
coronary heart disease (Marma & Lloyd-Jones, 2009).  Thus with the predominantly 
female sample, it is not surprising that so few participants were categorized as moderate 
to high risk based on a mean age of 58. Likewise, the FRS also underestimates risk in 
younger men, and this sample had an overall mean age of 58 years. It was not really 
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surprising that the FRS was not correlated with current risk perception (CRIP) since that 
is not the aim of the tool.  
Analysis of the Relationship between CRIP Scores and HHS and FRS. When 
comparing HHS and FRS, it was interesting to find that the FRS revealed more of the 
sample to be at “low risk” while the HHS found the majority of the sample to be in the 
“high risk” and “intermediate risk” range. Given this fact, it was not surprising that only 
one of the methods (HHS) was correlated with risk perception. The explanation is likely 
due to the differences in the methods used for calculating current and projected risk, but 
may also be due to the large proportion of women in the study. 
Discussion of Aim 2  
  The second aim of this study was to examine the relationship between perceived 
risk and key sociodemographic and psychological variables thought to influence risk 
perception. This section will begin with a discussion on the psychological variables of 
optimism, life satisfaction and depression. 
Optimism: Life Orientation Test- revised (LOT-r)  
Previous research has shown that optimism is linked to multiple positive 
outcomes including mental and physical well-being (Carver, Scheier, & Sergerstom, 
2010), less incidence of depression (Chang, Wang, Li, & Liu, 2011; Giltay, Zitman, & 
Kromhout, 2006; Manjilovich, 2005; Tindle et al. 2012), decreased risk of CVD (Boehm, 
Peterson, Kivimaki, & Kubzansky, 2011; Kubzansky & Thurston, 2007), and even 
decreased mortality (Giltay, Geleijnse, Zitman, Hoekstra, & Schouten, 2004). 
The LOT-r was administered and scored without any changes to either the 
contents or format. Participants completed the instrument easily without questions on 
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how to complete the instrument or on specific items. Scoring of the instrument was 
equally uneventful. The sample indicated that overall they were moderately optimistic 
about life (mean of 16.45, SD + 4.55). Glazer, Emery, Frid, and Banyasz (2002) found 
that when controlling for age, higher levels of optimism and lower levels of both 
depression and neuroticism had a positive effect on adherence to exercise. However, this 
all male sample with known cardiac disease was much smaller with only 46 participants, 
thus limiting the generalizability of the results. Lastly, Matthews et al. (2004) used a 
prospective design to follow 209 middle- aged women for a total of 13.5 years and found 
that women with the highest reported levels of optimism showed less progression of 
CVD as measured by carotid intimal thickening. While both of these studies used the 
original LOT instrument, it should be noted that Scheier, Carver, & Bridges (1994) 
conducted an evaluation between the two instruments and found a correlation of 0.95 and 
stated there was no reason to believe that the revised scale would produce any 
appreciable differences in study findings. In addition, the authors of the LOT and LOT-r 
have never assigned cut points for either scale. Instead, they ascribe to the interpretation 
that higher scores represent increased levels of optimism whereas lower scores represent 
decreased levels of optimism. So it is therefore prudent to examine overall study results 
and the variables that correlate with optimism rather than focusing solely on mean study 
scores for any population.  
It was surprising that in this study there was no significant inverse correlation 
between optimism and depression as has been noted in the literature (Chang, Wang, Li, & 
Liu, 2011; Giltay, Zitman, & Kromhout, 2006; Manjilovich, 2005; Tindle et al. 2012). 
However, there were differences between these studies and the current study that may 
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explain this result. For example, Giltay and colleagues (2006) did examine the same 
constructs but used different instruments to do so. Giltay used a 15 year prospective study 
of 464 men between 64 and 84 years, but used the dispositional optimism scale and the 
Zung depression scale. In addition, these authors disclosed that a major limitation for this 
study was that the dispositional optimism scale has not been validated against the LOT or 
LOT-r. So while these researchers did study the same constructs/variables, they used 
different scales with clear limitations to measurement validity. 
Chang et al., (2011) studied 314 staff nurses in Taiwan exploring depression rates 
among nurses and reported that 52.5% of the nurses reported mild to moderate depressive 
symptoms. Chang and colleagues used the Center for Epidemiologic Studies-Depression 
Scale (CES-D), the LOT-r, and General Self-Efficacy Scare (GSES) and found 
depression to be significantly correlated to optimism (r= -.50, p<0.01) and self-efficacy 
(r= -.43, p<0.01). Multiple regression analysis showed that optimism (β -.38, p< 0.01) 
and self-efficacy (β -.44, p< 0.01) protected against depression. Since the CES-D and 
LOT-r instruments have been used widely and have acceptable psychometric properties, 
it is more likely results from the current study differ due to the population being studied, 
the smaller sample size, or the fact that the sample reported much lower levels of 
depression than the nurses in Taiwan, not to mention the possibility of cultural 
differences in these variables.    
Life Satisfaction: Life Engagement Test (LET) 
The concept of life satisfaction is similar to optimism in that both can be 
categorized as a positive emotion. Work completed in this area has shown that there is a 
positive relationship between emotional vitality and lack of CVD (Cohen & Pressman, 
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2006; Kubzansky & Thurston, 2007, Matthews, Owens, Lee & Kuller, 2006). However, 
research specifically related to the use of the life engagement test related to 
cardiovascular disease is somewhat limited (Matthews, Owens, Lee & Kuller, 2006). 
This might be explained by the fact that this is a relatively new tool.  
 The LET was administered and scored without any changes to either the contents or 
format. Participants found this brief instrument easy to complete. Scoring of the 
instrument was equally uneventful. The sample indicated high levels of life satisfaction 
(25.23, SD + 3.53). These scores were similar to two recent cohort studies. Pearson et al. 
(2012) studied a cohort of 545 community dwelling adults ages 55-94 to establish 
normative data on a non-clinical sample of adults. The survey was administered twice, 12 
months apart as part of a larger study on relocation to a residential retirement facility. 
These researchers found that scores on the LET at both time intervals were high (mean= 
24.86, SD + 4.16; mean= 23.43, + 3.79). In addition, the scores for the designated age 
groups (55-64 years, 65-74 years, and >75 years) were all similar.  
 Both increased age and income were significantly correlated with increased levels 
of life satisfaction. This may be explained by the fact that as a person ages there is more 
certainty, stability and satisfaction in life. This may be especially true in this well-
educated, largely employed and relatively healthy group of individuals.  
     Optimism was significantly correlated with life satisfaction. This finding is 
supported by the work done in the construction and validation of the LET instrument (r= 
.39, p < 0.01) (Scheier et al., 2006). It is logical that if someone is optimistic that they 
would also tend be satisfied with life. Since that time, this is the only study that has 
compared these two constructs at the same time. In the two studies by Matthews, 
125 
discussed in previous parts of this paper and also below, these constructs were studied 
separately with respect to the surrogate markers for CVD.  Matthews et al. (2006) 
followed 155 healthy women enrolled in the Healthy Women Study and found that those 
with the highest scores on the LET had lower aortic calcium scores (p= 01). This is a 
follow up to their 2004 study that reported that women with the highest LOT-r scores had 
the least progression of CVD as measured by carotid intimal thickening.  Thus optimism 
and life satisfaction seem to correlate with less evidence of CAD and may be acting as 
mediating variables. 
Patient Health Questionnaire-8 questions (PHQ-8) 
Depression is well recognized as a risk factor for CVD and a consequence of 
CVD (Baune, Stuart, Gilmour, Wersching, Arolt, & Berger, 2012; Borowicz et al., 2002; 
Grenon, Hiramoto, Smoderen, Vittinghoff, Whooley & Cohen, 2012). Previous research 
has shown that major depressive disorder (MDD) occurs in as many as 20% of those with 
CVD (Thombs et al., 2004). Furthermore, even in the absence of MDD, the presence of 
depressive symptoms has been shown to increase the incidence of CVD (Thombs et al., 
2004) as well as morbidity and mortality associated with CVD (Stewart, et al., 2003).   
 The PHQ-8 was administered and scored without any changes to either the 
contents or format. Participants were able to complete this instrument without 
explanation or assistance. The instrument was scored without any difficulty.  The sample 
generally reported low to mild levels of depression (mean= 3.27 + 3.1) with more than 
70% of the sample reporting no depression and 21% reporting mild depression. The mean 
score is comparable to a study by Pressler et al. (2010) who reported a score of: mean= 
2.6 (+ 3.0) in 63 healthy persons, mean= 3.7 (+ 3.4) in 102 medical patients, and 
126 
mean=6.5 (+ 5.5) in 249 patients with heart failure. So, while this sample fell between the 
healthy person and medical patients, keep in mind that scores below 5 indicate no 
depression. In addition to this comparison, it is noteworthy to highlight that scores on the 
PHQ-8 in this study were significantly correlated with risk perception. This will be 
further discussed in the following section.  
Analysis of the Relationship between Predictor Variables and Risk Perception 
 It should be noted that although there were some significant correlations, none of 
them were particularly strong. In fact, they were all < .334. Despite this fact, there are 
several interesting relationships to discuss. For example, women had higher life 
satisfaction scores (r = -.196, p< .05). As previously discussed above those with increased 
levels of optimism also had higher life satisfaction scores (r = .256, p<.01). In addition, 
one unexpected finding was that optimism was not correlated with depression since this 
finding has been reported in previous studies (Giltay, Zitman, & Kromhout, 2006; Chang, 
Wang, Li, and Liu, 2010; Weber, Puskar, & Ren, 2010). Scheier et al. (2006) in an article 
describing the LET instrument stated “It is our belief that purpose in life represents an 
important but overlooked psychosocial predictor of health outcomes” (p. 291). In the 
construction of this instrument, Scheier and colleagues found that depression and LET 
scores were inversely correlated to depression in six separate samples including 
undergraduate students, community based samples of women, female osteoarthritis 
patients and their spouses, and women with various stages of breast cancer. However, the 
CES-D was used to operationalize the construct of depression.  
 One of the most surprising findings in this study was that although there is much 
written about optimism and positive health outcomes, it was not found to correlate with 
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risk perception as expected.  Those with higher levels of education reported higher levels 
of optimism (r= .187, p<.05) which has also been noted in previous studies (Robb, 
Simon, & Wardle, 2009).  In addition, those reporting higher levels of optimism also 
report lower depression levels (r = - .188, p<.05). This finding not only appears as a 
logical conclusion, but it supported by empirical findings as discussed in the above 
sections on optimism and depression. 
 An expected finding was that increased levels of reported depression was also 
correlated with increased risk perception (r = .334, p< .01). Since depression has been 
established as a risk factor for CVD (Baune, Stuart, Gilmour, Wersching, Arolt, & 
Berger, 2012; Grenon, Hiramoto, Smoderen, Vittinghoff, Whooley & Cohen, 2012), it is 
important that persons suffering from depressive symptoms recognize that they are at risk 
for CVD.  
 One of the objectives of this study was to examine the variables thought to 
contribute to the formation of risk. Unfortunately, results from this study did not meet 
this objective. Multiple regression analysis showed that depression was the only variable 
found to be a significant predictor of risk perception (β = .278, p = .003). Perhaps the 
absence of optimism is not as powerful as the presence of depressive symptoms. Perhaps 
there are other sociodemographic and psychological variables that will provide more 
insight into this puzzle. So, while this study did not shed light in this area, it provides this 
researcher, as well as others the opportunity to examine other variables in the quest for a 
more viable model attempting to explain the perception of risk. Clearly, more research 
needs to be conducted in this area to understand how risk perception is formed.  
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Summary of Aim 2 
 The majority of the sample exhibited moderate levels of optimism, high levels of 
life satisfaction, and low levels of depression. In addition, while there were some 
interesting relationships found between variables, the relationships were weak at best. 
Lastly, depression was the sole predictor in the model examining factors that contributing 
to the formation of risk perception, accounting for a modest 11.3% of the model.  Clearly, 
further exploration is needed to identify other variables that may contribute to the 
formation of risk perception.  
Study Limitations 
The limitations of any study are based on study design as well as threats to internal 
and external validity. A descriptive correlational design cannot establish causation 
between variables. Despite this fact, this study was able to highlight some of the 
relationships that exist between risk perception and several demographic and 
psychological variables. Thus, this study provides a solid foundation on which to build 
further studies in the area of risk perception. In addition, since this was a cohort study, 
data for risk perception was only collected at the time of screening prior to participants 
truly knowing their calculated risk. Therefore, this study cannot establish if or how much 
CRIP scores would change if individuals knew the results of their tests. Furthermore, the 
use of survey instruments limits the researcher’s ability to gain insight into how persons 
express their personal risk.  
There were threats to both internal and external validity identified in this study. The 
use of a convenience sample contributes to participant selection bias and limits 
generalizability of the results. Self-selection bias was also evident in the study. Although 
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many of the participants were referred by their primary care providers for screening as a 
cost-effective way to have lab work completed, the vast majority of the sample was self-
selected and therefore, may represent “the walking well” or those who are at least more 
conscious about their health status. In addition, the sample was primarily women 
potentially contributing to gender bias in the results. The current sample was also well-
educated, presently employed either part- or full-time, had health insurance and the 
majority were “at goal” for major risk factors, except for weight and physical activity. 
Exclusion criteria also limit applicability of the results. This study excluded those with 
established heart disease or diagnosed depression as well as those younger than 40 years. 
Therefore, results from the study can only be applied to similar groups.  
While the instruments selected for this study had acceptable reported reliability and 
validity statistics, the information was self-reported which also introduces bias and limits 
generalizability of the findings. The CRIP and the LET are relatively new instruments. 
While both exhibit strong validity, there are fewer published studies and thus less 
normative data available for comparison. The same can be said for the HHS scores as 
Wellsource© has not published normative data, despite using current guidelines 
established for risk factor data as well as collecting health screening data for so many 
years.  
Summary of Major Findings 
 Study participants had a mean age of 58 years, 69% were female, 70% were 
White Caucasian (non-Hispanic), and were predominantly married, well-educated, 
employed, and had private insurance. Overall the sample recognized heart disease as the 
leading cause of death for men and women and could identify the key prevention steps to 
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reduce personal risk. While physiological measurements obtained during the screenings 
also revealed a relatively healthy group, with the majority of participants at goal for 
glucose, LDL-C, HDL-C and triglyceride levels, the majority of participants were either 
overweight or obese and reported being physically inactive. Overall, 80% had 2 or more 
self-reported risk factors, and 43% had three or more. 
The prevalence of risk factors (self-reported) was significantly correlated with 
higher levels of risk perception as measured by the CRIP (r=.44, p < .01). HHS scores 
showed that more than 55% of the participants were categorized as either “Needs 
Improving” or “High Risk”, indicating the presence of multiple risk factors. HHS scores 
were also statistically correlated with risk perception (r=.40, p < .01). In addition, chi 
square analysis showed a significant relationship between increased risk (using HHS) and 
increased risk perception scores (using CRIP). Framingham Risk Scores, a measure of 
projected future cardiac risk, were not correlated with current risk perception. 
The majority of the sample had increased levels of optimism and life satisfaction 
and low levels of depression.  While three variables (having a friend with CVD, 
optimism, and depression) were correlated with risk perception, depression was found to 
be the single predictor of risk perception when entered into multiple regression analysis 
(β = .278, p = .003). 
Implications for Providers 
 The sample in this study was knowledgeable about both CVD and risk factors. In 
addition, those with risk factors had an accurate perception of their risk. This knowledge 
may be related to their familiarity and participation in other wellness programs within 
this community hospital system.  Hospital administrators should be encouraged to 
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continue with these successful primary prevention efforts. Perhaps ‘having a friend with 
CVD” also helped raise their awareness. It may be useful for health care providers to 
explore such personal experiences with their patients as this may enhance attention to risk 
factor reduction.   
 The majority of the sample was “at goal” for most of the major risk factors with the 
exception of weight and physical activity. Those with lipid disorders and hypertension 
may be motivated to stay at goal, are compliant with their prescribed treatment regimes, 
and use the community screening opportunities to “check their status”. This provides an 
excellent opportunity for health care providers to reinforce participants’ efforts as a way 
to foster ongoing compliance.      
 It is possible that the group is “a work in progress” with regards to their weight and 
that while they are still categorized as either overweight or obese, they are attempting to 
address this risk factor.  The lack of physical activity is of concern, however, since the 
majority of the group is either employed full or part-time and may not have made 
physical activity a priority, especially if they are otherwise doing well. While persons 
may understand that there are consequences to their health behaviors it is possible that 
they are not inclined to exercise or lose weight since subclinical atherosclerosis goes 
unnoticed. Thus health care providers should continue to use every opportunity, 
especially as related to community screenings, to counsel participants on effective 
methods for promoting physical activity and weight loss.  
 More than 80% of the sample reported having seen, read, or heard about CVD in 
the last 12 months, while only 35% reported having had a discussion about CVD in the 
last year. It is noteworthy that the general public is gaining more awareness and 
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knowledge about heart disease and the effects it has on health and well-being. However, 
this sample has shown that they are getting most of the information from mass media and 
not from health care providers. In addition, they have shown that they worry about heart 
disease, especially those that have risk factors.  While it is positive that media campaigns 
are increasing health literacy, it is also very important that health care providers be more 
proactive about discussing heart disease with their patients.    They need to take 
advantage of teachable moments when persons present with risk factors, and take every 
opportunity when reviewing results from routine lab work or from health screening 
events to reinforce that patients can reduce their risk of heart disease. 
 Depression needs to become more of a focus during screening events. Depression 
was the single predictor of risk perception in this study.  In recent years, research has 
highlighted the relationship between depression and CVD and the need for depression 
screening. However, screening is only recommended for those who have been diagnosed 
with CVD (Lichtman et al., 2008) and not for the general public. It makes sense that if we 
believe that there is a relationship between depression and CVD, that screening should be 
part of primary prevention efforts and treated as a modifiable risk factor.  
 Lastly, there was a disparity in how the sample viewed smoking. While greater than 
90% identified “quitting smoking” as an activity they believed could prevent or reduce 
the risk of getting heart disease, only 28% of the sample identified it as a major cause or 
risk factor for heart disease. This was a surprise since this sample was well educated. It is 
therefore very important for providers to make sure that discussions about smoking be 
included in health teaching.  
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Implications for Future Research 
 In order to learn more about risk perception in cardiovascular disease, more studies 
need to examine risk perception and must be designed so that the construct of risk 
perception is being measured. As demonstrated in the review of the literature, the term 
risk perception is often used when risk knowledge is being measured. Moreover, other 
instruments such as the LOT and LOT-r have been used to operationalize risk perception 
rather than the optimism and life satisfaction that they were designed to measure. 
Furthermore, studies should use validated instruments such as the CRIP to measure risk 
perception as opposed to one or two question items. Lastly, qualitative studies in this area 
may help to elucidate how persons think about their risk for CVD, thus providing more 
insight into formation of risk. Since depression was the only variable that contributed to 
risk perception in this study, it is important to plan further studies to examine different 
variables and constructs that may contribute to the formation of risk which may lead to 
more effective education measures and tailored interventions.    
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Author Type of Risk Number of Items/Type of Measure 
Effect 
Size 
(g) 
Variable 
Cole et al. Comparative 1/Verbal 0.36 Mammography 
Donovan & 
Tucker Comparative 1/Verbal or Numerical 
0.32 
0.75 
Race/culture 
Family History 
Facione et al. Comparative 1/Verbal 1.20 Optimistic bias 
Hughes et al. Comparative 1/Verbal 
0.51 
0.31 
0.28 
0.98 
Mammography 
Age 
Education 
Worry 
McDonald et al. Comparative 1/Verbal 1.65 Optimistic bias 
Bowen et al. Subjective 1/Numerical 0.29 Family history 
Clark et al. Subjective 1/Numerical 5.08 Optimistic bias 
Daly et al. Subjective 1/Numerical 2.07 
0.35 
Optimistic Bias 
Race/culture 
Dolan et al. Subjective 1/Numerical 0.34 Optimistic bias 
Erlich et al. Subjective 1/Numerical 0.57 Family History 
Jacobsen et al. Subjective 1/Numerical 0.51 Genetic Testing 
Lindberg & 
Wellisch Subjective 1/Numerical 
0.59 
0.49 
Mammography 
Breast self-exam 
Meiser et al. Subjective 1/Numerical 
0.53 
0.35 
0.15 
Optimistic bias 
Age 
Education 
Metcalf & Narod Subjective 1/Numerical 
0.88 
1.73 
Optimistic bias 
Prophylactic 
Mastectomy 
Schwartz et al. Subjective 1/Numerical 0.48 Mammography 
Stefanek et al. Subjective 1/Numerical 0.71 
Prophylactic 
Mastectomy 
Audrain et al. Subjective 1/Verbal 
0.31 
0.69 
0.27 
Education 
Race/culture 
Mammography 
Culver et al. Subjective 1/Verbal 0.40 Genetic testing 
Diefenbach et al. Subjective 1/Verbal 0.13 Mammography 
Foxall et al. Subjective 1/Verbal 
0.12 
0.52 
Race/culture 
Mammography 
Lipkus et al. Subjective 1/Verbal 
0.75 
1.25 
0.41 
Family History 
Worry 
Perceived control 
Vernon et al. Subjective 1/Verbal 
1.23 
0.12 
0.12 
0.25 
0.24 
0.05 
Family History 
Race/culture 
Age 
Breast symptom 
Mammography 
Breast self-exam 
Absetz et al. Subjective 2/Verbal 0.48 Optimistic bias 
Andrykowski  et Comparative & 2/Numerical 0.59 Mammography 
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al. Subjective 
McCaul et al. Comparative & 
Subjective 
2/Numerical 0.47 Worry 
Aiken et al. Comparative & 
Subjective 
2/Verbal 
0.45 
0.56 
0.45 
0.79 
Optimistic bias 
Family history 
Breast symptoms 
Breast self exam 
Brain et al. Comparative & 
Subjective 
2/Verbal 
0.26 
0.69 
0.19 
0.07 
Age 
Worry 
Breast self exam 
Mammography 
Clemow et al. Comparative & 
Subjective 
2/Verbal 0.13 Mammography 
Evans et al. Comparative & 
Subjective 
2/Verbal 0.35 Optimistic bias 
Foster et al. Comparative & 
Subjective 
2/Verbal 2.17 Optimistic bias 
Mouchawar et al. 
Comparative & 
Subjective 
2/Numerical & Verbal 0.79 Family history 
Polednak et al. Comparative & 
Subjective 
2/Numerical & Verbal 0.72 Family history 
Finney & Iannotti 
et al. Subjective 3/Verbal 0.91 Family history 
Lipkus et al. Comparative & 
Subjective 
3/Numerical & Verbal 
0.74 
0.67 
Optimistic bias 
Worry 
Drossaert et al. Comparative & 
Subjective 
4/Numerical & Verbal 
0.38 
0.18 
0.32 
0.18 
Family history 
Age 
Anxiety 
Mammography 
Lipkus et al. Comparative & 
Subjective 
4/Numerical & Verbal 0.22 Breast symptoms 
Hatcher et al. Comparative & 
Subjective 
5/Numerical & Verbal 0.25 
Prophylactic 
mastectomy 
 
Black et al. 
 
Comparative & 
Subjective 
8/Quantitative & 
probability estimates 
0.57 Education 
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Please be as honest and accurate as you can throughout.  Try not to let your response to 
one statement influence your responses to other statements.  There are no "correct" or 
"incorrect" answers.  Answer according to your own feelings, rather than how you think 
"most people" would answer.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I disagree a little  
E = I disagree a lot 
1.  In uncertain times, I usually expect the best.  
2.  It's easy for me to relax. 
3.  If something can go wrong for me, it will.  
4.  I'm always optimistic about my future.  
5.  I enjoy my friends a lot.  
6.  It's important for me to keep busy.  
7.  I hardly ever expect things to go my way.  
8.  I don't get upset too easily.  
9.  I rarely count on good things happening to me.  
10.  Overall, I expect more good things to happen to me than bad.  
------------------------------------------------------------------------  
Note:  
Items 2, 5, 6, and 8 are fillers.   Responses to "scored" items are to be coded so that high 
values imply optimism.  Researchers who are interested in testing the potential difference 
between affirmation of optimism and disaffirmation of pessimism should compute 
separate subtotals of the relevant items.  
http://www.psy.miami.edu/faculty/ccarver/sclLOT-R.html 
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Study Title:  Risk Perception in Heart Disease 
Principal Investigator: Michelle Block 
Phone Number: 219-989-2847 
 
INTRODUCTION:  
 
You are being asked to take part in a research study because you are over 40 years of age and 
want to take part in a Coronary Health Appraisal at one of the hospitals in The Community 
Healthcare System. You will not be able to participate if you have been diagnosed with 
depression, have experienced a heart attack or a heart intervention, such as an angioplasty, stent, 
or heart bypass surgery. 
 
This study is being conducted by Michelle Block, Assistant Professor of Nursing, Purdue 
University Calumet, as part of a PhD dissertation at Loyola University Chicago.  
 
Please read this form carefully and ask any questions you have before deciding if you want to 
take part in this study.  
 
WHY IS THIS STUDY BEING DONE? 
 
The purpose of this study is to look at how people perceive (look at) their risk for getting heart 
disease and to see if people can tell their own risk for developing heart disease.  
 
HOW MANY PEOPLE WILL TAKE PART IN THE STUDY? 
 
Approximately 120 people (participants) will be a part of this study. The participants will have all 
taken part in a Coronary Health Risk Appraisal screening at one of the hospitals in the 
Community Healthcare System. 
 
WHAT IS INVOLVED IN THE STUDY? 
 
If you agree to be in this study, you will be asked to: 
• Complete a booklet of questions about your personal background, risk perception for 
cardiovascular disease, your outlook on life, your satisfaction about life issues, and how 
you have felt over the last few weeks.  
• Give permission to share the answers you provided for the Coronary Health Appraisal 
and the results of the laboratory work that is part of the appraisal. This information will 
be used to calculate your chance of getting heart disease.  
 
 
 
                 
Version/Date:              
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HOW LONG WILL I BE IN THE STUDY? 
 
Participation in this study will take approximately 20 minutes and is voluntary. If you do not want 
to be in this study, you do not have to participate. Even if you agree to participate in this study, 
you do not have to answer any question if it makes you uncomfortable or you may withdraw at 
any time without penalty.  
 
WHAT ARE THE RISKS OF THE STUDY? 
 
There is minimal risk in participating in this study. It is possible that thinking about your health 
and risk for heart disease will be upsetting. 
 
ARE THERE ANY BENEFITS TO TAKING PART IN THE STUDY? 
 
You may benefit from participating in this research because it may help you to understand your 
views and risk for developing heart disease. Your participation in this study may help health 
professionals understand the factors that play a part in the formation of risk perception. This 
understanding may lead to new approaches in the prevention of heart disease. 
 
CONFIDENTIALITY:  
 
If you are eligible to take part in this study, you will be assigned a participant number. The data 
collected will be identified using this number and your name will be removed from all collected 
information. Records will be stored in a locked cabinet and the computer used to enter data will 
be password secured.  Study information including your original records, research/clinic/hospital 
records may be reviewed by representatives of the Institutional Review Board (CHS CIRB), the 
board charged with the protection of human subjects involved in research at The Community 
Healthcare System.  
 
Because these parties may inspect your study records, absolute confidentiality cannot be 
guaranteed.  Results from this study may be published for scientific purposes, but your name will 
remain confidential. Study records will be kept confidential to the extent provided by law.  The 
name of individual subjects or other identifying information will not be used in any publications 
of this study. 
 
WHAT ARE THE COSTS? 
 
 
There is no cost to participate in this study. In appreciation for taking time to participate and once 
the study question booklet is completed, you will be given a $10.00 Meijer gift card.  
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FINANCIAL DISCLOSURE   
 
Michelle Block, the principal investigator, will not be receiving funds from outside companies to 
defray the costs to conduct this research study.   
 
WHAT ARE MY RIGHTS AS A PARTICIPANT? 
 
For questions about your rights as a research participant, contact the Community Healthcare 
System Central Institutional Review Board (which is a group of people who review the research 
to protect your rights) or the Human Protections Administrator (the patient advocate) at 219-836-
6862.  
 
Taking part in this study is voluntary.  You may choose not to take part or may leave the study at 
any time.  Leaving the study will not result in any penalty or loss of benefits to which you are 
entitled.  No matter what decision you make, leaving the study will not affect your medical care.  
 
WHOM DO I CALL IF I HAVE QUESTIONS OR PROBLEMS?  
WHERE CAN I GET MORE INFORMATION? 
 
You will get a copy of this form.  You may also request a copy of the protocol (full study plan).  
Michelle Block is available to answer any questions you have. She can be reached at 219-989-
2847.   
 
Patient Statement 
My signature on this consent form means the following: 
• The study has been fully explained to me and all of my questions have been answered.  
• I understand that I may ask questions at any time during the study by contacting                                 
Michelle Block at 219-989-2847. 
• I understand what will be required of me to participate in this study.  
• I understand that I may withdraw my consent at any time during the study. 
• I agree to take part in this study.   
 
 
___________________________________    ________________________ 
Participant’s Signature      Date  
 
___________________________________ 
Participant’s Printed Name 
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Statement of Investigator Obtaining Informed Consent 
I have fully explained the details of this study to my patient.  In my judgment, there was sufficient 
access to information, including risks and benefits, to make an informed consent.     
 
___________________________________   ________________________ 
Investigator Signature      Date 
 
___________________________________  
Investigator Printed Name 
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HIPAA Authorization 
 
The Community Hospital and its representatives are committed to protecting your health 
information.  Protected health information is information in any form relating to the 
health care provided to you.  By signing this form, you agree to permit the Community 
Hospital staff, and any member of the Community Hospital clinical research team to 
retrieve, use and disclose your health care information. 
 
Your health care information will include any records that are retrieved and created 
during the extent of the research study in which you are participating in.  The documents 
include but are not limited to: 
 
• past, present and future health information in your medical records relevant to the 
research 
• medical records from my primary care and consulting physicians relating to 
participation in research 
• data created and recorded specifically for the research study 
 
The Community Hospital, its staff, the sponsors of the research and their contractors will 
do everything possible to ensure the privacy of your personal health information.  Any 
publications related to the research study will not contain any identifying information 
about you. 
 
Participant Authorization Statement: 
 
To the extent permitted by the applicable laws and regulations, I give my permission to 
release my personal health information to the following entities: 
 
• Michelle Block, the principal investigator and  her dissertation committee at 
Loyola University Chicago 
• Members, consultants and staff of the Community Healthcare System Central 
Institutional Review Board 
• Members, consultants and staff of Loyola University Chicago Institutional 
Review Board  
• Community Hospital billing and quality assurance personnel 
• Joint Commission of Accreditation of Health Care Organizations 
• The Food and Drug Administration 
• Other regulatory authorities to whom this research may be submitted 
 
The researchers, Community Hospital staff, sponsor and other agents, may use and share 
my personal health information among themselves in order to conduct the  
 
research.  My health information may be used for verification of research procedures and 
data. 
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I understand that once my personal health information is disclosed to a third party, 
federal privacy laws may no longer protect the information from further disclosure. 
 
I know that I do not have to sign this authorization; however, I have been told that if I do 
not sign this authorization, I may not be able to participate in this research study. 
 
I may revoke my authorization at any time and for whatever reason.  I will be asked to 
revoke this authorization in writing to the Principal investigator at: 
 
    Michelle Block, MS, RN 
                                        c/o Meg Gulanick, PhD, RN 
              Loyola University Medical Center 
                                                    Bldg 105 Room 2840 
2160 South First Avenue 
Maywood, Illinois 60153 
 
I realize that if I revoke this authorization, I will not be allowed to continue participation 
in the research study.  I also am aware that the researchers and sponsor and their agents 
may continue to use and disclose any information that they have retrieved prior to my 
revoking the authorization. 
 
I understand that while the research is being conducted, I will not be able to access or see 
my health information that was collected or created for the purposes of this research 
study because it may affect the integrity of the research.  I, however, may access this 
information after the completion of the research study.   
 
Who to contact if you have any questions about confidentiality: 
If at any time before, during and after the study, you have questions about the use or 
disclosure of your study related information, you may contact the following person (s): 
 
   Community Healthcare System 
Privacy Officer 
   219-836-3620 
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I give my authorization with no ending date, however, I understand that I may revoke this 
authorization at any time. 
 
I will be given a copy of this authorization. 
 
 
             
Participant Signature      Date and Time 
 
 
       
Printed Name of Participant 
 
 
             
Legally Authorized Representative     Date and Time 
(If applicable) 
 
 
        
Printed Name of Legally Authorized Representative 
 
 
        
Relationship of Authorized Representative to Participant 
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Tell me how much you disagree or agree with each statement.  
                                   
 Strongly 
Disagree 
n/% 
Disagree 
n/% 
Somewhat 
Disagree 
n/% 
Somewhat  
Agree 
n/% 
Agree 
n/% 
Strongly 
Agree 
n/% 
 1 2 3 4 5 6 
1. I’m as healthy as anybody I 
know.                            
      
2. Compared to others my age 
and sex, I am at lower risk of a 
stroke. 
      
3. I am at low-risk of a heart 
attack. 
      
4. In general, my health is 
very good. 
      
5. Following a low-fat diet 
takes too much effort. 
      
6. Compared to a year ago, my 
health is better now. 
      
7. I worry that I might die 
from a heart attack. 
      
8. I’m at low risk of having a 
stroke. 
      
9. Compared to others my age 
and sex, I am at lower risk of a 
heart attack.  
      
10. Compared to others my 
age and sex, I am in good 
health. 
      
11. I worry about having a 
heart attack. 
      
12. I worry that I might die 
from a stroke.  
      
13. I think my personal efforts 
will help control my risk of 
having a heart attack. 
      
14. I worry more about having 
a heart attack than a stroke. 
      
15. I don’t mind the effort it 
takes to exercise. 
      
16. I have a low lifetime risk 
of a heart attack.  
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Thank you for taking part in this research study:  Risk Perception in Heart Disease. 
 
 
 
 
 
The question booklet is made up of 6 sections.  Feel free to ask the researcher if you have any 
questions while you are filling out the booklet. 
 
 
 
 
 
 
 
 
Let’s get started………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please place an “X” next to the answer(s) you choose 
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1. What do you think is the one greatest problem today? (Choose only one) 
 
  AIDS     Heart Disease/Heart Attach 
  Alzheimer’s     Lung Cancer 
  Breast Cancer    Obesity 
  Cancer (general)    Osteoporosis 
  Diabetes     Smoking 
  Drug Addiction/Alcoholism   Stroke 
 
2. As far as you know, what is the leading cause of death for men?  (Choose only one) 
 
  AIDS     Heart Disease/Heart Attack 
  Alzheimer’s     Lung Cancer 
  Breast Cancer    Obesity 
  Cancer (general)    Osteoporosis 
  Diabetes     Smoking 
  Drug Addiction/Alcoholism   Stroke 
 
3. As far as you know, what is the leading cause of death for women?  (Choose only one) 
 
  AIDS     Heart Disease/Heart Attack 
  Alzheimer’s     Lung Cancer 
  Breast Cancer    Obesity 
  Cancer (general)    Osteoporosis 
  Diabetes     Smoking 
  Drug Addiction/Alcoholism   Stroke 
 
4. Using the following scale, how much do you worry about getting each of the 
    following health conditions?   
 
 Worry a Lot 
 
(1) 
Worry a Little 
 
(2) 
Do not worry 
At all 
(3) 
Don’t know 
 
(4) 
Cancer (in general)     
Heart Disease or 
Heart Attack 
    
AIDS     
Breast Cancer     
Lung Cancer     
Drug 
Addiction/Alcoholism 
    
Violent Crime     
Stroke     
Alzheimer’s Disease     
Diabetes     
Osteoporosis     
Obesity     
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5. Have you seen, heard, or read information about heart disease within the past 12  
     months? 
 
  Yes 
   No 
   Don’t Know 
 
6. If you answered YES to Question 5, where did you see, hear, or read this 
    information?  (Choose ALL that apply) 
 
  In a magazine    On the radio 
  In a book     On TV 
  Information in a brochure   Library 
  In a newspaper    On the internet 
  Provided by physician, nurse, or other healthcare provider 
  From a friend or relative 
  Other:  Please be specific: 
 
7. Have any of your doctors ever discussed heart disease with you when discussing  
    your health? 
 
  YES 
   NO 
 
8. How informed are you about heart disease? 
 
Very well informed 
 Well informed 
 Moderately informed 
Not at all informed 
  Don't know 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For questions 9, 10 and 11, indicate if you:  “strongly agree”, “somewhat agree”, 
“somewhat disagree”, “strongly disagree”, or “don’t know” 
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 Strongly 
Agree 
1 
Somewhat 
Agree 
2 
Somewhat 
Disagree 
3 
Strongly 
Disagree 
4 
Don’t 
Know 
5 
9.  When you think about heart 
disease, you most often think of 
someone having a heart attack and 
dying quickly. 
     
10.  There is nothing you can do to 
prevent yourself from getting heart 
disease. 
     
11.  You are comfortable talking 
with your doctor about preventive 
and treatment options regarding 
your health. 
     
 
12. Based on what you know, what are the major causes of heart disease?  (Choose all 
      that apply) 
 
  A family history of heart disease   Aging 
  Being overweight     Diabetes 
  Drinking alcohol     High Blood Pressure 
  High Cholesterol     High Triglycerides 
  Low levels of estrogen    Menopause 
  Not exercising     Smoking 
  Stress      Your racial Heritage 
  Don’t know 
  Other, please specify: _____________________________________________ 
 __________________________________________________________________ 
 __________________________________________________________________ 
  
13. Which of the following activities do you believe can prevent or reduce the risk of  
       getting heart disease?  (Choose all that apply) 
 
  Quitting smoking    Getting physical exercise 
  Losing weight    Reducing dietary cholesterol intake 
  Reducing stress    Maintaining a healthy blood pressure 
  Taking multivitamins with folic  Reducing dietary sodium or sale 
      Acid     Maintaining a healthy cholesterol level 
  Taking aspirin regularly (daily)  Taking special vitamins like C, D & E 
  Taking hormone replacement therapy (for women) 
  Reducing animal products in your diet such as meats, whole milk, butter and 
          Cream 
  Aromatherapy (the practice of using natural plant oils, such as lavender or 
      Lemongrass, for psychological and physical well-being) 
 
 
For questions 14 through 25, indicate if you:  “strongly agree”, “somewhat agree”,  
“somewhat disagree”, “strongly disagree”, or “not sure”. 
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 Strongly 
Agree 
1 
Somewhat 
Agree 
2 
Somewhat 
Disagree 
3 
Strongly 
Disagree 
4 
Not  
Sure 
5 
      
14.  You know how much exercise 
you need to prevent heart disease. 
     
15.  You know what type of diet is 
best to protect your heart. 
     
16.  You know how to stop 
smoking. 
     
17.  You know how to control your 
cholesterol. 
     
18.  You know how to control your 
blood pressure. 
     
19.  You know how to control your 
weight. 
     
20.  You know if fish oils are 
recommended to prevent heart 
disease. 
     
21.  You know if you should take 
aspirin routinely 
     
22.  You know if you should take 
antioxidant vitamin supplements to 
prevent heart disease. 
     
23.  You know how depression 
affects your heart. 
     
24.  You know how stress affects 
your heart. 
     
25.  You know how to take the 
medications prescribed to you. 
     
 
 
 
 
 
 
 
 
YOU HAVE COMPLETED THE FIRST SECTION……..Please continue to the next section. 
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Section 2: This section asks a few questions about you.  This information is for research purposes 
only.  No one will be able to identify you based on your answers to these questions.  Everything 
is kept confidential. 
 
1. What is your age?  __________ 
 
2. Gender:      Male  Female 
 
3. What is your occupation:  ___________________________________________ 
 
4. Are you currently? 
  
  Employed (full or part-time) 
  Retired 
  Homemaker, raising children, caretaker for others 
  Disabled, unable to work 
  Other, please specify: ________________________________________ 
 
5. How worried are you about your employment status at this time? 
 
  Worried a lot  Worried a little  Not worried at all 
 
6. What is your health insurance now?  (Mark all that apply) 
 
  Pre-paid private insurance (for example: HMO, HIP, etc.) 
  Other private insurance (for example:  Blue Cross, Aetna, etc.) 
  Medicaid or Public Assistance (for example:  DPA or ADCC) 
  Medicare 
  No Insurance 
  Other, Please specify:  ________________________________________ 
 
7. What is your marital status? 
 
  Married    Living in a marriage-like relationship 
  Divorced or separated  Widow/Widower 
  Never married   Other, please specify:_________________   
        
8. How would you describe your race/ethnicity?  Are you? 
 
  Hispanic/Latino culture 
  Black/African American (non-Hispanic) 
  Causasian/White (non-Hispanic) 
  Asian/Pacific Islander 
  Other, please specify: ___________________________________ 
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9. What is the highest grade or year in school that you completed?  If less than a high 
     school diploma, fill in two digits to indicate the last grade completed (e.g. 07 for 
     7th grade). 
 
  ___grade 
  High school diploma or GED 
  No formal schooling 
  Vocational school, some college or Associate degree 
  College graduate/degree or higher 
  Other, please specify:  ______________________________________ 
 
10. Household Income:  What is the total annual income before taxes of everyone 
      living in the household? 
 
  Under $20,000 a year 
  $20,000 to less than $35,000 
  $35,000 to less than $50,000 
  $50,000 to less than $75,000 
  $75,000 to less than $100,000 
  $100,000 to less than $150,000 
  $150,000 to less than $200,000 
  $200,000 or more a year 
 
11. Activity Level:  Aerobic exercise means activities that are continued for a least 
      20 minutes at a time and that raise the heart rate.  This can include things like 
      jogging, walking, riding a bike, and raking leaves.  How much aerobic activity are 
      you doing? 
 
  Less that 20-30 minutes at a time, 5 days per week or less 
      (Less than 150 minutes per week) 
  20-30 minutes of aerobic activity, 5 days per week 
       (150 minutes per week) 
  More than 20-30 minutes, 5 or more days per week or more 
      (Greater than 150 minutes per week) 
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Personal and Family History:  Do you or any of your blood relatives have any of 
     of the following: 
Has a healthcare provider (or doctor) said that YOU have or ever 
had… 
 
12. High Blood Pressure 
 
_____Yes          _____No                   
13. Diabetes (sugar) in your blood _____Yes          _____No 
 
14. Congestive Heart Failure _____Yes          _____No 
 
15. Angina (Chest pain with exertion) _____Yes          _____No 
 
16. Stroke _____Yes          _____No 
 
17. Trans-ischemic attacks (TIAs or mini-strokes) _____Yes          _____No 
 
18. Peripheral Artery Disease (Blockage in the legs) _____Yes          _____No 
 
19. Depression _____Yes          _____No 
 
 
Now we want to know about your family history….. 
Have any of the following relatives had… Who? 
20. High Blood Pressure… if YES, then who? _____Father 
_____Mother 
_____Brother or Sister 
21. Diabetes (sugar in the blood)…if YES, then who? _____Father 
_____Mother 
_____Brother or Sister 
22. Congestive heart failure…if YES, then who? _____Father 
_____Mother 
_____Brother or Sister 
23: Angina (chest paid with exertion)…if YES, then who? _____Father 
_____Mother 
_____Brother or Sister 
24.  Stroke…if YES, then who? 
 
_____Father 
_____Mother 
_____Brother or Sister 
25. Transischemic attacks (TIAs or ministrokes)… 
       if YES, then who? 
_____Father 
_____Mother 
_____Brother or Sister 
26. Peripheral Artery Disease (Blockage in the legs)…if 
      YES, then who? 
_____Father 
_____Mother 
_____Brother or Sister 
27. Depression…if YES, then who? _____Father 
_____Mother 
_____Brother or Sister 
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Health Treatment: 
 
28. How often do you see your primary care provider? 
  
  Every year   When I have a health concern 
 
29.  How often do you visit your dentist? 
 
  Every 6 months  Every year   When I have a dental problem 
 
30.  Do you receive a flu vaccine every year? 
 
  Always   Sometimes   Never 
 
31.  Do you know anyone living with heart disease?  Yes   No 
       If so, are they a:  friend  relative 
 
32.  When was the last time you had the following checked: 
        
        Blood Pressure__________________________  I am unsure 
        Lipid Levels (Cholesterol)_________________  I am unsure 
        Blood Sugar____________________________  I am unsure 
 
 
Please list any additional health problems. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Current Medications. Please list all medications you are currently taking. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
YOU are Doing Great! 
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Instructions and Items: 
Please answer the following questions about yourself by indicating the extent of your 
agreement using the following scale: 
 
    (1) = strongly disagree 
    (2) = disagree 
    (3) = neutral 
    (4) = agree 
    (5) = strongly agree 
 
Be as honest as you can throughout, and try not to let your response to one question 
influence your response to other questions.  There are no right or wrong answers. 
 
 
 
1.  There is not enough purpose in my life. 
 
2.  To me, the things I do are all worthwhile. 
 
3.  Most of what I do seems trivial and unimportant to me. 
 
4.  I value my activities a lot. 
 
5.  I don’t care very much about the things I do. 
 
6.  I have lots of reasons for living. 
 
 
Scoring: 
 
1.  Reverse code items 1, 3 and 5 prior to scoring. 
 
2.  Sum six items together to obtain an overall score 
 
Citation: Scheier, M. E, Wrosch, C., Baum, A, Cohen, S., Martire, L M., Matthews, 
K. A., Schulz, R., & Zdaniuk, B. (2006). The Life Engagement Test: Assessing 
purpose in life. Joumal ojBehavioral Medicine, 29, 29!-298. 
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 Not At 
All 
 
N (%) 
Several 
Days 
 
N (%) 
More than 
half the 
days 
N (%) 
Nearly 
Every day 
 
N (%) 
Item Response Score 1 2 3 4 
1. Little interest or pleasure in doing 
things. 
    
2. Feeling down, depressed, or 
hopeless. 
 
    
3. Trouble falling or staying asleep, or 
sleeping too much. 
    
4. Feeling tired or having little energy. 
 
    
5. Poor appetite or over-eating. 
 
    
6. Feeling bad about yourself – or that 
you are a failure or have let yourself 
or your family down.  
    
7. Trouble concentrating on things, 
such as reading the newspaper or 
watching TV. 
    
8. Moving or speaking so slowly that 
other people could have noticed?  Or 
the opposite- being so fidgety or 
restless that you have been moving 
around a lot more than usual.  
    
     
 Not at 
all 
difficult 
Somewhat 
difficult 
Very 
Difficult 
Extremely 
difficult 
If you checked off ANY problems, 
how difficult have these problems 
made it for you to do your work, take 
care of things at home or get along 
with other people?  
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  MULTIPLE REGRESSION ANALYSIS STATISTICS 
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ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 2737.786 3 912.595 5.388 .002b 
Residual 18461.683 109 169.373   
Total 21199.469 112    
2 
Regression 2402.688 2 1201.344 7.030 .001c 
Residual 18796.781 110 170.880   
Total 21199.469 112    
a. Dependent Variable: CRIPTOT_RC    b. Predictors: (Constant), PHQtotal, FriendCVD, LETtotal 
c. Predictors: (Constant), PHQtotal, FriendCVD 
 
Coefficientsa 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for 
B 
Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 52.540 10.849  4.843 .000 31.038 74.041      
FriendCVD 4.111 2.588 .144 1.589 .115 -1.018 9.239 .192 .150 .142 .968 1.033 
LETtotal -.505 .359 -.129 -1.407 .162 -1.217 .207 -.202 -.134 -.126 .943 1.060 
PHQtotal 1.132 .406 .255 2.792 .006 .328 1.936 .295 .258 .250 .957 1.045 
2 
(Constant) 38.609 4.448  8.680 .000 29.795 47.424      
FriendCVD 4.632 2.572 .163 1.801 .074 -.466 9.730 .192 .169 .162 .989 1.012 
PHQtotal 1.234 .401 .278 3.078 .003 .439 2.028 .295 .282 .276 .989 1.012 
a. Dependent Variable: CRIPTOT_RC 
 
Regression Analysis Model Summaryc 
Model R R 
Square 
Adjusted 
R 
Square 
Std. Error of 
the Estimate 
Change Statistics Durbin-
Watson R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .359a .129 .105 13.01435 .129 5.388 3 109 .002  
2 .337b .113 .097 13.07210 -.016 1.978 1 109 .162 2.036 
a. Predictors: (Constant), PHQtotal, FriendCVD, LETtotal 
b. Predictors: (Constant), PHQtotal, FriendCVD 
c. Dependent Variable: CRIPTOT_RC 
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